[Congressional Record Volume 168, Number 106 (Wednesday, June 22, 2022)]
[House]
[Pages H5752-H5795]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                              {time}  1400
      RESTORING HOPE FOR MENTAL HEALTH AND WELL-BEING ACT OF 2022

  Mr. PALLONE. Mr. Speaker, pursuant to House Resolution 1191, I call 
up the bill (H.R. 7666) to amend the Public Health Service Act to 
reauthorize certain programs relating to mental health and substance 
use disorders, and for other purposes, and ask for its immediate 
consideration in the House.
  The Clerk read the title of the bill.
  The SPEAKER pro tempore (Mr. Cleaver). Pursuant to House Resolution 
1191, in lieu of the amendment in the nature of a substitute 
recommended by the Committee on Energy and Commerce printed in the 
bill, an amendment in the nature of a substitute consisting of the text 
of Rules Committee print 117-51, modified by the amendment printed in 
part D of House Report 117-381, is adopted and the bill, as amended, is 
considered read.
  The text of the bill, as amended, is as follows:

                               H.R. 7666

       Be it enacted by the Senate and House of Representatives of 
     the United States of America in Congress assembled.

     SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

       (a) Short Title.--This Act may be cited as the ``Restoring 
     Hope for Mental Health and Well-Being Act of 2022''.
       (b) Table of Contents.--The table of contents for this Act 
     is as follows:

Sec. 1. Short title; table of contents.

              TITLE I--MENTAL HEALTH AND CRISIS CARE NEEDS

       Subtitle A--Crisis Care Services and 9-8-8 Implementation

Sec. 101. Behavioral Health Crisis Coordinating Office.
                                                       ================  



Subtitle B--Into the Light for Maternal Mental Health and Substance Use 
                               Disorders

Sec. 111. Screening and treatment for maternal mental health and 
              substance use disorders.
Sec. 112. Maternal mental health hotline.
Sec. 113. Task force on maternal mental health.

   Subtitle C--Reaching Improved Mental Health Outcomes for Patients

Sec. 121. Innovation for mental health.
Sec. 122. Crisis care coordination.
Sec. 123. Treatment of serious mental illness.

                     Subtitle D--Anna Westin Legacy

Sec. 131. Maintaining education and training on eating disorders.

       Subtitle E--Community Mental Health Services Block Grant 
                            Reauthorization

Sec. 141. Reauthorization of block grants for community mental health 
                                                       ================  



           Subtitle F--Peer-Supported Mental Health Services

                                                       ================  



 TITLE II--SUBSTANCE USE DISORDER PREVENTION, TREATMENT, AND RECOVERY 
                                SERVICES

                                                       ================  



        Subtitle A--Native Behavioral Health Access Improvement

Sec. 201. Behavioral health and substance use disorder services for 
              Native Americans.

[[Page H5753]]

     Subtitle B--Summer Barrow Prevention, Treatment, and Recovery

Sec. 211. Grants for the benefit of homeless individuals.
Sec. 212. Priority substance abuse treatment needs of regional and 
              national significance.
Sec. 213. Evidence-based prescription opioid and heroin treatment and 
              interventions demonstration.
Sec. 214. Priority substance use disorder prevention needs of regional 
              and national significance.
Sec. 215.  Sober Truth on Preventing (STOP) Underage Drinking 
              Reauthorization.
Sec. 216. Grants for jail diversion programs.
Sec. 217. Formula grants to States.
Sec. 218. Projects for Assistance in Transition From Homelessness.
Sec. 219. Grants for reducing overdose deaths.
Sec. 220. Opioid overdose reversal medication access and education 
              grant programs.
Sec. 221. State demonstration grants for comprehensive opioid abuse 
              response.
Sec. 222. Emergency department alternatives to opioids.

               Subtitle C--Excellence in Recovery Housing

Sec. 231. Clarifying the role of SAMHSA in promoting the availability 
              of high-quality recovery housing.
Sec. 232. Developing guidelines for States to promote the availability 
              of high-quality recovery housing.
Sec. 233. Coordination of Federal activities to promote the 
              availability of recovery housing.
Sec. 234. NAS study and report.
Sec. 235. Grants for States to promote the availability of recovery 
              housing and services.
Sec. 236. Funding.
                                                       ================  



Subtitle D--Substance Use Prevention, Treatment, and Recovery Services 
                              Block Grant

Sec. 241. Eliminating stigmatizing language relating to substance use.
Sec. 242. Authorized activities.
Sec. 243. Requirements relating to certain infectious diseases and 
              human immunodeficiency virus.
Sec. 244. State plan requirements.
Sec. 245. Updating certain language relating to Tribes.
Sec. 246. Block grants for substance use prevention, treatment, and 
              recovery services.
Sec. 247. Requirement of reports and audits by States.
Sec. 248. Study on assessment for use in distribution of limited State 
              resources.

          Subtitle E--Timely Treatment for Opioid Use Disorder

Sec. 251. Study on exemptions for treatment of opioid use disorder 
              through opioid treatment programs during the COVID-19 
              public health emergency.
                                                       ================  



   Subtitle F--Additional Provisions Relating to Addiction Treatment

Sec. 261. Prohibition.
Sec. 262. Eliminating additional requirements for dispensing narcotic 
              drugs in schedule III, IV, and V for maintenance or 
              detoxification treatment.
Sec. 263. Requiring prescribers of controlled substances to complete 
              training.

          TITLE III--ACCESS TO MENTAL HEALTH CARE AND COVERAGE

       Subtitle A--Collaborate in an Orderly and Cohesive Manner

Sec. 301. Increasing uptake of the collaborative care model.

        Subtitle B--Helping Enable Access to Lifesaving Services

Sec. 311. Reauthorization and provision of certain programs to 
              strengthen the health care workforce.

Subtitle C--Eliminating the Opt-Out for Nonfederal Governmental Health 
                                 Plans

Sec. 321. Eliminating the opt-out for nonfederal governmental health 
              plans.

      Subtitle D--Mental Health and Substance Use Disorder Parity 
                             Implementation

Sec. 331. Grants to support mental health and substance use disorder 
              parity implementation.

                      TITLE IV--CHILDREN AND YOUTH

                                                       ================  



      Subtitle A--Supporting Children's Mental Health Care Access

Sec. 401. Pediatric mental health care access grants.
Sec. 402. Infant and early childhood mental health promotion, 
              intervention, and treatment.

          Subtitle B--Continuing Systems of Care for Children

Sec. 411. Comprehensive Community Mental Health Services for Children 
              with Serious Emotional Disturbances.
Sec. 412. Substance Use Disorder Treatment and Early Intervention 
              Services for Children and Adolescents.

         Subtitle C--Garrett Lee Smith Memorial Reauthorization

Sec. 421. Suicide prevention technical assistance center.
Sec. 422. Youth suicide early intervention and prevention strategies.
Sec. 423. Mental health and substance use disorder services for 
              students in higher education.
Sec. 424. Mental and behavioral health outreach and education at 
              institutions of higher education.

              TITLE I--MENTAL HEALTH AND CRISIS CARE NEEDS

  


       Subtitle A--Crisis Care Services and 9-8-8 Implementation

     SEC. 101. BEHAVIORAL HEALTH CRISIS COORDINATING OFFICE.

       Part A of title V of the Public Health Service Act (42 
     U.S.C. 290aa et seq.) is amended by adding at the end the 
     following:

     ``SEC. 506B. BEHAVIORAL HEALTH CRISIS COORDINATING OFFICE.

       ``(a) In General.--The Secretary shall establish, within 
     the Substance Abuse and Mental Health Services 
     Administration, an office to coordinate work relating to 
     behavioral health crisis care across the operating divisions 
     and agencies of the Department of Health and Human Services, 
     including the Substance Abuse and Mental Health Services 
     Administration, the Centers for Medicare & Medicaid Services, 
     and the Health Resources and Services Administration, and 
     external stakeholders.
       ``(b) Duty.--The office established under subsection (a) 
     shall--
       ``(1) convene Federal, State, Tribal, local, and private 
     partners;
       ``(2) launch and manage Federal workgroups charged with 
     making recommendations regarding behavioral health crisis 
     issues, including with respect to health care best practices, 
     workforce development, mental health disparities, data 
     collection, technology, program oversight, public awareness, 
     and engagement; and
       ``(3) support technical assistance, data analysis, and 
     evaluation functions in order to assist States, localities, 
     Territories, Tribes, and Tribal communities to develop crisis 
     care systems and establish nationwide best practices with the 
     objective of expanding the capacity of, and access to, local 
     crisis call centers, mobile crisis care, crisis 
     stabilization, psychiatric emergency services, and rapid 
     post-crisis follow-up care provided by--
       ``(A) the National Suicide Prevention and Mental Health 
     Crisis Hotline and Response System;
       ``(B) community mental health centers (as defined in 
     section 1861(ff)(3)(B) of the Social Security Act);
       ``(C) certified community behavioral health clinics, as 
     described in section 223 of the Protecting Access to Medicare 
     Act of 2014; and
       ``(D) other community mental health and substance use 
     disorder providers.
       ``(c) Authorization of Appropriations.--There is authorized 
     to be appropriated to carry out this section $5,000,000 for 
     each of fiscal years 2023 through 2027.''.

     SEC. 102. CRISIS RESPONSE CONTINUUM OF CARE.

       Subpart 3 of part B of title V of the Public Health Service 
     Act (42 U.S.C. 290bb-31 et seq.) is amended by adding at the 
     end the following:

     ``SEC. 520N. CRISIS RESPONSE CONTINUUM OF CARE.

       ``(a) In General.--The Secretary shall publish best 
     practices for a crisis response continuum of care for use by 
     health care providers, crisis services administrators, and 
     crisis services providers in responding to individuals 
     (including children and adolescents) experiencing mental 
     health crises, substance-related crises, and crises arising 
     from co-occurring disorders.
       ``(b) Best Practices.--
       ``(1) Scope of best practices.--The best practices 
     published under subsection (a) shall define--
       ``(A) a minimum set of core crisis response services, as 
     determined by the Secretary, for each entity that furnishes 
     such services, that--
       ``(i) do not require prior authorization from an insurance 
     provider or group health plan nor a referral from a health 
     care provider prior to the delivery of services;
       ``(ii) provide for serving all individuals regardless of 
     age or ability to pay;
       ``(iii) provide for operating 24 hours a day, 7 days a 
     week; and
       ``(iv) provide for care and support through resources 
     described in paragraph (2)(A) until the individual has been 
     stabilized or transferred to the next level of crisis care; 
     and
       ``(B) psychiatric stabilization, including the point at 
     which a case may be closed for--
       ``(i) individuals screened over the phone; and
       ``(ii) individuals stabilized on the scene by mobile teams.
       ``(2) Identification of essential functions.--The best 
     practices published under subsection (a) shall identify the 
     essential functions of each service in the crisis response 
     continuum, which shall include at least the following:
       ``(A) Identification of resources for referral and 
     enrollment in continuing mental health, substance use, or 
     other human services relevant for the individual in crisis 
     where necessary.
       ``(B) Delineation of access and entry points to services 
     within the crisis response continuum.
       ``(C) Development of protocols and agreements for the 
     transfer and receipt of individuals to and from other 
     segments of the crisis response continuum segments as needed, 
     and from outside referrals including health care providers, 
     first responders including law enforcement, paramedics, and 
     firefighters, education institutions, and community-based 
     organizations.
       ``(D) Description of the qualifications of crisis services 
     staff, including roles for physicians, licensed clinicians, 
     case managers, and peers (in accordance with State licensing 
     requirements or

[[Page H5754]]

     requirements applicable to Tribal health professionals).
       ``(E) The convening of collaborative meetings of crisis 
     response service providers, first responders including law 
     enforcement, paramedics, and firefighters, and community 
     partners (including National Suicide Prevention Lifeline or 
     9-8-8 call centers, 9-1-1 public service answering points, 
     and local mental health and substance use disorder treatment 
     providers) operating in a common region for the discussion of 
     case management, best practices, and general performance 
     improvement.
       ``(3) Service capacity and quality best practices.--The 
     best practices under subsection (a) shall include 
     recommendations on--
       ``(A) adequate volume of services to meet population need;
       ``(B) appropriate timely response; and
       ``(C) capacity to meet the needs of different patient 
     populations that may experience a mental health or substance 
     use crisis, including children, families, and all age groups, 
     cultural and linguistic minorities, individuals with co-
     occurring mental health and substance use disorders, 
     individuals with cognitive disabilities, individuals with 
     developmental delays, and individuals with chronic medical 
     conditions and physical disabilities.
       ``(4) Implementation timeframe.--The Secretary shall--
       ``(A) not later than 1 year after the date of enactment of 
     this section, publish and maintain the best practices 
     required by subsection (a); and
       ``(B) every two years thereafter, publish updates.
       ``(5) Data collection and evaluations.--The Secretary, 
     directly or through grants, contracts, or interagency 
     agreements, shall collect data and conduct evaluations with 
     respect to the provision of services and programs offered on 
     the crisis response continuum for purposes of assessing the 
     extent to which the provision of such services and programs 
     meet certain objectives and outcomes measures as determined 
     by the Secretary. Such objectives shall include--
       ``(A) a reduction in reliance on law enforcement response, 
     as appropriate, to individuals in crisis who would be more 
     appropriately served by a mobile crisis team capable of 
     responding to mental health and substance-related crises;
       ``(B) a reduction in boarding or extended holding of 
     patients in emergency room facilities who require further 
     psychiatric care, including care for substance use disorders;
       ``(C) evidence of adequate access to crisis care centers 
     and crisis bed services; and
       ``(D) evidence of adequate linkage to appropriate post-
     crisis care and longitudinal treatment for mental health or 
     substance use disorder when relevant.''.

Subtitle B--Into the Light for Maternal Mental Health and Substance Use 
                               Disorders

     SEC. 111. SCREENING AND TREATMENT FOR MATERNAL MENTAL HEALTH 
                   AND SUBSTANCE USE DISORDERS.

       (a) In General.--Section 317L-1 of the Public Health 
     Service Act (42 U.S.C. 247b-13a) is amended--
       (1) in the section heading, by striking ``maternal 
     depression'' and inserting ``maternal mental health and 
     substance use disorders''; and
       (2) in subsection (a)--
       (A) by inserting ``, Indian Tribes and Tribal organizations 
     (as such terms are defined in section 4 of the Indian Self-
     Determination and Education Assistance Act), and Urban Indian 
     organizations (as such term is defined under the Federally 
     Recognized Indian Tribe List Act of 1994)'' after ``States''; 
     and
       (B) by striking ``for women who are pregnant, or who have 
     given birth within the preceding 12 months, for maternal 
     depression'' and inserting ``for women who are postpartum, 
     pregnant, or have given birth within the preceding 12 months, 
     for maternal mental health and substance use disorders''.
       (b) Application.--Subsection (b) of section 317L-1 of the 
     Public Health Service Act (42 U.S.C. 247b-13a) is amended--
       (1) by striking ``a State shall submit'' and inserting ``an 
     entity listed in subsection (a) shall submit''; and
       (2) in paragraphs (1) and (2), by striking ``maternal 
     depression'' each place it appears and inserting ``maternal 
     mental health and substance use disorders''.
       (c) Priority.--Subsection (c) of section 317L-1 of the 
     Public Health Service Act (42 U.S.C. 247b-13a) is amended--
       (1) by striking ``may give priority to States proposing to 
     improve or enhance access to screening'' and inserting the 
     following: ``shall give priority to entities listed in 
     subsection (a) that--
       ``(1) are proposing to create, improve, or enhance 
     screening, prevention, and treatment'';
       (2) by striking ``maternal depression'' and inserting 
     ``maternal mental health and substance use disorders'';
       (3) by striking the period at the end of paragraph (1), as 
     so designated, and inserting a semicolon; and
       (4) by inserting after such paragraph (1) the following:
       ``(2) are currently partnered with, or will partner with, a 
     community-based organization to address maternal mental 
     health and substance use disorders;
       ``(3) are located in an area with high rates of adverse 
     maternal health outcomes or significant health, economic, 
     racial, or ethnic disparities in maternal health and 
     substance use disorder outcomes; and
       ``(4) operate in a health professional shortage area 
     designated under section 332.''.
       (d) Use of Funds.--Subsection (d) of section 317L-1 of the 
     Public Health Service Act (42 U.S.C. 247b-13a) is amended--
       (1) in paragraph (1)--
       (A) in subparagraph (A), by striking ``to health care 
     providers; and'' and inserting ``on maternal mental health 
     and substance use disorder screening, brief intervention, 
     treatment (as applicable for health care providers), and 
     referrals for treatment to health care providers in the 
     primary care setting and nonclinical perinatal support 
     workers;'';
       (B) in subparagraph (B), by striking ``to health care 
     providers, including information on maternal depression 
     screening, treatment, and followup support services, and 
     linkages to community-based resources; and'' and inserting 
     ``on maternal mental health and substance use disorder 
     screening, brief intervention, treatment (as applicable for 
     health care providers) and referrals for treatment, follow-up 
     support services, and linkages to community-based resources 
     to health care providers in the primary care setting and 
     clinical perinatal support workers; and''; and
       (C) by adding at the end the following:
       ``(C) enabling health care providers (such as obstetrician-
     gynecologists, nurse practitioners, nurse midwives, 
     pediatricians, psychiatrists, mental and other behavioral 
     health care providers, and adult primary care clinicians) to 
     provide or receive real-time psychiatric consultation (in-
     person or remotely), including through the use of technology-
     enabled collaborative learning and capacity building models 
     (as defined in section 330N), to aid in the treatment of 
     pregnant and postpartum women; and''; and
       (2) in paragraph (2)--
       (A) by striking subparagraph (A) and redesignating 
     subparagraphs (B) and (C) as subparagraphs (A) and (B), 
     respectively;
       (B) in subparagraph (A), as redesignated, by striking 
     ``and'' at the end;
       (C) in subparagraph (B), as redesignated--
       (i) by inserting ``, including'' before ``for rural 
     areas''; and
       (ii) by striking the period at the end and inserting a 
     semicolon; and
       (D) by inserting after subparagraph (B), as redesignated, 
     the following:
       ``(C) providing assistance to pregnant and postpartum women 
     to receive maternal mental health and substance use disorder 
     treatment, including patient consultation, care coordination, 
     and navigation for such treatment;
       ``(D) coordinating with maternal and child health programs 
     of the Federal Government and State, local, and Tribal 
     governments, including child psychiatric access programs;
       ``(E) conducting public outreach and awareness regarding 
     grants under subsection (a);
       ``(F) creating multistate consortia to carry out the 
     activities required or authorized under this subsection; and
       ``(G) training health care providers in the primary care 
     setting and nonclinical perinatal support workers on trauma-
     informed care, culturally and linguistically appropriate 
     services, and best practices related to training to improve 
     the provision of maternal mental health and substance use 
     disorder care for racial and ethnic minority populations, 
     including with respect to perceptions and biases that may 
     affect the approach to, and provision of, care.''.
       (e) Additional Provisions.--Section 317L-1 of the Public 
     Health Service Act (42 U.S.C. 247b-13a) is amended--
       (1) by redesignating subsection (e) as subsection (h); and
       (2) by inserting after subsection (d) the following:
       ``(e) Technical Assistance.--The Secretary shall provide 
     technical assistance to grantees and entities listed in 
     subsection (a) for carrying out activities pursuant to this 
     section.
       ``(f) Dissemination of Best Practices.--The Secretary, 
     based on evaluation of the activities funded pursuant to this 
     section, shall identify and disseminate evidence-based or 
     evidence-informed best practices for screening, assessment, 
     and treatment services for maternal mental health and 
     substance use disorders, including culturally and 
     linguistically appropriate services, for women during 
     pregnancy and 12 months following pregnancy.
       ``(g) Matching Requirement.--The Federal share of the cost 
     of the activities for which a grant is made to an entity 
     under subsection (a) shall not exceed 90 percent of the total 
     cost of such activities.''.
       (f) Authorization of Appropriations.--Subsection (h) of 
     section 317L-1 (42 U.S.C. 247b-13a) of the Public Health 
     Service Act, as redesignated, is further amended--
       (1) by striking ``$5,000,000'' and inserting 
     ``$24,000,000''; and
       (2) by striking ``2018 through 2022'' and inserting ``2023 
     through 2027''.

     SEC. 112. MATERNAL MENTAL HEALTH HOTLINE.

       Part P of title III of the Public Health Service Act (42 
     U.S.C. 280g et seq.) is amended by adding at the end the 
     following:

     ``SEC. 399V-7. MATERNAL MENTAL HEALTH HOTLINE.

       ``(a) In General.--The Secretary shall maintain, directly 
     or by grant or contract, a national hotline to provide 
     emotional support, information, brief intervention, and 
     mental health and substance use disorder resources to 
     pregnant and postpartum women at risk of, or affected by, 
     maternal mental health and substance use disorders, and to 
     their families or household members.
       ``(b) Requirements for Hotline.--The hotline under 
     subsection (a) shall--
       ``(1) be a 24/7 real-time hotline;
       ``(2) provide voice and text support;
       ``(3) be staffed by certified peer specialists, licensed 
     health care professionals, or licensed mental health 
     professionals who are trained on--
       ``(A) maternal mental health and substance use disorder 
     prevention, identification, and intervention; and
       ``(B) providing culturally and linguistically appropriate 
     support; and

[[Page H5755]]

       ``(4) provide maternal mental health and substance use 
     disorder assistance and referral services to meet the needs 
     of underserved populations, individuals with disabilities, 
     and family and household members of pregnant or postpartum 
     women at risk of experiencing maternal mental health and 
     substance use disorders.
       ``(c) Additional Requirements.--In maintaining the hotline 
     under subsection (a), the Secretary shall--
       ``(1) consult with the Domestic Violence Hotline, National 
     Suicide Prevention Lifeline, and Veterans Crisis Line to 
     ensure that pregnant and postpartum women are connected in 
     real-time to the appropriate specialized hotline service, 
     when applicable;
       ``(2) conduct a public awareness campaign for the hotline; 
     and
       ``(3) consult with Federal departments and agencies, 
     including the Centers of Excellence of the Substance Abuse 
     and Mental Health Services Administration and the Department 
     of Veterans Affairs, to increase awareness regarding the 
     hotline.
       ``(d) Annual Report.--The Secretary shall submit an annual 
     report to the Congress on the hotline under subsection (a) 
     and implementation of this section, including--
       ``(1) an evaluation of the effectiveness of activities 
     conducted or supported under subsection (a);
       ``(2) a directory of entities or organizations to which 
     staff maintaining the hotline funded under this section may 
     make referrals; and
       ``(3) such additional information as the Secretary 
     determines appropriate.
       ``(e) Authorization of Appropriations.--To carry out this 
     section, there are authorized to be appropriated $10,000,000 
     for each of fiscal years 2023 through 2027.''.

     SEC. 113. TASK FORCE ON MATERNAL MENTAL HEALTH.

       Part B of title III of the Public Health Service Act (42 
     U.S.C. 243 et seq.) is amended by inserting after section 
     317L-1 (42 U.S.C. 247b-13a) the following:

     ``SEC. 317L-2. TASK FORCE ON MATERNAL MENTAL HEALTH.

       ``(a) Establishment.--Not later than 180 days after the 
     date of enactment of the Restoring Hope for the Mental Health 
     and Well-Being Act of 2022, the Secretary, for purposes of 
     identifying, evaluating, and making recommendations to 
     coordinate and improve Federal responses to maternal mental 
     health conditions, shall--
       ``(1) establish a task force to be known as the Task Force 
     on Maternal Mental Health (in this section referred to as the 
     `Task Force'); or
       ``(2) incorporate the duties, public meetings, and reports 
     specified in subsections (c) through (f) into existing 
     Federal policy forums, including the Maternal Health 
     Interagency Policy Committee and the Maternal Health Working 
     Group, as appropriate.
       ``(b) Membership.--
       ``(1) Composition.--The Task Force shall be composed of--
       ``(A) the Federal members under paragraph (2); and
       ``(B) the non-Federal members under paragraph (3).
       ``(2) Federal members.--The Federal members of the Task 
     Force shall consist of the following heads of Federal 
     departments and agencies (or their designees):
       ``(A) The Assistant Secretary for Health of the Department 
     of Health and Human Services, who shall serve as Chair.
       ``(B) The Assistant Secretary for Planning and Evaluation 
     of the Department of Health and Human Services.
       ``(C) The Assistant Secretary of the Administration for 
     Children and Families.
       ``(D) The Director of the Centers for Disease Control and 
     Prevention.
       ``(E) The Administrator of the Centers for Medicare & 
     Medicaid Services.
       ``(F) The Administrator of the Health Resources and 
     Services Administration.
       ``(G) The Director of the Indian Health Service.
       ``(H) The Assistant Secretary for Mental Health and 
     Substance Use.
       ``(I) Such other Federal departments and agencies as the 
     Secretary determines appropriate that serve individuals with 
     maternal mental health conditions.
       ``(3) Non-federal members.--The non-Federal members of the 
     Task Force shall--
       ``(A) compose not more than one-half, and not less than 
     one-third, of the total membership of the Task Force;
       ``(B) be appointed by the Secretary; and
       ``(C) include--
       ``(i) representatives of medical societies with expertise 
     in maternal or mental health;
       ``(ii) representatives of nonprofit organizations with 
     expertise in maternal or mental health;
       ``(iii) relevant industry representatives; and
       ``(iv) other representatives, as appropriate.
       ``(4) Deadline for designating designees.--If the Assistant 
     Secretary for Health, or the head of a Federal department or 
     agency serving as a member of the Task Force under paragraph 
     (2), chooses to be represented on the Task Force by a 
     designee, the Assistant Secretary or department or agency 
     head shall designate such designee not later than 90 days 
     after the date of the enactment of this section.
       ``(c) Duties.--The Task Force shall--
       ``(1) prepare and regularly update a report that analyzes 
     and evaluates the state of national maternal mental health 
     policy and programs at the Federal, State, and local levels, 
     and identifies best practices with respect to maternal mental 
     health policy, including--
       ``(A) a set of evidence-based, evidence-informed, and 
     promising practices with respect to--
       ``(i) prevention strategies for individuals at risk of 
     experiencing a maternal mental health condition, including 
     strategies and recommendations to address health inequities;
       ``(ii) the identification, screening, diagnosis, 
     intervention, and treatment of individuals and families 
     affected by a maternal mental health condition;
       ``(iii) the expeditious referral to, and implementation of, 
     practices and supports that prevent and mitigate the effects 
     of a maternal mental health condition, including strategies 
     and recommendations to eliminate the racial and ethnic 
     disparities that exist in maternal mental health; and
       ``(iv) community-based or multigenerational practices that 
     support individuals and families affected by a maternal 
     mental health condition; and
       ``(B) Federal and State programs and activities to prevent, 
     screen, diagnose, intervene, and treat maternal mental health 
     conditions;
       ``(2) develop and regularly update a national strategy for 
     maternal mental health, taking into consideration the 
     findings of the report under paragraph (1), on how the Task 
     Force and Federal departments and agencies represented on the 
     Task Force may prioritize options for, and may implement a 
     coordinated approach to, addressing maternal mental health 
     conditions, including by--
       ``(A) increasing prevention, screening, diagnosis, 
     intervention, treatment, and access to care, including 
     clinical and nonclinical care such as peer-support and 
     community health workers, through the public and private 
     sectors;
       ``(B) providing support for pregnant or postpartum 
     individuals who are at risk for or experiencing a maternal 
     mental health condition, and their families, as appropriate;
       ``(C) reducing racial, ethnic, geographic, and other health 
     disparities for prevention, diagnosis, intervention, 
     treatment, and access to care;
       ``(D) identifying options for modifying, strengthening, and 
     coordinating Federal programs and activities, such as the 
     Medicaid program under title XIX of the Social Security Act 
     and the State Children's Health Insurance Program under title 
     XXI of such Act, including existing infant and maternity 
     programs, in order to increase research, prevention, 
     identification, intervention, and treatment with respect to 
     maternal mental health; and
       ``(E) planning, data sharing, and communication within and 
     across Federal departments, agencies, offices, and programs;
       ``(3) solicit public comments from stakeholders for the 
     report under paragraph (1) and the national strategy under 
     paragraph (2), including comments from frontline service 
     providers, mental health professionals, researchers, experts 
     in maternal mental health, institutions of higher education, 
     public health agencies (including maternal and child health 
     programs), and industry representatives, in order to inform 
     the activities and reports of the Task Force; and
       ``(4) disaggregate any data collected under this section by 
     race, ethnicity, geographical location, age, marital status, 
     socioeconomic level, and other factors, as the Secretary 
     determines appropriate.
       ``(d) Meetings.--The Task Force shall--
       ``(1) meet not less than two times each year; and
       ``(2) convene public meetings, as appropriate, to fulfill 
     its duties under this section.
       ``(e) Reports to Public and Federal Leaders.--The Task 
     Force shall make publicly available and submit to the heads 
     of relevant Federal departments and agencies, the Committee 
     on Energy and Commerce of the House of Representatives, the 
     Committee on Health, Education, Labor, and Pensions of the 
     Senate, and other relevant congressional committees, the 
     following:
       ``(1) Not later than 1 year after the first meeting of the 
     Task Force, an initial report under subsection (c)(1).
       ``(2) Not later than 2 years after the first meeting of the 
     Task Force, an initial national strategy under subsection 
     (c)(2).
       ``(3) Each year thereafter--
       ``(A) an updated report under subsection (c)(1);
       ``(B) an updated national strategy under subsection (c)(2); 
     or
       ``(C) if no update is made under subsection (c)(1) or 
     (c)(2), a report summarizing the activities of the Task 
     Force.
       ``(f) Reports to Governors.--Upon finalizing the initial 
     national strategy under subsection (c)(2), and upon making 
     relevant updates to such strategy, the Task Force shall 
     submit a report to the Governors of all States describing 
     opportunities for local- and State-level partnerships 
     identified under subsection (c)(2)(D).
       ``(g) Sunset.--The Task Force shall terminate on September 
     30, 2027.
       ``(h) Nonduplication of Federal Efforts.--The Secretary may 
     relieve the Task Force, in carrying out subsections (c) 
     through (f), from responsibility for carrying out such 
     activities as may be specified by the Secretary as 
     duplicative with other activities carried out by the 
     Department of Health and Human Services.''.

   Subtitle C--Reaching Improved Mental Health Outcomes for Patients

     SEC. 121. INNOVATION FOR MENTAL HEALTH.

       (a) National Mental Health and Substance Use Policy 
     Laboratory.--Section 501A of the Public Health Service Act 
     (42 U.S.C. 290aa-0) is amended--
       (1) in subsection (e)(1), by striking ``Indian tribes or 
     tribal organizations'' and inserting ``Indian Tribes or 
     Tribal organizations'';
       (2) by striking subsection (e)(3); and
       (3) by adding at the end the following:
       ``(f) Authorization of Appropriations.--To carry out this 
     section, there is authorized to be appropriated $10,000,000 
     for each of fiscal years 2023 through 2027.''.

[[Page H5756]]

       (b) Interdepartmental Serious Mental Illness Coordinating 
     Committee.--
       (1) In general.--Part A of title V of the Public Health 
     Service Act (42 U.S.C. 290aa et seq.) is amended by inserting 
     after section 501A (42 U.S.C. 290aa-0) the following:

     ``SEC. 501B. INTERDEPARTMENTAL SERIOUS MENTAL ILLNESS 
                   COORDINATING COMMITTEE.

       ``(a) Establishment.--
       ``(1) In general.--The Secretary of Health and Human 
     Services, or the designee of the Secretary, shall establish a 
     committee to be known as the Interdepartmental Serious Mental 
     Illness Coordinating Committee (in this section referred to 
     as the `Committee').
       ``(2) Federal advisory committee act.--Except as provided 
     in this section, the provisions of the Federal Advisory 
     Committee Act (5 U.S.C. App.) shall apply to the Committee.
       ``(b) Meetings.--The Committee shall meet not fewer than 2 
     times each year.
       ``(c) Responsibilities.--The Committee shall submit, on a 
     biannual basis, to Congress and any other relevant Federal 
     department or agency a report including--
       ``(1) a summary of advances in serious mental illness and 
     serious emotional disturbance research related to the 
     prevention of, diagnosis of, intervention in, and treatment 
     and recovery of serious mental illnesses, serious emotional 
     disturbances, and advances in access to services and support 
     for adults with a serious mental illness or children with a 
     serious emotional disturbance;
       ``(2) an evaluation of the effect Federal programs related 
     to serious mental illness have on public health, including 
     public health outcomes such as--
       ``(A) rates of suicide, suicide attempts, incidence and 
     prevalence of serious mental illnesses, serious emotional 
     disturbances, and substance use disorders, overdose, overdose 
     deaths, emergency hospitalizations, emergency room boarding, 
     preventable emergency room visits, interaction with the 
     criminal justice system, homelessness, and unemployment;
       ``(B) increased rates of employment and enrollment in 
     educational and vocational programs;
       ``(C) quality of mental and substance use disorders 
     treatment services; or
       ``(D) any other criteria as may be determined by the 
     Secretary; and
       ``(3) specific recommendations for actions that agencies 
     can take to better coordinate the administration of mental 
     health services for adults with a serious mental illness or 
     children with a serious emotional disturbance.
       ``(d) Membership.--
       ``(1) Federal members.--The Committee shall be composed of 
     the following Federal representatives, or the designees of 
     such representatives--
       ``(A) the Secretary of Health and Human Services, who shall 
     serve as the Chair of the Committee;
       ``(B) the Assistant Secretary for Mental Health and 
     Substance Use;
       ``(C) the Attorney General;
       ``(D) the Secretary of Veterans Affairs;
       ``(E) the Secretary of Defense;
       ``(F) the Secretary of Housing and Urban Development;
       ``(G) the Secretary of Education;
       ``(H) the Secretary of Labor;
       ``(I) the Administrator of the Centers for Medicare & 
     Medicaid Services; and
       ``(J) the Commissioner of Social Security.
       ``(2) Non-federal members.--The Committee shall also 
     include not less than 14 non-Federal public members appointed 
     by the Secretary of Health and Human Services, of which--
       ``(A) at least 2 members shall be an individual who has 
     received treatment for a diagnosis of a serious mental 
     illness;
       ``(B) at least 1 member shall be a parent or legal guardian 
     of an adult with a history of a serious mental illness or a 
     child with a history of a serious emotional disturbance;
       ``(C) at least 1 member shall be a representative of a 
     leading research, advocacy, or service organization for 
     adults with a serious mental illness;
       ``(D) at least 2 members shall be--
       ``(i) a licensed psychiatrist with experience in treating 
     serious mental illnesses;
       ``(ii) a licensed psychologist with experience in treating 
     serious mental illnesses or serious emotional disturbances;
       ``(iii) a licensed clinical social worker with experience 
     treating serious mental illnesses or serious emotional 
     disturbances; or
       ``(iv) a licensed psychiatric nurse, nurse practitioner, or 
     physician assistant with experience in treating serious 
     mental illnesses or serious emotional disturbances;
       ``(E) at least 1 member shall be a licensed mental health 
     professional with a specialty in treating children and 
     adolescents with a serious emotional disturbance;
       ``(F) at least 1 member shall be a mental health 
     professional who has research or clinical mental health 
     experience in working with minorities;
       ``(G) at least 1 member shall be a mental health 
     professional who has research or clinical mental health 
     experience in working with medically underserved populations;
       ``(H) at least 1 member shall be a State certified mental 
     health peer support specialist;
       ``(I) at least 1 member shall be a judge with experience in 
     adjudicating cases related to criminal justice or serious 
     mental illness;
       ``(J) at least 1 member shall be a law enforcement officer 
     or corrections officer with extensive experience in 
     interfacing with adults with a serious mental illness, 
     children with a serious emotional disturbance, or individuals 
     in a mental health crisis; and
       ``(K) at least 1 member shall have experience providing 
     services for homeless individuals and working with adults 
     with a serious mental illness, children with a serious 
     emotional disturbance, or individuals in a mental health 
     crisis.
       ``(3) Terms.--A member of the Committee appointed under 
     paragraph (2) shall serve for a term of 3 years, and may be 
     reappointed for 1 or more additional 3-year terms. Any member 
     appointed to fill a vacancy for an unexpired term shall be 
     appointed for the remainder of such term. A member may serve 
     after the expiration of the member's term until a successor 
     has been appointed.
       ``(e) Working Groups.--In carrying out its functions, the 
     Committee may establish working groups. Such working groups 
     shall be composed of Committee members, or their designees, 
     and may hold such meetings as are necessary.
       ``(f) Sunset.--The Committee shall terminate on September 
     30, 2027.''.
       (2) Conforming amendments.--
       (A) Section 501(l)(2) of the Public Health Service Act (42 
     U.S.C. 290aa(l)(2)) is amended by striking ``section 6031 of 
     such Act'' and inserting ``section 501B of this Act''.
       (B) Section 6031 of the Helping Families in Mental Health 
     Crisis Reform Act of 2016 (Division B of Public Law 114-255) 
     is repealed (and by conforming the item relating to such 
     section in the table of contents in section 1(b)).
       (c) Priority Mental Health Needs of Regional and National 
     Significance.--Section 520A of the Public Health Service Act 
     (42 U.S.C. 290bb-32) is amended--
       (1) in subsection (a), by striking ``Indian tribes or 
     tribal organizations'' and inserting ``Indian Tribes or 
     Tribal organizations''; and
       (2) in subsection (f), by striking ``$394,550,000 for each 
     of fiscal years 2018 through 2022'' and inserting 
     ``$599,036,000 for each of fiscal years 2023 through 2027''.

     SEC. 122. CRISIS CARE COORDINATION.

       (a) Strengthening Community Crisis Response Systems.--
     Section 520F of the Public Health Service Act (42 U.S.C. 
     290bb-37) is amended to read as follows:

     ``SEC. 520F. MENTAL HEALTH CRISIS RESPONSE PARTNERSHIP PILOT 
                   PROGRAM.

       ``(a) In General.--The Secretary shall establish a pilot 
     program under which the Secretary will award competitive 
     grants to States, localities, territories, Indian Tribes, and 
     Tribal organizations to establish new, or enhance existing, 
     mobile crisis response teams that divert the response for 
     mental health and substance use crises from law enforcement 
     to mobile crisis teams, as described in subsection (b).
       ``(b) Mobile Crisis Teams Described.--A mobile crisis team 
     described in this subsection is a team of individuals--
       ``(1) that is available to respond to individuals in crisis 
     and provide immediate stabilization, referrals to community-
     based mental health and substance use disorder services and 
     supports, and triage to a higher level of care if medically 
     necessary;
       ``(2) which may include licensed counselors, clinical 
     social workers, physicians, paramedics, crisis workers, peer 
     support specialists, or other qualified individuals; and
       ``(3) which may provide support to divert behavioral health 
     crisis calls from the 9-1-1 system to the 9-8-8 system.
       ``(c) Priority.--In awarding grants under this section, the 
     Secretary shall prioritize applications which account for the 
     specific needs of the communities to be served, including 
     children and families, veterans, rural and underserved 
     populations, and other groups at increased risk of death from 
     suicide or overdose.
       ``(d) Report.--
       ``(1) Initial report.--Not later than September 30, 2024, 
     the Secretary shall submit to Congress a report on steps 
     taken by the entities specified in subsection (a) as of such 
     date of enactment to strengthen the partnerships among mental 
     health providers, substance use disorder treatment providers, 
     primary care physicians, mental health and substance use 
     crisis teams, paramedics, law enforcement officers, and other 
     first responders.
       ``(2) Progress reports.--Not later than one year after the 
     date on which the first grant is awarded to carry out this 
     section, and for each year thereafter, the Secretary shall 
     submit to Congress a report on the grants made during the 
     year covered by the report, which shall include--
       ``(A) impact data on the teams and people served by such 
     programs, including demographic information of individuals 
     served, volume, and types of service utilization;
       ``(B) outcomes of the number of linkages to community-based 
     resources, short-term crisis receiving and stabilization 
     facilities, and diversion from law enforcement or hospital 
     emergency department settings;
       ``(C) data consistent with the State block grant 
     requirements for continuous evaluation and quality 
     improvement, and other relevant data as determined by the 
     Secretary; and
       ``(D) the Secretary's recommendations and best practices 
     for--
       ``(i) States and localities providing mobile crisis 
     response and stabilization services for youth and adults; and
       ``(ii) improvements to the program established under this 
     section.
       ``(e) Authorization of Appropriations.--There are 
     authorized to be appropriated to carry out this section, 
     $10,000,000 for each of fiscal years 2023 through 2027.''.
       (b) Mental Health Awareness Training Grants.--
       (1) In general.--Section 520J(b) of the Public Health 
     Service Act (42 U.S.C. 290bb-41(b)) is amended--
       (A) in paragraph (1), by striking ``Indian tribes, tribal 
     organizations'' and inserting ``Indian Tribes, Tribal 
     organizations'';
       (B) in paragraph (4), by striking ``Indian tribe, tribal 
     organization'' and inserting ``Indian Tribe, Tribal 
     organization'';
       (C) in paragraph (5)--

[[Page H5757]]

       (i) by striking ``Indian tribe, tribal organization'' and 
     inserting ``Indian Tribe, Tribal organization'';
       (ii) in subparagraph (A), by striking ``and'' at the end;
       (iii) in subparagraph (B)(ii), by striking the period at 
     the end and inserting ``; and''; and
       (iv) by adding at the end the following:
       ``(C) suicide intervention and prevention, including 
     recognizing warning signs and how to refer someone for 
     help.'';
       (D) in paragraph (6), by striking ``Indian tribe, tribal 
     organization'' and inserting ``Indian Tribe, Tribal 
     organization''; and
       (E) in paragraph (7), by striking ``$14,693,000 for each of 
     fiscal years 2018 through 2022'' and inserting ``$24,963,000 
     for each of fiscal years 2023 through 2027''.
       (2) Technical corrections.--Section 520J(b) of the Public 
     Health Service Act (42 U.S.C. 290bb-41(b)) is amended--
       (A) in the heading of paragraph (2), by striking 
     ``Emergency Services Personnel'' and inserting ``Emergency 
     services personnel''; and
       (B) in the heading of paragraph (3), by striking 
     ``Distribution of Awards'' and inserting ``Distribution of 
     awards''.
       (c) Adult Suicide Prevention.--Section 520L of the Public 
     Health Service Act (42 U.S.C. 290bb-43) is amended--
       (1) in subsection (a)--
       (A) in paragraph (2)--
       (i) by striking ``Indian tribe'' each place it appears and 
     inserting ``Indian Tribe''; and
       (ii) by striking ``tribal organization'' each place it 
     appears and inserting ``Tribal organization''; and
       (B) by amending paragraph (3)(C) to read as follows:
       ``(C) Raising awareness of suicide prevention resources, 
     promoting help seeking among those at risk for suicide.''; 
     and
       (2) in subsection (d), by striking ``$30,000,000 for the 
     period of fiscal years 2018 through 2022'' and inserting 
     ``$30,000,000 for each of fiscal years 2023 through 2027''.

     SEC. 123. TREATMENT OF SERIOUS MENTAL ILLNESS.

       (a) Assertive Community Treatment Grant Program.--
       (1) Technical amendment.--Section 520M(b) of the Public 
     Health Service Act (42 U.S.C. 290bb-44(b)) is amended by 
     striking ``Indian tribe or tribal organization'' and 
     inserting ``Indian Tribe or Tribal organization''.
       (2) Report to congress.--Section 520M(d)(1) of the Public 
     Health Service Act (42 U.S.C. 290bb-44(d)(1)) is amended by 
     striking ``not later than the end of fiscal year 2021'' and 
     inserting ``not later than the end of fiscal year 2026''.
       (3) Authorization of appropriations.--Section 520M(e)(1) of 
     the Public Health Service Act (42 U.S.C. 290bb-44(d)(1)) is 
     amended by striking ``$5,000,000 for the period of fiscal 
     years 2018 through 2022'' and inserting ``$9,000,000 for each 
     of fiscal years 2023 through 2027''.
       (b) Assisted Outpatient Treatment.--Section 224 of the 
     Protecting Access to Medicare Act of 2014 (42 U.S.C. 290aa 
     note) is amended to read as follows:

     ``SEC. 224. ASSISTED OUTPATIENT TREATMENT GRANT PROGRAM FOR 
                   INDIVIDUALS WITH SERIOUS MENTAL ILLNESS.

       ``(a) In General.--The Secretary shall carry out a program 
     to award grants to eligible entities for assisted outpatient 
     treatment programs for individuals with serious mental 
     illness.
       ``(b) Consultation.--The Secretary shall carry out this 
     section in consultation with the Director of the National 
     Institute of Mental Health, the Attorney General of the 
     United States, the Administrator of the Administration for 
     Community Living, and the Assistant Secretary for Mental 
     Health and Substance Use.
       ``(c) Selecting Among Applicants.--In awarding grants under 
     this section, the Secretary--
       ``(1) may give preference to applicants that have not 
     previously implemented an assisted outpatient treatment 
     program; and
       ``(2) shall evaluate applicants based on their potential to 
     reduce hospitalization, homelessness, incarceration, and 
     interaction with the criminal justice system while improving 
     the health and social outcomes of the patient.
       ``(d) Program Requirements.--An assisted outpatient 
     treatment program funded with a grant awarded under this 
     section shall include--
       ``(1) evaluating the medical and social needs of the 
     patients who are participating in the program;
       ``(2) preparing and executing treatment plans for such 
     patients that--
       ``(A) include criteria for completion of court-ordered 
     treatment if applicable; and
       ``(B) provide for monitoring of the patient's compliance 
     with the treatment plan, including compliance with medication 
     and other treatment regimens;
       ``(3) providing for case management services that support 
     the treatment plan;
       ``(4) ensuring appropriate referrals to medical and social 
     services providers;
       ``(5) evaluating the process for implementing the program 
     to ensure consistency with the patient's needs and State law; 
     and
       ``(6) measuring treatment outcomes, including health and 
     social outcomes such as rates of incarceration, health care 
     utilization, and homelessness.
       ``(e) Report.--Not later than the end of fiscal year 2027, 
     the Secretary shall submit a report to the appropriate 
     congressional committees on the grant program under this 
     section. Such report shall include an evaluation of the 
     following:
       ``(1) Cost savings and public health outcomes such as 
     mortality, suicide, substance abuse, hospitalization, and use 
     of services.
       ``(2) Rates of incarceration of patients.
       ``(3) Rates of homelessness of patients.
       ``(4) Patient and family satisfaction with program 
     participation.
       ``(5) Demographic information regarding participation of 
     those served by the grant compared to demographic information 
     in the population of the grant recipient.
       ``(f) Definitions.--In this section:
       ``(1) The term `assisted outpatient treatment' means 
     medically prescribed mental health treatment that a patient 
     receives while living in a community under the terms of a law 
     authorizing a State or local civil court to order such 
     treatment.
       ``(2) The term `eligible entity' means a county, city, 
     mental health system, mental health court, or any other 
     entity with authority under the law of the State in which the 
     entity is located to implement, monitor, and oversee an 
     assisted outpatient treatment program.
       ``(g) Funding.--
       ``(1) Amount of grants.--
       ``(A) Maximum amount.--The amount of a grant under this 
     section shall not exceed $1,000,000 for any fiscal year.
       ``(B) Determination.--Subject to subparagraph (A), the 
     Secretary shall determine the amount of each grant under this 
     section based on the population of the area to be served 
     through the grant and an estimate of the number of patients 
     to be served.
       ``(2) Authorization of appropriations.--There is authorized 
     to be appropriated to carry out this section $22,000,000 for 
     each of fiscal years 2023 through 2027.''.

                     Subtitle D--Anna Westin Legacy

     SEC. 131. MAINTAINING EDUCATION AND TRAINING ON EATING 
                   DISORDERS.

        Subpart 3 of part B of title V of the Public Health 
     Service Act (42 U.S.C. 290bb-31 et seq.), as amended by 
     section 102, is further amended by adding at the end the 
     following:

     ``SEC. 520O. CENTER OF EXCELLENCE FOR EATING DISORDERS FOR 
                   EDUCATION AND TRAINING ON EATING DISORDERS.

       ``(a) In General.--The Secretary, acting through the 
     Assistant Secretary, shall maintain, by competitive grant or 
     contract, a Center of Excellence for Eating Disorders 
     (referred to in this section as the `Center') to improve the 
     identification of, interventions for, and treatment of eating 
     disorders in a manner that is developmentally, culturally, 
     and linguistically appropriate.
       ``(b) Subgrants and Subcontracts.--The Center shall 
     coordinate and implement the activities under subsection (c), 
     in whole or in part, by awarding competitive subgrants or 
     subcontracts--
       ``(1) across geographical regions; and
       ``(2) in a manner that is not duplicative.
       ``(c) Activities.--The Center--
       ``(1) shall--
       ``(A) provide training and technical assistance for--
       ``(i) primary care and behavioral health care providers to 
     carry out screening, brief intervention, and referral to 
     treatment for individuals experiencing, or at risk for, 
     eating disorders; and
       ``(ii) nonclinical community support workers to identify 
     and support individuals with, or at disproportionate risk 
     for, eating disorders;
       ``(B) develop and provide training materials to health care 
     providers, including primary care and behavioral health care 
     providers, in the effective treatment and ongoing support of 
     individuals with eating disorders, including children and 
     marginalized populations at disproportionate risk for eating 
     disorders;
       ``(C) provide collaboration and coordination to other 
     centers of excellence, technical assistance centers, and 
     psychiatric consultation lines of the Substance Abuse and 
     Mental Health Services Administration and the Health 
     Resources and Services Administration on the identification, 
     effective treatment, and ongoing support of individuals with 
     eating disorders; and
       ``(D) coordinate with the Director of the Centers for 
     Disease Control and Prevention and the Administrator of the 
     Health Resources and Services Administration to disseminate 
     training to primary care and behavioral health care 
     providers; and
       ``(2) may--
       ``(A) coordinate with electronic health record systems for 
     the integration of protocols pertaining to screening, brief 
     intervention, and referral to treatment for individuals 
     experiencing, or at risk for, eating disorders;
       ``(B) develop and provide training materials to health care 
     providers, including primary care and behavioral health care 
     providers, in the effective treatment and ongoing support for 
     members of the Armed Forces and veterans experiencing, or at 
     risk for, eating disorders; and
       ``(C) consult with the Secretary of Defense and the 
     Secretary of Veterans Affairs on prevention, identification, 
     intervention for, and treatment of eating disorders.
       ``(d) Authorization of Appropriations.--To carry out this 
     section, there is authorized to be appropriated $1,000,000 
     for each of fiscal years 2023 through 2027.''.

       Subtitle E--Community Mental Health Services Block Grant 
                            Reauthorization

     SEC. 141. REAUTHORIZATION OF BLOCK GRANTS FOR COMMUNITY 
                   MENTAL HEALTH SERVICES.

       (a) Funding.--Section 1920(a) of the Public Health Service 
     Act (42 U.S.C. 300x-9(a)) is amended by striking 
     ``$532,571,000 for each of fiscal years 2018 through 2022'' 
     and inserting ``$857,571,000 for each of fiscal years 2023 
     through 2027''.
       (b) Set-Aside for Evidence-based Crisis Care Services.--
     Section 1920 of the Public Health Service Act (42 U.S.C. 
     300x-9) is amended by adding at the end the following:
       ``(d) Crisis Care.--
       ``(1) In general.--Except as provided in paragraph (3), a 
     State shall expend at least 5 percent of the amount the State 
     receives pursuant to

[[Page H5758]]

     section 1911 for each fiscal year to support evidenced-based 
     programs that address the crisis care needs of--
       ``(A) individuals, including children and adolescents, 
     experiencing mental health crises, substance-related crises, 
     or crises arising from co-occurring disorders; and
       ``(B) persons with intellectual and developmental 
     disabilities.
       ``(2) Core elements.--At the discretion of the single State 
     agency responsible for the administration of the program of 
     the State under a grant under section 1911, funds expended 
     pursuant to paragraph (1) may be used to fund some or all of 
     the core crisis care service components, delivered according 
     to evidence-based principles, including the following:
       ``(A) Crisis call centers.
       ``(B) 24/7 mobile crisis services.
       ``(C) Crisis stabilization programs offering acute care or 
     subacute care in a hospital or appropriately licensed 
     facility, as determined by the Substance Abuse and Mental 
     Health Services Administration, with referrals to inpatient 
     or outpatient care.
       ``(3) State flexibility.--In lieu of expending 5 percent of 
     the amount the State receives pursuant to section 1911 for a 
     fiscal year to support evidence-based programs as required by 
     paragraph (1), a State may elect to expend not less than 10 
     percent of such amount to support such programs by the end of 
     two consecutive fiscal years.
       ``(4) Rule of construction.--With respect to funds expended 
     pursuant to the set-aside in paragraph (1), section 
     1912(b)(1)(A)(vi) shall not apply.''.
       (c) Early Intervention.--
       (1) State plan option.--Section 1912(b)(1)(A)(vii) of the 
     Public Health Service Act (42 U.S.C. 300x-1(b)(1)(A)(vii)) is 
     amended--
       (A) in subclause (III), by striking ``and'' at the end;
       (B) in subclause (IV), by striking the period at the end 
     and inserting ``; and''; and
       (C) by adding at the end the following:

       ``(V) a description of any evidence-based early 
     intervention strategies and programs the State provides to 
     prevent, delay, or reduce the severity and onset of mental 
     illness and behavioral problems, including for children and 
     adolescents, irrespective of experiencing a serious mental 
     illness or serious emotional disturbance, as defined under 
     subsection (c)(1).''.

       (2) Allocation allowance; reports.--Section 1920 of the 
     Public Health Service Act (42 U.S.C. 300x-9), as amended by 
     subsection (c), is further amended by adding at the end the 
     following:
       ``(e) Early Intervention Services.--In the case of a State 
     with a State plan that provides for strategies and programs 
     specified in section 1912(b)(1)(A)(vii)(VI), such State may 
     expend not more than 5 percent of the amount of the allotment 
     of the State pursuant to a funding agreement under section 
     1911 for each fiscal year to support such strategies and 
     programs.
       ``(f) Reports to Congress.--Not later than September 30, 
     2025, and biennially thereafter, the Secretary shall provide 
     a report to the Congress on the crisis care and early 
     intervention strategies and programs pursued by States 
     pursuant to subsections (d) and (e). Each such report shall 
     include--
       ``(1) a description of the each State's crisis care and 
     early intervention activities;
       ``(2) the population served, including information on 
     demographics, including age;
       ``(3) the outcomes of such activities, including--
       ``(A) how such activities reduced hospitalizations and 
     hospital stays;
       ``(B) how such activities reduced incidents of suicidal 
     ideation and behaviors; and
       ``(C) how such activities reduced the severity of onset of 
     serious mental illness and serious emotional disturbance; and
       ``(4) any other relevant information the Secretary deems 
     necessary.''.

           Subtitle F--Peer-Supported Mental Health Services

     SEC. 151. PEER-SUPPORTED MENTAL HEALTH SERVICES.

       Subpart 3 of part B of title V of the Public Health Service 
     Act (42 U.S.C. 290bb--31 et seq.) is amended by inserting 
     after section 520G (42 U.S.C. 290bb--38) the following:

     ``SEC. 520H. PEER-SUPPORTED MENTAL HEALTH SERVICES.

       ``(a) Grants Authorized.--The Secretary, acting through the 
     Director of the Center for Mental Health Services, shall 
     award grants to eligible entities to enable such entities to 
     develop, expand, and enhance access to mental health peer-
     delivered services.
       ``(b) Use of Funds.--Grants awarded under subsection (a) 
     shall be used to develop, expand, and enhance national, 
     statewide, or community-focused programs, including virtual 
     peer-support services and infrastructure, including by--
       ``(1) carrying out workforce development, recruitment, and 
     retention activities, to train, recruit, and retain peer-
     support providers;
       ``(2) building connections between mental health treatment 
     programs, including between community organizations and peer-
     support networks, including virtual peer-support networks, 
     and with other mental health support services;
       ``(3) reducing stigma associated with mental health 
     disorders;
       ``(4) expanding and improving virtual peer mental health 
     support services, including adoption of technologies to 
     expand access to virtual peer mental health support services, 
     including by acquiring--
       ``(A) appropriate physical hardware for such virtual 
     services;
       ``(B) software and programs to efficiently run peer-support 
     services virtually; and
       ``(C) other technology for establishing virtual waiting 
     rooms and virtual video platforms for meetings; and
       ``(5) conducting research on issues relating to mental 
     illness and the impact peer-support has on resiliency, 
     including identifying--
       ``(A) the signs of mental illness;
       ``(B) the resources available to individuals with mental 
     illness and to their families; and
       ``(C) the resources available to help support individuals 
     living with mental illness.
       ``(c) Special Consideration.--In carrying out this section, 
     the Secretary shall give special consideration to the unique 
     needs of rural areas.
       ``(d) Definition.--In this section, the term `eligible 
     entity' means--
       ``(1) a nonprofit consumer-run organization that--
       ``(A) is principally governed by people living with a 
     mental health condition; and
       ``(B) mobilizes resources within and outside of the mental 
     health community, which may include through peer-support 
     networks, to increase the prevalence and quality of long-term 
     wellness of individuals living with a mental health 
     condition, including those with a co-occurring substance use 
     disorder; or
       ``(2) a Federally recognized Tribe, Tribal organization, 
     Urban Indian organization, or consortium of Tribes or Tribal 
     organizations.
       ``(e) Authorization of Appropriations.--There is authorized 
     to be appropriated to carry out this section $13,000,000 for 
     each of fiscal years 2023 through 2027.''.

 TITLE II--SUBSTANCE USE DISORDER PREVENTION, TREATMENT, AND RECOVERY 
                                SERVICES

        Subtitle A--Native Behavioral Health Access Improvement

     SEC. 201. BEHAVIORAL HEALTH AND SUBSTANCE USE DISORDER 
                   SERVICES FOR NATIVE AMERICANS.

       Section 506A of the Public Health Service Act (42 U.S.C. 
     290aa-5a) is amended to read as follows:

     ``SEC. 506A. BEHAVIORAL HEALTH AND SUBSTANCE USE DISORDER 
                   SERVICES FOR NATIVE AMERICANS.

       ``(a) Definitions.--In this section:
       ``(1) The term `eligible entity' means an Indian Tribe, a 
     Tribal organization, an Urban Indian organization, and a 
     Native Hawaiian health organization.
       ``(2) The terms `Indian Tribe', `Tribal organization', and 
     `Urban Indian organization' have the meanings given to the 
     terms `Indian tribe', `tribal organization', and `Urban 
     Indian organization' in section 4 of the Indian Health Care 
     Improvement Act.
       ``(3) The term `Native Hawaiian health organization' means 
     `Papa Ola Lokahi' as defined in section 12 of the Native 
     Hawaiian Health Care Improvement Act.
       ``(b) Formula Funds.--
       ``(1) In general.--The Secretary, in consultation with the 
     Director of the Indian Health Service, as appropriate, shall 
     award funds to eligible entities, in amounts determined 
     pursuant to the formula described in paragraph (2), to be 
     used by the eligible entity to provide culturally appropriate 
     mental health and substance use disorder prevention, 
     treatment, and recovery services to American Indians, Alaska 
     Natives, and Native Hawaiians.
       ``(2) Formula.--The Secretary, using the process described 
     in subsection (d), shall develop a formula to determine the 
     amount of an award under paragraph (1). Such formula shall 
     take into account the populations of eligible entities whose 
     rates of overdose deaths or suicide are substantially higher 
     relative to the populations of other Indian Tribes, Tribal 
     organizations, Urban Indian organizations, or Native Hawaiian 
     health organizations, as applicable.
       ``(c) Technical Assistance and Program Evaluation.--
       ``(1) In general.--The Secretary shall--
       ``(A) provide technical assistance to applicants and 
     awardees under this section; and
       ``(B) collect and evaluate information on the program 
     carried out under this section.
       ``(2) Consultation on evaluation measures, and data 
     submission and reporting requirements.--The Secretary shall, 
     using the process described in subsection (d), develop 
     evaluation measures and data submission and reporting 
     requirements for purposes of the collection and evaluation of 
     information.
       ``(3) Data submission and reporting.--As a condition on 
     receipt of funds under this section, an applicant shall agree 
     to submit data and reports in a timely manner consistent with 
     the evaluation measures and data submission and reporting 
     requirements developed under subsection (d).
       ``(d) Regulations.--
       ``(1) Promulgation.--Not later than 180 days after the date 
     of enactment of the Restoring Hope for Mental Health and 
     Well-Being Act of 2022, the Secretary shall initiate 
     procedures under subchapter III of chapter 5 of title 5, 
     United States Code, to negotiate and promulgate such 
     regulations as are necessary to carry out this section, 
     including development of the funding formula described in 
     subsection (b) and the program evaluation and reporting 
     requirements under subsection (c).
       ``(2) Publication.--Not later than 18 months after the date 
     of enactment of the Restoring Hope for Mental Health and 
     Well-Being Act of 2022, the Secretary shall publish in the 
     Federal Register proposed regulations to implement this 
     section.
       ``(3) Committee.--A negotiated rulemaking committee 
     established pursuant to section 565 of title 5, United States 
     Code, to carry out this subsection shall have as its members 
     only representatives of the Federal Government, Tribal 
     Governments, and Urban Indian organizations. For purposes of 
     such rulemaking, the Indian Health Service shall be the lead 
     agency for the Department.
       ``(4) Adaptation of procedures.--In carrying out this 
     subsection, the Secretary shall

[[Page H5759]]

     adapt any negotiated rulemaking procedures to the unique 
     context of the government-to-government relationship between 
     the United States and Indian Tribes.
       ``(5) Effect.--The lack of promulgated regulations under 
     this subsection shall not limit the effect or implementation 
     of this section.
       ``(e) Application.--An entity desiring an award under 
     subsection (b) shall submit an application to the Secretary 
     at such time, in such manner, and accompanied by such 
     information as the Secretary may reasonably require.
       ``(f) Report.--Not later than 3 years after the date of the 
     enactment of the Restoring Hope for Mental Health and Well-
     Being Act of 2022, and annually thereafter, the Secretary 
     shall prepare and submit, to the Committee on Health, 
     Education, Labor, and Pensions of the Senate, and the 
     Committee on Energy and Commerce of the House of 
     Representatives, a report describing the services provided 
     pursuant to this section.
       ``(g) Authorization of Appropriations.--There are 
     authorized to be appropriated to carry out this section, 
     $40,000,000 for each of fiscal years 2023 through 2027.''.

     Subtitle B--Summer Barrow Prevention, Treatment, and Recovery

     SEC. 211. GRANTS FOR THE BENEFIT OF HOMELESS INDIVIDUALS.

       Section 506(e) of the Public Health Service Act (42 U.S.C. 
     290aa-5(e)) is amended by striking ``2018 through 2022'' and 
     inserting ``2023 through 2027''.

     SEC. 212. PRIORITY SUBSTANCE ABUSE TREATMENT NEEDS OF 
                   REGIONAL AND NATIONAL SIGNIFICANCE.

       Section 509 of the Public Health Service Act (42 U.S.C. 
     290bb-2) is amended--
       (1) in the section heading, by striking ``abuse'' and 
     inserting ``use disorder'';
       (2) in subsection (a)--
       (A) by striking ``tribes and tribal organizations (as the 
     terms `Indian tribes' and `tribal organizations' are 
     defined'' and inserting ``Tribes and Tribal organizations (as 
     such terms are defined''; and
       (B) in paragraph (3), by striking ``in substance abuse'';
       (3) in subsection (b), in the subsection heading, by 
     striking ``Abuse'' and inserting ``Use Disorder''; and
       (4) in subsection (f), by striking ``$333,806,000 for each 
     of fiscal years 2018 through 2022'' and inserting 
     ``$521,517,000 for each of fiscal years 2023 through 2027''.

     SEC. 213. EVIDENCE-BASED PRESCRIPTION OPIOID AND HEROIN 
                   TREATMENT AND INTERVENTIONS DEMONSTRATION.

       Section 514B of the Public Health Service Act (42 U.S.C. 
     290bb-10) is amended--
       (1) in subsection (a)(1)--
       (A) by striking ``substance abuse'' and inserting 
     ``substance use disorder'';
       (B) by striking ``tribes and tribal organizations'' and 
     inserting ``Tribes and Tribal organizations''; and
       (C) by striking ``addiction'' and inserting ``substance use 
     disorders'';
       (2) in subsection (e)(3), by striking ``tribes and tribal 
     organizations'' and inserting ``Tribes and Tribal 
     organizations''; and
       (3) in subsection (f), by striking ``2017 through 2021'' 
     and inserting ``2023 through 2027''.

     SEC. 214. PRIORITY SUBSTANCE USE DISORDER PREVENTION NEEDS OF 
                   REGIONAL AND NATIONAL SIGNIFICANCE.

       Section 516 of the Public Health Service Act (42 U.S.C. 
     290bb-22) is amended--
       (1) in subsection (a)--
       (A) in paragraph (3), by striking ``abuse'' and inserting 
     ``use''; and
       (B) in the matter following paragraph (3), by striking 
     ``tribes or tribal organizations'' and inserting ``Tribes or 
     Tribal organizations'';
       (2) in subsection (b), in the subsection heading, by 
     striking ``Abuse'' and inserting ``Use Disorder''; and
       (3) in subsection (f), by striking ``$211,148,000 for each 
     of fiscal years 2018 through 2022'' and inserting 
     ``$218,219,000 for each of fiscal years 2023 through 2027''.

     SEC. 215. SOBER TRUTH ON PREVENTING (STOP) UNDERAGE DRINKING 
                   REAUTHORIZATION.

       Section 519B of the Public Health Service Act (42 U.S.C. 
     290bb-25b) is amended--
       (1) by amending subsection (a) to read as follows:
       ``(a) Definitions.--For purposes of this section:
       ``(1) The term `alcohol beverage industry' means the 
     brewers, vintners, distillers, importers, distributors, and 
     retail or online outlets that sell or serve beer, wine, and 
     distilled spirits.
       ``(2) The term `school-based prevention' means programs, 
     which are institutionalized, and run by staff members or 
     school-designated persons or organizations in any grade of 
     school, kindergarten through 12th grade.
       ``(3) The term `youth' means persons under the age of 
     21.''; and
       (2) by striking subsections (c) through (g) and inserting 
     the following:
       ``(c) Interagency Coordinating Committee; Annual Report on 
     State Underage Drinking Prevention and Enforcement 
     Activities.--
       ``(1) Interagency coordinating committee on the prevention 
     of underage drinking.--
       ``(A) In general.--The Secretary, in collaboration with the 
     Federal officials specified in subparagraph (B), shall 
     continue to support and enhance the efforts of the 
     interagency coordinating committee, that began operating in 
     2004, focusing on underage drinking (referred to in this 
     subsection as the `Committee').
       ``(B) Other agencies.--The officials referred to in 
     subparagraph (A) are the Secretary of Education, the Attorney 
     General, the Secretary of Transportation, the Secretary of 
     the Treasury, the Secretary of Defense, the Surgeon General, 
     the Director of the Centers for Disease Control and 
     Prevention, the Director of the National Institute on Alcohol 
     Abuse and Alcoholism, the Assistant Secretary for Mental 
     Health and Substance Use, the Director of the National 
     Institute on Drug Abuse, the Assistant Secretary for Children 
     and Families, the Director of the Office of National Drug 
     Control Policy, the Administrator of the National Highway 
     Traffic Safety Administration, the Administrator of the 
     Office of Juvenile Justice and Delinquency Prevention, the 
     Chairman of the Federal Trade Commission, and such other 
     Federal officials as the Secretary of Health and Human 
     Services determines to be appropriate.
       ``(C) Chair.--The Secretary of Health and Human Services 
     shall serve as the chair of the Committee.
       ``(D) Duties.--The Committee shall guide policy and program 
     development across the Federal Government with respect to 
     underage drinking, provided, however, that nothing in this 
     section shall be construed as transferring regulatory or 
     program authority from an Agency to the Coordinating 
     Committee.
       ``(E) Consultations.--The Committee shall actively seek the 
     input of and shall consult with all appropriate and 
     interested parties, including States, public health research 
     and interest groups, foundations, and alcohol beverage 
     industry trade associations and companies.
       ``(F) Annual report.--
       ``(i) In general.--The Secretary, on behalf of the 
     Committee, shall annually submit to the Congress a report 
     that summarizes--

       ``(I) all programs and policies of Federal agencies 
     designed to prevent and reduce underage drinking, focusing 
     particularly on programs and policies that support the 
     adoption and enforcement of State policies designed to 
     prevent and reduce underage drinking as specified in 
     paragraph (2);
       ``(II) the extent of progress in preventing and reducing 
     underage drinking at State and national levels;
       ``(III) data that the Secretary shall collect with respect 
     to the information specified in clause (ii); and
       ``(IV) such other information regarding underage drinking 
     as the Secretary determines to be appropriate.

       ``(ii) Certain information.--The report under clause (i) 
     shall include information on the following:

       ``(I) Patterns and consequences of underage drinking as 
     reported in research and surveys such as, but not limited to, 
     Monitoring the Future, Youth Risk Behavior Surveillance 
     System, the National Survey on Drug Use and Health, and the 
     Fatality Analysis Reporting System.
       ``(II) Measures of the availability of alcohol from 
     commercial and non-commercial sources to underage 
     populations.
       ``(III) Measures of the exposure of underage populations to 
     messages regarding alcohol in advertising, social media, and 
     the entertainment media.
       ``(IV) Surveillance data, including information on the 
     onset and prevalence of underage drinking, consumption 
     patterns, beverage preferences, prevalence of drinking among 
     students at institutions of higher education, correlations 
     between adult and youth drinking, and the means of underage 
     access, including trends over time for these surveillance 
     data. The Secretary shall develop a plan to improve the 
     collection, measurement, and consistency of reporting Federal 
     underage alcohol data.
       ``(V) Any additional findings resulting from research 
     conducted or supported under subsection (f).
       ``(VI) Evidence-based best practices to prevent and reduce 
     underage drinking including a review of the research 
     literature related to State laws, regulations, and policies 
     designed to prevent and reduce underage drinking, as 
     described in paragraph (2)(B)(i).

       ``(2) Annual report on state underage drinking prevention 
     and enforcement activities.--
       ``(A) In general.--The Secretary shall, with input and 
     collaboration from other appropriate Federal agencies, 
     States, Indian Tribes, territories, and public health, 
     consumer, and alcohol beverage industry groups, annually 
     issue a report on each State's performance in enacting, 
     enforcing, and creating laws, regulations, and policies to 
     prevent or reduce underage drinking based on an assessment of 
     best practices developed pursuant to paragraph (1)(F)(ii)(VI) 
     and subparagraph (B)(i). For purposes of this paragraph, each 
     such report, with respect to a year, shall be referred to as 
     the `State Report'. Each State Report shall be designed as a 
     resource tool for Federal agencies assisting States in the 
     their underage drinking prevention efforts, State public 
     health and law enforcement agencies, State and local 
     policymakers, and underage drinking prevention coalitions 
     including those receiving grants pursuant to subsection (e).
       ``(B) State performance measures.--
       ``(i) In general.--The Secretary shall develop, in 
     consultation with the Committee, a set of measures to be used 
     in preparing the State Report on best practices as they 
     relate to State laws, regulations, policies, and enforcement 
     practices.
       ``(ii) State report content.--The State Report shall 
     include updates on State laws, regulations, and policies 
     included in previous reports to Congress, including with 
     respect to the following:

       ``(I) Whether or not the State has comprehensive anti-
     underage drinking laws such as for the illegal sale, 
     purchase, attempt to purchase, consumption, or possession of 
     alcohol; illegal use of fraudulent ID; illegal furnishing or 
     obtaining of alcohol for an individual under 21 years; the 
     degree of strictness of the penalties for such offenses; and 
     the prevalence of the enforcement of each of these 
     infractions.
       ``(II) Whether or not the State has comprehensive liability 
     statutes pertaining to underage access to alcohol such as 
     dram shop, social host,

[[Page H5760]]

     and house party laws, and the prevalence of enforcement of 
     each of these laws.
       ``(III) Whether or not the State encourages and conducts 
     comprehensive enforcement efforts to prevent underage access 
     to alcohol at retail outlets, such as random compliance 
     checks and shoulder tap programs, and the number of 
     compliance checks within alcohol retail outlets measured 
     against the number of total alcohol retail outlets in each 
     State, and the result of such checks.

       ``(IV) Whether or not the State encourages training on the 
     proper selling and serving of alcohol for all sellers and 
     servers of alcohol as a condition of employment.
       ``(V) Whether or not the State has policies and regulations 
     with regard to direct sales to consumers and home delivery of 
     alcoholic beverages.
       ``(VI) Whether or not the State has programs or laws to 
     deter adults from purchasing alcohol for minors; and the 
     number of adults targeted by these programs.
       ``(VII) Whether or not the State has enacted graduated 
     drivers licenses and the extent of those provisions.

       ``(iii) Additional categories.--In addition to the updates 
     on State laws, regulations, and policies listed in clause 
     (ii), the Secretary shall consider the following:

       ``(I) Whether or not States have adopted laws, regulations, 
     and policies that deter underage alcohol use, as described in 
     `The Surgeon General's Call to Action to Prevent and Reduce 
     Underage Drinking' issued in 2007 and `Facing Addiction in 
     America: The Surgeon General's Report on Alcohol, Drugs and 
     Health' issued in 2016, including restrictions on low-price, 
     high-volume drink specials, and wholesaler pricing 
     provisions.
       ``(II) Whether or not States have adopted laws, 
     regulations, and policies designed to reduce alcohol 
     advertising messages attractive to youth and youth exposure 
     to alcohol advertising and marketing in measured and 
     unmeasured media and digital and social media.
       ``(III) Whether or not States have laws and policies that 
     promote underage drinking prevention policy development by 
     local jurisdictions.
       ``(IV) Whether or not States have adopted laws, 
     regulations, and policies to restrict youth access to 
     alcoholic beverages that may pose special risks to youth, 
     including but not limited to alcoholic mists, gelatins, 
     freezer pops, premixed caffeinated alcoholic beverages, and 
     flavored malt beverages.
       ``(V) Whether or not States have adopted uniform best 
     practices protocols for conducting compliance checks and 
     shoulder tap programs.
       ``(VI) Whether or not States have adopted uniform best 
     practices penalty protocols for violations of laws 
     prohibiting retail licensees from selling or furnishing of 
     alcohol to minors.

       ``(iv) Uniform data system.--For performance measures 
     related to enforcement of underage drinking laws as specified 
     in clauses (ii) and (iii), the Secretary shall develop and 
     test a uniform data system for reporting State enforcement 
     data, including the development of a pilot program for this 
     purpose. The pilot program shall include procedures for 
     collecting enforcement data from both State and local law 
     enforcement jurisdictions.
       ``(3) Authorization of appropriations.--There is authorized 
     to be appropriated to carry out this subsection $1,000,000 
     for each of fiscal years 2023 through 2027.
       ``(d) National Media Campaign To Prevent Underage 
     Drinking.--
       ``(1) In general.--The Secretary, in consultation with the 
     National Highway Traffic Safety Administration, shall develop 
     an intensive, multifaceted, adult-oriented national media 
     campaign to reduce underage drinking by influencing attitudes 
     regarding underage drinking, increasing the willingness of 
     adults to take actions to reduce underage drinking, and 
     encouraging public policy changes known to decrease underage 
     drinking rates.
       ``(2) Purpose.--The purpose of the national media campaign 
     described in this section shall be to achieve the following 
     objectives:
       ``(A) Instill a broad societal commitment to reduce 
     underage drinking.
       ``(B) Increase specific actions by adults that are meant to 
     discourage or inhibit underage drinking.
       ``(C) Decrease adult conduct that tends to facilitate or 
     condone underage drinking.
       ``(3) Components.--When implementing the national media 
     campaign described in this section, the Secretary shall--
       ``(A) educate the public about the public health and safety 
     benefits of evidence-based policies to reduce underage 
     drinking, including minimum legal drinking age laws, and 
     build public and parental support for and cooperation with 
     enforcement of such policies;
       ``(B) educate the public about the negative consequences of 
     underage drinking;
       ``(C) promote specific actions by adults that are meant to 
     discourage or inhibit underage drinking, including positive 
     behavior modeling, general parental monitoring, and 
     consistent and appropriate discipline;
       ``(D) discourage adult conduct that tends to facilitate 
     underage drinking, including the hosting of underage parties 
     with alcohol and the purchasing of alcoholic beverages on 
     behalf of underage youth;
       ``(E) establish collaborative relationships with local and 
     national organizations and institutions to further the goals 
     of the campaign and assure that the messages of the campaign 
     are disseminated from a variety of sources;
       ``(F) conduct the campaign through multi-media sources; and
       ``(G) conduct the campaign with regard to changing 
     demographics and cultural and linguistic factors.
       ``(4) Consultation requirement.--In developing and 
     implementing the national media campaign described in this 
     section, the Secretary shall consult recommendations for 
     reducing underage drinking published by the National Academy 
     of Sciences and the Surgeon General. The Secretary shall also 
     consult with interested parties including medical, public 
     health, and consumer and parent groups, law enforcement, 
     institutions of higher education, community organizations and 
     coalitions, and other stakeholders supportive of the goals of 
     the campaign.
       ``(5) Annual report.--The Secretary shall produce an annual 
     report on the progress of the development or implementation 
     of the media campaign described in this subsection, including 
     expenses and projected costs, and, as such information is 
     available, report on the effectiveness of such campaign in 
     affecting adult attitudes toward underage drinking and adult 
     willingness to take actions to decrease underage drinking.
       ``(6) Research on youth-oriented campaign.--The Secretary 
     may, based on the availability of funds, conduct research on 
     the potential success of a youth-oriented national media 
     campaign to reduce underage drinking. The Secretary shall 
     report any such results to Congress with policy 
     recommendations on establishing such a campaign.
       ``(7) Administration.--The Secretary may enter into a 
     subcontract with another Federal agency to delegate the 
     authority for execution and administration of the adult-
     oriented national media campaign.
       ``(8) Authorization of appropriations.--There is authorized 
     to be appropriated to carry out this section $2,500,000 for 
     each of fiscal years 2023 through 2027.
       ``(e) Community-Based Coalition Enhancement Grants To 
     Prevent Underage Drinking.--
       ``(1) Authorization of program.--The Assistant Secretary 
     for Mental Health and Substance Use, in consultation with the 
     Director of the Office of National Drug Control Policy, shall 
     award enhancement grants to eligible entities to design, 
     implement, evaluate, and disseminate comprehensive strategies 
     to maximize the effectiveness of community-wide approaches to 
     preventing and reducing underage drinking. This subsection is 
     subject to the availability of appropriations.
       ``(2) Purposes.--The purposes of this subsection are to--
       ``(A) prevent and reduce alcohol use among youth in 
     communities throughout the United States;
       ``(B) strengthen collaboration among communities, the 
     Federal Government, Tribal Governments, and State and local 
     governments;
       ``(C) enhance intergovernmental cooperation and 
     coordination on the issue of alcohol use among youth;
       ``(D) serve as a catalyst for increased citizen 
     participation and greater collaboration among all sectors and 
     organizations of a community that first demonstrates a long-
     term commitment to reducing alcohol use among youth;
       ``(E) implement state-of-the-art science-based strategies 
     to prevent and reduce underage drinking by changing local 
     conditions in communities; and
       ``(F) enhance, not supplant, effective local community 
     initiatives for preventing and reducing alcohol use among 
     youth.
       ``(3) Application.--An eligible entity desiring an 
     enhancement grant under this subsection shall submit an 
     application to the Assistant Secretary at such time, and in 
     such manner, and accompanied by such information and 
     assurances, as the Assistant Secretary may require. Each 
     application shall include--
       ``(A) a complete description of the entity's current 
     underage alcohol use prevention initiatives and how the grant 
     will appropriately enhance the focus on underage drinking 
     issues; or
       ``(B) a complete description of the entity's current 
     initiatives, and how it will use this grant to enhance those 
     initiatives by adding a focus on underage drinking 
     prevention.
       ``(4) Uses of funds.--Each eligible entity that receives a 
     grant under this subsection shall use the grant funds to 
     carry out the activities described in such entity's 
     application submitted pursuant to paragraph (3) and obtain 
     specialized training and technical assistance by the entity 
     funded under section 4 of Public Law 107-82, as amended (21 
     U.S.C. 1521 note). Grants under this subsection shall not 
     exceed $60,000 per year and may not exceed four years.
       ``(5) Supplement not supplant.--Grant funds provided under 
     this subsection shall be used to supplement, not supplant, 
     Federal and non-Federal funds available for carrying out the 
     activities described in this subsection.
       ``(6) Evaluation.--Grants under this subsection shall be 
     subject to the same evaluation requirements and procedures as 
     the evaluation requirements and procedures imposed on 
     recipients of drug-free community grants.
       ``(7) Definitions.--For purposes of this subsection, the 
     term `eligible entity' means an organization that is 
     currently receiving or has received grant funds under the 
     Drug-Free Communities Act of 1997.
       ``(8) Administrative expenses.--Not more than 6 percent of 
     a grant under this subsection may be expended for 
     administrative expenses.
       ``(9) Authorization of appropriations.--There is authorized 
     to be appropriated to carry out this subsection $11,500,000 
     for each of fiscal years 2023 through 2027.
       ``(f) Grants to Professional Pediatric Provider 
     Organizations To Reduce Underage Drinking Through Screening 
     and Brief Interventions.--
       ``(1) In general.--The Secretary, acting through the 
     Assistant Secretary for Mental Health and Substance Use, 
     shall make one or more grants to professional pediatric 
     provider organizations to increase among the members of such 
     organizations effective practices to reduce the prevalence of 
     alcohol use among individuals under the age of 21, including 
     college students.

[[Page H5761]]

       ``(2) Purposes.--Grants under this subsection shall be made 
     to promote the practices of--
       ``(A) screening adolescents for alcohol use;
       ``(B) offering brief interventions to adolescents to 
     discourage such use;
       ``(C) educating parents about the dangers of and methods of 
     discouraging such use;
       ``(D) diagnosing and treating alcohol use disorders; and
       ``(E) referring patients, when necessary, to other 
     appropriate care.
       ``(3) Use of funds.--A professional pediatric provider 
     organization receiving a grant under this section may use the 
     grant funding to promote the practices specified in paragraph 
     (2) among its members by--
       ``(A) providing training to health care providers;
       ``(B) disseminating best practices, including culturally 
     and linguistically appropriate best practices, and 
     developing, printing, and distributing materials; and
       ``(C) supporting other activities approved by the Assistant 
     Secretary.
       ``(4) Application.--To be eligible to receive a grant under 
     this subsection, a professional pediatric provider 
     organization shall submit an application to the Assistant 
     Secretary at such time, and in such manner, and accompanied 
     by such information and assurances as the Secretary may 
     require. Each application shall include--
       ``(A) a description of the pediatric provider organization;
       ``(B) a description of the activities to be completed that 
     will promote the practices specified in paragraph (2);
       ``(C) a description of the organization's qualifications 
     for performing such practices; and
       ``(D) a timeline for the completion of such activities.
       ``(5) Definitions.--For the purpose of this subsection:
       ``(A) Brief intervention.--The term `brief intervention' 
     means, after screening a patient, providing the patient with 
     brief advice and other brief motivational enhancement 
     techniques designed to increase the insight of the patient 
     regarding the patient's alcohol use, and any realized or 
     potential consequences of such use to effect the desired 
     related behavioral change.
       ``(B) Adolescents.--The term `adolescents' means 
     individuals under 21 years of age.
       ``(C) Professional pediatric provider organization.--The 
     term `professional pediatric provider organization' means an 
     organization or association that--
       ``(i) consists of or represents pediatric health care 
     providers; and
       ``(ii) is qualified to promote the practices specified in 
     paragraph (2).
       ``(D) Screening.--The term `screening' means using 
     validated patient interview techniques to identify and assess 
     the existence and extent of alcohol use in a patient.
       ``(6) Authorization of appropriations.--There is authorized 
     to be appropriated to carry out this subsection $3,000,000 
     for each of fiscal years 2023 through 2027.
       ``(g) Data Collection and Research.--
       ``(1) Additional research on underage drinking.--
       ``(A) In general.--The Secretary shall, subject to the 
     availability of appropriations, collect data, and conduct or 
     support research that is not duplicative of research 
     currently being conducted or supported by the Department of 
     Health and Human Services, on underage drinking, with respect 
     to the following:
       ``(i) Improve data collection in support of evaluation of 
     the effectiveness of comprehensive community-based programs 
     or strategies and statewide systems to prevent and reduce 
     underage drinking, across the underage years from early 
     childhood to age 21, such as programs funded and implemented 
     by governmental entities, public health interest groups and 
     foundations, and alcohol beverage companies and trade 
     associations, through the development of models of State-
     level epidemiological surveillance of underage drinking by 
     funding in States or large metropolitan areas new 
     epidemiologists focused on excessive drinking including 
     underage alcohol use.
       ``(ii) Obtain and report more precise information than is 
     currently collected on the scope of the underage drinking 
     problem and patterns of underage alcohol consumption, 
     including improved knowledge about the problem and progress 
     in preventing, reducing, and treating underage drinking, as 
     well as information on the rate of exposure of youth to 
     advertising and other media messages encouraging and 
     discouraging alcohol consumption.
       ``(iii) Synthesize, expand on, and widely disseminate 
     existing research on effective strategies for reducing 
     underage drinking, including translational research, and make 
     this research easily accessible to the general public.
       ``(iv) Improve and conduct public health surveillance on 
     alcohol use and alcohol-related conditions in States by 
     increasing the use of surveys, such as the Behavioral Risk 
     Factor Surveillance System, to monitor binge and excessive 
     drinking and related harms among individuals who are at least 
     18 years of age, but not more than 20 years of age, including 
     harm caused to self or others as a result of alcohol use that 
     is not duplicative of research currently being conducted or 
     supported by the Department of Health and Human Services.
       ``(B) Authorization of appropriations.--There is authorized 
     to be appropriated to carry out this paragraph $5,000,000 for 
     each of fiscal years 2023 through 2027.
       ``(2) National academy of sciences study.--
       ``(A) In general.--Not later than 12 months after the 
     enactment of the Restoring Hope for Mental Health and Well-
     Being Act of 2022, the Secretary shall--
       ``(i) contract with the National Academy of Sciences to 
     study developments in research on underage drinking and the 
     public policy implications of these developments; and
       ``(ii) report to the Congress on the results of such 
     review.
       ``(B) Authorization of appropriations.--There is authorized 
     to be appropriated to carry out this paragraph $500,000 for 
     fiscal year 2023.''.

     SEC. 216. GRANTS FOR JAIL DIVERSION PROGRAMS.

       Section 520G of the Public Health Service Act (42 U.S.C. 
     290bb-38) is amended--
       (1) in subsection (a)--
       (A) by striking ``up to 125''; and
       (B) by striking ``tribes and tribal organizations'' and 
     inserting ``Tribes and Tribal organizations'';
       (2) in subsection (b)(2), by striking ``tribes, and tribal 
     organizations'' and inserting ``Tribes, and Tribal 
     organizations'';
       (3) in subsection (c)--
       (A) in paragraph (1), by striking ``tribe or tribal 
     organization'' and inserting ``Tribe or Tribal organization, 
     health facility or program described in subsection (a), or 
     public or nonprofit entity referred to in subsection (a)''; 
     and
       (B) in paragraph (2)(A)(iii), by striking ``tribe, or 
     tribal organization'' and inserting ``Tribe, or Tribal 
     organization'';
       (4) in subsection (e)--
       (A) in the matter preceding paragraph (1), by striking 
     ``tribe, or tribal organization'' and inserting ``Tribe, or 
     Tribal organization''; and
       (B) in paragraph (5), by striking ``or arrest'' and 
     inserting ``, arrest, or release'';
       (5) in subsection (f), by striking ``tribe, or tribal 
     organization'' each place it appears and inserting ``Tribe, 
     or Tribal organization'';
       (6) in subsection (h), by striking ``tribe, or tribal 
     organization'' and inserting ``Tribe, or Tribal 
     organization''; and
       (7) in subsection (j), by striking ``$4,269,000 for each of 
     fiscal years 2018 through 2022'' and inserting ``$14,000,000 
     for each of fiscal years 2023 through 2027''.

     SEC. 217. FORMULA GRANTS TO STATES.

       Section 521 of the Public Health Service Act (42 U.S.C. 
     290cc-21) is amended by striking ``2018 through 2022'' and 
     inserting ``2023 through 2027''.

     SEC. 218. PROJECTS FOR ASSISTANCE IN TRANSITION FROM 
                   HOMELESSNESS.

       Section 535(a) of the Public Health Service Act (42 U.S.C. 
     290cc-35(a)) is amended by striking ``2018 through 2022'' and 
     inserting ``2023 through 2027''.

     SEC. 219. GRANTS FOR REDUCING OVERDOSE DEATHS.

       (a) Grants.--
       (1) Repeal of maximum grant amount.--Paragraph (2) of 
     section 544(a) of the Public Health Service Act (42 U.S.C. 
     290dd-3(a)) is hereby repealed.
       (2) Eligible entity; subgrants.--Section 544(a) of the 
     Public Health Service Act (42 U.S.C. 290dd-3(a)) is amended 
     by striking paragraph (3) and inserting the following:
       ``(2) Eligible entity.--For purposes of this section, the 
     term `eligible entity' means a State, Territory, locality, 
     Indian Tribe (as defined in the Federally Recognized Indian 
     Tribe List Act of 1994), Tribal organization, or Urban Indian 
     organization (as those terms are defined in section 4 of the 
     Indian Health Care Improvement Act).
       ``(3) Subgrants.--For the purposes for which a grant is 
     awarded under this section, the eligible entity receiving the 
     grant may award subgrants to a Federally qualified health 
     center (as defined in section 1861(aa) of the Social Security 
     Act), an opioid treatment program (as defined in section 8.2 
     of title 42, Code of Federal Regulations (or any successor 
     regulations)), any practitioner dispensing narcotic drugs 
     pursuant to section 303(g) of the Controlled Substances Act, 
     or any nonprofit organization that the Secretary deems 
     appropriate.''.
       (3) Prescribing.--Section 544(a)(4) of the Public Health 
     Service Act (42 U.S.C. 290dd-3(a)(4)) is amended--
       (A) in subparagraph (A), by inserting ``, including 
     patients prescribed with both an opioid and a 
     benzodiazepine'' before the semicolon at the end; and
       (B) in subparagraph (D), by striking ``drug overdose'' and 
     inserting ``substance overdose''.
       (4) Use of funds.--Paragraph (5) of section 544(c) of the 
     Public Health Service Act (42 U.S.C. 290dd-3(c)) is amended 
     to read as follows:
       ``(5) To establish protocols to connect patients who have 
     experienced an overdose with appropriate treatment, including 
     overdose reversal medications, medication assisted treatment, 
     and appropriate counseling and behavioral therapies.''.
       (5) Improving access to overdose treatment.--Section 544 of 
     the Public Health Service Act (42 U.S.C. 290dd-3) is 
     amended--
       (A) by redesignating subsections (d) through (f) as 
     subsections (e) through (g), respectively;
       (B) in subsection (f), as so redesignated, by striking 
     ``subsection (d)'' and inserting ``subsection (e)''; and
       (C) by inserting after subsection (c) the following:
       ``(d) Improving Access to Overdose Treatment.--
       ``(1) Information on best practices.--
       ``(A) Health and human services.--The Secretary of Health 
     and Human Services may provide information to States, 
     localities, Indian Tribes, Tribal organizations, and Urban 
     Indian organizations on best practices for prescribing or co-
     prescribing a drug or device approved, cleared, or otherwise 
     authorized under the Federal Food, Drug, and Cosmetic Act for 
     emergency treatment of known or suspected opioid overdose, 
     including for patients receiving chronic opioid therapy and 
     patients being treated for opioid use disorders.

[[Page H5762]]

       ``(B) Defense.--The Secretary of Defense may provide 
     information to prescribers within Department of Defense 
     medical facilities on best practices for prescribing or co-
     prescribing a drug or device approved, cleared, or otherwise 
     authorized under the Federal Food, Drug, and Cosmetic Act for 
     emergency treatment of known or suspected opioid overdose, 
     including for patients receiving chronic opioid therapy and 
     patients being treated for opioid use disorders.
       ``(C) Veterans affairs.--The Secretary of Veterans Affairs 
     may provide information to prescribers within Department of 
     Veterans Affairs medical facilities on best practices for 
     prescribing or co-prescribing a drug or device approved, 
     cleared, or otherwise authorized under the Federal Food, 
     Drug, and Cosmetic Act for emergency treatment of known or 
     suspected opioid overdose, including for patients receiving 
     chronic opioid therapy and patients being treated for opioid 
     use disorders.
       ``(2) Rule of construction.--Nothing in this subsection 
     shall be construed as establishing or contributing to a 
     medical standard of care.''.
       (6) Authorization of appropriations.--Section 544(g) of the 
     Public Health Service Act (42 U.S.C. 290dd-3), as 
     redesignated, is amended by striking ``fiscal years 2017 
     through 2021'' and inserting ``fiscal years 2023 through 
     2027''.
       (7) Technical amendments.--
       (A) Section 544 of the Public Health Service Act (42 U.S.C. 
     290dd-3), as amended, is further amended by striking 
     ``approved or cleared'' each place it appears and inserting 
     ``approved, cleared, or otherwise authorized''.
       (B) Section 107 of the Comprehensive Addiction and Recovery 
     Act of 2016 (Public Law 114-198) is amended by striking 
     subsection (b).

     SEC. 220. OPIOID OVERDOSE REVERSAL MEDICATION ACCESS AND 
                   EDUCATION GRANT PROGRAMS.

       (a) Grants.--Section 545 of the Public Health Service Act 
     (42 U.S.C. 290ee) is amended--
       (1) in the section heading, by striking ``access and 
     education grant programs'' and inserting ``access, education, 
     and co-prescribing grant programs'';
       (2) in the heading of subsection (a), by striking ``Grants 
     to States'' and inserting ``Grants'';
       (3) in subsection (a), by striking ``shall make grants to 
     States'' and inserting ``shall make grants to States, 
     localities, Indian Tribes (as defined by the Federally 
     Recognized Indian Tribe List Act of 1994), Tribal 
     organizations, and Urban Indian organizations (as those terms 
     are defined in section 4 of the Indian Health Care 
     Improvement Act)'';
       (4) in subsection (a)(1), by striking ``implement 
     strategies for pharmacists to dispense a drug or device'' and 
     inserting ``implement strategies that increase access to 
     drugs or devices'';
       (5) by redesignating paragraphs (3) and (4) as paragraphs 
     (4) and (5), respectively; and
       (6) by inserting after paragraph (2) the following:
       ``(3) encourage health care providers to co-prescribe, as 
     appropriate, drugs or devices approved, cleared, or otherwise 
     authorized under the Federal Food, Drug, and Cosmetic Act for 
     emergency treatment of known or suspected opioid overdose;''.
       (b) Grant Period.--Section 545(d)(2) of the Public Health 
     Service Act (42 U.S.C. 290ee(d)(2)) is amended by striking 
     ``3 years'' and inserting ``5 years''.
       (c) Limitation.--Paragraph (3) of section 545(d) of the 
     Public Health Service Act (42 U.S.C. 290ee(d)) is amended to 
     read as follows:
       ``(3) Limitations.--A State may--
       ``(A) use not more than 10 percent of a grant under this 
     section for educating the public pursuant to subsection 
     (a)(5); and
       ``(B) use not less than 20 percent of a grant under this 
     section to offset cost-sharing for distribution and 
     dispensing of drugs or devices approved, cleared, or 
     otherwise authorized under the Federal Food, Drug, and 
     Cosmetic Act for emergency treatment of known or suspected 
     opioid overdose.''.
       (d) Authorization of Appropriations.--Section 545(h)(1) of 
     the Public Health Service Act, is amended by striking 
     ``fiscal years 2017 through 2019'' and inserting ``fiscal 
     years 2023 through 2027''.
       (e) Technical Amendment.--Section 545 of the Public Health 
     Service Act (42 U.S.C. 290ee), as amended, is further amended 
     by striking ``approved or cleared'' each place it appears and 
     inserting ``approved, cleared, or otherwise authorized''.

     SEC. 221. STATE DEMONSTRATION GRANTS FOR COMPREHENSIVE OPIOID 
                   ABUSE RESPONSE.

       Section 548 of the Public Health Service Act (42 U.S.C. 
     290ee-3) is amended--
       (1) in the section heading, by striking ``abuse'' and 
     inserting ``use disorder'';
       (2) in subsection (b)--
       (A) in the subsection heading, by striking ``Abuse'' and 
     inserting ``Use Disorder'';
       (B) in paragraph (1), by striking ``abuse'' and inserting 
     ``use disorder'';
       (C) in paragraph (2)--
       (i) in the matter preceding subparagraph (A), by striking 
     ``abuse'' and inserting ``use disorder'';
       (ii) in subparagraph (A), by striking ``opioid use, 
     treatment, and addiction recovery'' and inserting ``opioid 
     use disorders, and treatment for, and recovery from opioid 
     use disorders'';
       (iii) in subparagraph (C), by striking ``addiction'' each 
     place it appears and inserting ``use disorder'';
       (iv) by amending subparagraph (D) to read as follows:
       ``(D) developing, implementing, and expanding efforts to 
     prevent overdose death from opioid or other prescription 
     medication use disorders; and''; and
       (v) in subparagraph (E), by striking ``abuse'' and 
     inserting ``use disorders''; and
       (D) in paragraph (4), by striking ``abuse'' each place it 
     appears and inserting ``use disorders''; and
       (3) by striking ``2017 through 2021'' and inserting ``2023 
     through 2027''.

     SEC. 222. EMERGENCY DEPARTMENT ALTERNATIVES TO OPIOIDS.

       Section 7091 of the SUPPORT for Patients and Communities 
     Act (Public Law 115-271) is amended--
       (1) in the section heading, by striking ``demonstration'' 
     (and by conforming the item relating to such section in the 
     table of contents in section 1(b));
       (2) in subsection (a)--
       (A) by amending the subsection heading to read as follows: 
     ``Grant Program''; and
       (B) in paragraph (1), by striking ``demonstration'';
       (3) in subsection (b), in the subsection heading, by 
     striking ``Demonstration'';
       (4) in subsection (d)(4), by striking ``tribal'' and 
     inserting ``Tribal'';
       (5) in subsection (f), by striking ``Not later than 1 year 
     after completion of the demonstration program under this 
     section, the Secretary shall submit a report to the Congress 
     on the results of the demonstration program'' and inserting 
     ``Not later than the end of each of fiscal years 2024 and 
     2027, the Secretary shall submit to the Congress a report on 
     the results of the program''; and
       (6) in subsection (g), by striking ``2019 through 2021'' 
     and inserting ``2023 through 2027''.

               Subtitle C--Excellence in Recovery Housing

     SEC. 231. CLARIFYING THE ROLE OF SAMHSA IN PROMOTING THE 
                   AVAILABILITY OF HIGH-QUALITY RECOVERY HOUSING.

       Section 501(d) of the Public Health Service Act (42 U.S.C. 
     290aa) is amended--
       (1) in paragraph (24)(E), by striking ``and'' at the end;
       (2) in paragraph (25), by striking the period at the end 
     and inserting ``; and''; and
       (3) by adding at the end the following:
       ``(26) collaborate with national accrediting entities, 
     reputable providers, organizations or individuals with 
     established expertise in delivery of recovery housing 
     services, States, Federal agencies (including the Department 
     of Health and Human Services, the Department of Housing and 
     Urban Development, and the agencies listed in section 
     550(e)(2)(B)), and other relevant stakeholders, to promote 
     the availability of high-quality recovery housing and 
     services for individuals with a substance use disorder.''.

     SEC. 232. DEVELOPING GUIDELINES FOR STATES TO PROMOTE THE 
                   AVAILABILITY OF HIGH-QUALITY RECOVERY HOUSING.

       Section 550(a) of the Public Health Service Act (42 U.S.C. 
     290ee-5(a)) (relating to national recovery housing best 
     practices) is amended--
       (1) by amending paragraph (1) to read as follows:
       ``(1) In general.--The Secretary, in consultation with the 
     individuals and entities specified in paragraph (2), shall 
     build on existing best practices and previously developed 
     guidelines to develop and periodically update consensus-based 
     best practices, which may include model laws for implementing 
     suggested minimum standards for operating, and promoting the 
     availability of, high-quality recovery housing.'';
       (2) in paragraph (2)--
       (A) by striking subparagraphs (A) and (B) and inserting the 
     following:
       ``(A) Officials representing the agencies described in 
     subsection (e)(2).''; and
       (B) by redesignating subparagraphs (C) through (G) as 
     subparagraphs (B) through (F), respectively; and
       (3) by adding at the end the following:
       ``(3) Availability.--The best practices referred to in 
     paragraph (1) shall be--
       ``(A) made publicly available; and
       ``(B) published on the public website of the Substance 
     Abuse and Mental Health Services Administration.
       ``(4) Exclusion of guideline on treatment services.--In 
     developing the guidelines under paragraph (1), the Secretary 
     may not include any guidelines with respect to substance use 
     disorder treatment services.''.

     SEC. 233. COORDINATION OF FEDERAL ACTIVITIES TO PROMOTE THE 
                   AVAILABILITY OF RECOVERY HOUSING.

       Section 550 of the Public Health Service Act (42 U.S.C. 
     290ee-5) (relating to national recovery housing best 
     practices) is amended--
       (1) by redesignating subsections (e), (f), and (g) as 
     subsections (g), (h), and (i), respectively; and
       (2) by inserting after subsection (d) the following:
       ``(e) Coordination of Federal Activities To Promote the 
     Availability of Housing for Individuals Experiencing 
     Homelessness, Individuals With a Mental Illness, and 
     Individuals With a Substance Use Disorder.--
       ``(1) In general.--The Secretary, acting through the 
     Assistant Secretary, and the Secretary of Housing and Urban 
     Development shall convene an interagency working group for 
     the following purposes:
       ``(A) To increase collaboration, cooperation, and 
     consultation among the Department of Health and Human 
     Services, the Department of Housing and Urban Development, 
     and the Federal agencies listed in paragraph (2)(B), with 
     respect to promoting the availability of housing, including 
     recovery housing, for individuals experiencing homelessness, 
     individuals with mental illnesses, and individuals with 
     substance use disorder.
       ``(B) To align the efforts of such agencies and avoid 
     duplication of such efforts by such agencies.
       ``(C) To develop objectives, priorities, and a long-term 
     plan for supporting State, Tribal, and local efforts with 
     respect to the operation of recovery housing that is 
     consistent with the best practices developed under this 
     section.

[[Page H5763]]

       ``(D) To coordinate enforcement of fair housing practices, 
     as appropriate, among Federal and State agencies.
       ``(E) To coordinate data collection on the quality of 
     recovery housing.
       ``(2) Composition.--The interagency working group under 
     paragraph (1) shall be composed of--
       ``(A) the Secretary, acting through the Assistant 
     Secretary, and the Secretary of Housing and Urban 
     Development, who shall serve as the co-chairs; and
       ``(B) representatives of each of the following Federal 
     agencies:
       ``(i) The Centers for Medicare & Medicaid Services.
       ``(ii) The Substance Abuse and Mental Health Services 
     Administration.
       ``(iii) The Health Resources and Services Administration.
       ``(iv) The Office of Inspector General.
       ``(v) The Indian Health Service.
       ``(vi) The Department of Agriculture.
       ``(vii) The Department of Justice.
       ``(viii) The Office of National Drug Control Policy.
       ``(ix) The Bureau of Indian Affairs.
       ``(x) The Department of Labor.
       ``(xi) The Department of Veterans Affairs.
       ``(xii) Any other Federal agency as the co-chairs determine 
     appropriate.
       ``(3) Meetings.--The working group shall meet on a 
     quarterly basis.
       ``(4) Reports to congress.--Not later than 4 years after 
     the date of the enactment of this section, the working group 
     shall submit to the Committee on Energy and Commerce, the 
     Committee on Ways and Means, the Committee on Agriculture, 
     and the Committee on Financial Services of the House of 
     Representatives and the Committee on Health, Education, 
     Labor, and Pensions, the Committee on Agriculture, Nutrition, 
     and Forestry, and the Committee on Finance of the Senate a 
     report describing the work of the working group and any 
     recommendations of the working group to improve Federal, 
     State, and local coordination with respect to recovery 
     housing and other housing resources and operations for 
     individuals experiencing homelessness, individuals with a 
     mental illness, and individuals with a substance use 
     disorder.''.

     SEC. 234. NAS STUDY AND REPORT.

       (a) In General.--Not later than 60 days after the date of 
     enactment of this Act, the Secretary of Health and Human 
     Services, acting through the Assistant Secretary for Mental 
     Health and Substance Use shall--
       (1) contract with the National Academies of Sciences, 
     Engineering, and Medicine--
       (A) to study the quality and effectiveness of recovery 
     housing in the United States and whether the availability of 
     such housing meets demand; and
       (B) to identify recommendations to promote the availability 
     of high-quality recovery housing; and
       (2) report to the Congress on the results of such review.
       (b) Authorization of Appropriations.--To carry out this 
     section there is authorized to be appropriated $1,500,000 for 
     fiscal year 2023.

     SEC. 235. GRANTS FOR STATES TO PROMOTE THE AVAILABILITY OF 
                   RECOVERY HOUSING AND SERVICES.

       Section 550 of the Public Health Service Act (42 U.S.C. 
     290ee-5) (relating to national recovery housing best 
     practices), as amended by sections 232 and 233, is further 
     amended by inserting after subsection (e) (as inserted by 
     section 233) the following:
       ``(f) Grants for Implementing National Recovery Housing 
     Best Practices.--
       ``(1) In general.--The Secretary shall award grants to 
     States (and political subdivisions thereof), Tribes, and 
     territories--
       ``(A) for the provision of technical assistance to 
     implement the guidelines and recommendations developed under 
     subsection (a); and
       ``(B) to promote--
       ``(i) the availability of recovery housing for individuals 
     with a substance use disorder; and
       ``(ii) the maintenance of recovery housing in accordance 
     with best practices developed under this section.
       ``(2) State promotion plans.--Not later than 90 days after 
     receipt of a grant under paragraph (1), and every 2 years 
     thereafter, each State (or political subdivisions thereof,) 
     Tribe, or territory receiving a grant under paragraph (1) 
     shall submit to the Secretary, and publish on a publicly 
     accessible internet website of the State (or political 
     subdivisions thereof), Tribe, or territory--
       ``(A) the plan of the State (or political subdivisions 
     thereof), Tribe, or territory, with respect to the promotion 
     of recovery housing for individuals with a substance use 
     disorder located within the jurisdiction of such State (or 
     political subdivisions thereof), Tribe, or territory; and
       ``(B) a description of how such plan is consistent with the 
     best practices developed under this section.''.

     SEC. 236. FUNDING.

       Subsection (i) of section 550 of the Public Health Service 
     Act (42 U.S.C. 290ee-5) (relating to national recovery 
     housing best practices), as redesignated by section 233, is 
     amended by striking ``$3,000,000 for the period of fiscal 
     years 2019 through 2021'' and inserting ``$5,000,000 for the 
     period of fiscal years 2023 through 2027''.

     SEC. 237. TECHNICAL CORRECTION.

       Title V of the Public Health Service Act (42 U.S.C. 290aa 
     et seq.) is amended--
       (1) by redesignating section 550 (relating to Sobriety 
     Treatment and Recovery Teams) (42 U.S.C. 290ee-10), as added 
     by section 8214 of Public Law 115-271, as section 550A; and
       (2) by moving such section so it appears after section 550 
     (relating to national recovery housing best practices).

Subtitle D--Substance Use Prevention, Treatment, and Recovery Services 
                              Block Grant

     SEC. 241. ELIMINATING STIGMATIZING LANGUAGE RELATING TO 
                   SUBSTANCE USE.

       (a) Block Grants for Prevention and Treatment of Substance 
     Use.--Part B of title XIX of the Public Health Service Act 
     (42 U.S.C. 300x et seq.) is amended--
       (1) in the part heading, by striking ``substance abuse'' 
     and inserting ``substance use'';
       (2) in subpart II, by amending the subpart heading to read 
     as follows: ``Block Grants for Substance Use Prevention, 
     Treatment, and Recovery Services'';
       (3) in section 1922(a) (42 U.S.C. 300x-22(a))--
       (A) in paragraph (1), in the matter preceding subparagraph 
     (A), by striking ``substance abuse'' and inserting 
     ``substance use disorders''; and
       (B) by striking ``such abuse'' each place it appears in 
     paragraphs (1) and (2) and inserting ``such disorders'';
       (4) in section 1923 (42 U.S.C. 300x-23)--
       (A) in the section heading, by striking ``substance abuse'' 
     and inserting ``substance use''; and
       (B) in subsection (a), by striking ``drug abuse'' and 
     inserting ``substance use disorders'';
       (5) in section 1925(a)(1) (42 U.S.C. 300x-25(a)(1)), by 
     striking ``alcohol or drug abuse'' and inserting ``alcohol or 
     other substance use disorders'';
       (6) in section 1926(b)(2)(B) (42 U.S.C. 300x-26(b)(2)(B)), 
     by striking ``substance abuse'';
       (7) in section 1931(b)(2) (42 U.S.C. 300x-31(b)(2)), by 
     striking ``substance abuse'' and inserting ``substance use 
     disorders'';
       (8) in section 1933(d)(1) (42 U.S.C. 300x-33(d)), in the 
     matter following subparagraph (B), by striking ``abuse of 
     alcohol and other drugs'' and inserting ``use of 
     substances'';
       (9) by amending paragraph (4) of section 1934 (42 U.S.C. 
     300x-34) to read as follows:
       ``(4) The term `substance use disorder' means the recurrent 
     use of alcohol or other drugs that causes clinically 
     significant impairment.'';
       (10) in section 1935 (42 U.S.C. 300x-35)--
       (A) in subsection (a), by striking ``substance abuse'' and 
     inserting ``substance use disorders''; and
       (B) in subsection (b)(1), by striking ``substance abuse'' 
     each place it appears and inserting ``substance use 
     disorders'';
       (11) in section 1949 (42 U.S.C. 300x-59), by striking 
     ``substance abuse'' each place it appears in subsections (a) 
     and (d) and inserting ``substance use disorders'';
       (12) in section 1954(b)(4) (42 U.S.C. 300x-64(b)(4))--
       (A) by striking ``substance abuse'' and inserting 
     ``substance use disorders''; and
       (B) by striking ``such abuse'' and inserting ``such 
     disorders'';
       (13) in section 1955 (42 U.S.C. 300x-65), by striking 
     ``substance abuse'' each place it appears and inserting 
     ``substance use disorder''; and
       (14) in section 1956 (42 U.S.C. 300x-66), by striking 
     ``substance abuse'' and inserting ``substance use 
     disorders''.
       (b) Certain Programs Regarding Mental Health and Substance 
     Abuse.--Part C of title XIX of the Public Health Service Act 
     (42 U.S.C. 300y et seq.) is amended--
       (1) in the part heading, by striking ``substance abuse'' 
     and inserting ``substance use'';
       (2) in section 1971 (42 U.S.C. 300y), by striking 
     ``substance abuse'' each place it appears in subsections (a), 
     (b), and (f) and inserting ``substance use''; and
       (3) in section 1976 (42 U.S.C. 300y-11), by striking 
     ``intravenous abuse'' each place it appears and inserting 
     ``intravenous use''.

     SEC. 242. AUTHORIZED ACTIVITIES.

       Section 1921(b) of the Public Health Service Act (42 U.S.C. 
     300x-21(b)) is amended by striking ``prevent and treat 
     substance use disorders'' and inserting ``prevent, treat, and 
     provide recovery support services for substance use 
     disorders''.

     SEC. 243. REQUIREMENTS RELATING TO CERTAIN INFECTIOUS 
                   DISEASES AND HUMAN IMMUNODEFICIENCY VIRUS.

       Section 1924 of the Public Health Service Act (42 U.S.C. 
     300x-24) is amended--
       (1) in the section heading, by striking ``tuberculosis and 
     human immunodeficiency virus'' and inserting ``tuberculosis, 
     viral hepatitis, and human immunodeficiency virus'';
       (2) by amending subsection (a)(2) to read as follows:
       ``(2) Designated states.--
       ``(A) Fiscal years through fiscal year 2024.--For purposes 
     of this subsection, through September 30, 2024, a State 
     described in this paragraph is any State whose rate of cases 
     of acquired immune deficiency syndrome is 10 or more such 
     cases per 100,000 individuals (as indicated by the number of 
     such cases reported to and confirmed by the Director of the 
     Centers for Disease Control and Prevention for the most 
     recent calendar year for which such data are available).
       ``(B) Fiscal year 2025 and succeeding fiscal years.--
       ``(i) In general.--Beginning with fiscal year 2025, for 
     purposes of this subsection, a State described in this 
     paragraph is any State whose rate of cases of human 
     immunodeficiency virus is 10 or more such cases per 100,000 
     individuals (as indicated by the number of such cases newly 
     reported to and confirmed by the Director of the Centers for 
     Disease Control and Prevention for the most recent calendar 
     year for which such data are available).
       ``(ii) Continuation of designated state status.--In the 
     case of a State whose rate of cases of human immunodeficiency 
     virus falls below the threshold specified in clause (i) for a 
     calendar year, such State shall, notwithstanding clause (i), 
     continue to be described in this paragraph unless the rate of 
     cases falls below such threshold for three consecutive 
     calendar years.''.

[[Page H5764]]

       (3) by redesignating subsections (c) and (d) as subsections 
     (d) and (e), respectively; and
       (4) by inserting after subsection (b) the following:
       ``(c) Viral Hepatitis.--
       ``(1) In general.--A funding agreement for a grant under 
     section 1921 is that the State involved will require that any 
     entity receiving amounts from the grant for operating a 
     program of treatment for substance use disorders--
       ``(A) will, directly or through arrangements with other 
     public or nonprofit private entities, routinely make 
     available viral hepatitis services to each individual 
     receiving treatment for such disorders; and
       ``(B) in the case of an individual in need of such 
     treatment who is denied admission to the program on the basis 
     of the lack of the capacity of the program to admit the 
     individual, will refer the individual to another provider of 
     viral hepatitis services.
       ``(2) Viral hepatitis services.--For purposes of paragraph 
     (1), the term `viral hepatitis services', with respect to an 
     individual, means--
       ``(A) screening the individual for viral hepatitis; and
       ``(B) referring the individual to a provider whose practice 
     includes viral hepatitis vaccination and treatment.''.

     SEC. 244. STATE PLAN REQUIREMENTS.

       Section 1932(b)(1)(A) of the Public Health Service Act (42 
     U.S.C. 300x-32(b)(1)(A)) is amended--
       (1) by redesignating clauses (vi) through (ix) as clauses 
     (vii) through (x), respectively; and
       (2) by inserting after clause (v) the following:
       ``(vi) provides a description of--

       ``(I) the State's comprehensive statewide recovery support 
     services activities, including the number of individuals 
     being served, target populations, and priority needs; and
       ``(II) the amount of funds received under this subpart 
     expended on recovery support services, disaggregated by the 
     amount expended for type of service activity;''.

     SEC. 245. UPDATING CERTAIN LANGUAGE RELATING TO TRIBES.

       Section 1933(d) of the Public Health Service Act (42 U.S.C. 
     300x-33(d)) is amended--
       (1) in paragraph (1)--
       (A) in subparagraph (A)--
       (i) by striking ``of an Indian tribe or tribal 
     organization'' and inserting ``of an Indian Tribe or Tribal 
     organization''; and
       (ii) by striking ``such tribe'' and inserting ``such 
     Tribe'';
       (B) in subparagraph (B)--
       (i) by striking ``tribe or tribal organization'' and 
     inserting ``Tribe or Tribal organization''; and
       (ii) by striking ``Secretary under this'' and inserting 
     ``Secretary under this subpart''; and
       (C) in the matter following subparagraph (B), by striking 
     ``tribe or tribal organization'' and inserting ``Tribe or 
     Tribal organization'';
       (2) by amending paragraph (2) to read as follows:
       ``(2) Indian tribe or tribal organization as grantee.--The 
     amount reserved by the Secretary on the basis of a 
     determination under this subsection shall be granted to the 
     Indian Tribe or Tribal organization serving the individuals 
     for whom such a determination has been made.'';
       (3) in paragraph (3), by striking ``tribe or tribal 
     organization'' and inserting ``Tribe or Tribal 
     organization''; and
       (4) in paragraph (4)--
       (A) in the paragraph heading, by striking ``Definition'' 
     and inserting ``Definitions''; and
       (B) by striking ``The terms'' and all that follows through 
     ``given such terms'' and inserting the following: ``The terms 
     `Indian Tribe' and `Tribal organization' have the meanings 
     given the terms `Indian tribe' and `tribal organization' ''.

     SEC. 246. BLOCK GRANTS FOR SUBSTANCE USE PREVENTION, 
                   TREATMENT, AND RECOVERY SERVICES.

       (a) In General.--Section 1935(a) of the Public Health 
     Service Act (42 U.S.C. 300x-35(a)), as amended by section 
     241, is further amended by striking ``appropriated'' and all 
     that follows through ``2022..'' and inserting the following: 
     ``appropriated $1,908,079,000 for each of fiscal years 2023 
     through 2027.''.
       (b) Technical Corrections.--Section 1935(b)(1)(B) of the 
     Public Health Service Act (42 U.S.C. 300x-35(b)(1)(B)) is 
     amended by striking ``the collection of data in this 
     paragraph is''.

     SEC. 247. REQUIREMENT OF REPORTS AND AUDITS BY STATES.

       Section 1942(a) of the Public Health Service Act (42 U.S.C. 
     300x-52(a)) is amended--
       (1) in paragraph (1), by striking ``and'' at the end;
       (2) in paragraph (2), by striking the period at the end and 
     inserting ``; and''; and
       (3) by adding at the end the following:
       ``(3) the amount provided to each recipient in the previous 
     fiscal year.''.

     SEC. 248. STUDY ON ASSESSMENT FOR USE IN DISTRIBUTION OF 
                   LIMITED STATE RESOURCES.

       (a) In General.--The Secretary of Health and Human 
     Services, acting through the Assistant Secretary for Mental 
     Health and Substance Use (in this section referred to as the 
     ``Secretary''), shall, in consultation with States and other 
     local entities providing prevention, treatment, or recovery 
     support services related to substance use, conduct a study to 
     develop a model needs assessment process for States to 
     consider to help determine how best to allocate block grant 
     funding received under subpart II of part B of title XIX of 
     the Public Health Service Act (42 U.S.C. 300x-21) to provide 
     services to substance use disorder prevention, treatment, and 
     recovery support. The study shall include cost estimates with 
     each model needs assessment process.
       (b) Report.--Not later than 2 years after the date of the 
     enactment of this Act, the Secretary shall submit to the 
     Committee on Energy and Commerce of the House of 
     Representatives and the Committee on Health, Education, 
     Labor, and Pensions of the Senate a report on the results of 
     the study conducted under paragraph (1).

          Subtitle E--Timely Treatment for Opioid Use Disorder

     SEC. 251. STUDY ON EXEMPTIONS FOR TREATMENT OF OPIOID USE 
                   DISORDER THROUGH OPIOID TREATMENT PROGRAMS 
                   DURING THE COVID-19 PUBLIC HEALTH EMERGENCY.

       (a) Study.--The Assistant Secretary for Mental Health and 
     Substance Use shall conduct a study, in consultation with 
     patients and other stakeholders, on activities carried out 
     pursuant to exemptions granted--
       (1) to a State (including the District of Columbia or any 
     territory of the United States) or an opioid treatment 
     program;
       (2) pursuant to section 8.11(h) of title 42, Code of 
     Federal Regulations; and
       (3) during the period--
       (A) beginning on the declaration of the public health 
     emergency for the COVID-19 pandemic under section 319 of the 
     Public Health Service Act (42 U.S.C. 247d); and
       (B) ending on the earlier of--
       (i) the termination of such public health emergency, 
     including extensions thereof pursuant to such section 319; 
     and
       (ii) the end of calendar year 2022.
       (b) Privacy.--The section does not authorize the disclosure 
     by the Department of Health and Human Services of 
     individually identifiable information about patients.
       (c) Feedback.--In conducting the study under subsection 
     (a), the Assistant Secretary for Mental Health and Substance 
     Use shall gather feedback from the States and opioid 
     treatment programs on their experiences in implementing 
     exemptions described in subsection (a).
       (d) Report.--Not later than 180 days after the end of the 
     period described in subsection (a)(3)(B), and subject to 
     subsection (c), the Assistant Secretary for Mental Health and 
     Substance Use shall publish a report on the results of the 
     study under this section.

     SEC. 252. CHANGES TO FEDERAL OPIOID TREATMENT STANDARDS.

       (a) Mobile Medication Units.--Section 302(e) of the 
     Controlled Substances Act (21 U.S.C. 822(e)) is amended by 
     adding at the end the following:
       ``(3) Notwithstanding paragraph (1), a registrant that is 
     dispensing pursuant to section 303(g) narcotic drugs to 
     individuals for maintenance treatment or detoxification 
     treatment shall not be required to have a separate 
     registration to incorporate one or more mobile medication 
     units into the registrant's practice to dispense such 
     narcotics at locations other than the registrant's principal 
     place of business or professional practice described in 
     paragraph (1), so long as the registrant meets such standards 
     for operation of a mobile medication unit as the Attorney 
     General may establish.''.
       (b) Revise Opioid Treatment Program Admission Criteria to 
     Eliminate Requirement That Patients Have an Opioid Use 
     Disorder for at Least 1 Year.--Not later than 18 months after 
     the date of enactment of this Act, the Secretary of Health 
     and Human Services shall revise section 8.12(e)(1) of title 
     42, Code of Federal Regulations (or successor regulations), 
     to eliminate the requirement that an opioid treatment program 
     only admit an individual for treatment under the program if 
     the individual has been addicted to opioids for at least 1 
     year before being so admitted for treatment.
       (c) Final Regulation on Periods for Take-Home Supply 
     Requirements.--
       (1) In general.--Not later than 18 months after the date of 
     enactment of this Act, the Secretary of Health and Human 
     Services shall promulgate a final regulation amending 
     paragraphs (i)(3)(i) through (i)(3)(vi) of section 8.12 of 
     title 42, Code of Federal Regulations, as appropriate based 
     on the findings of the study under section 251 of this Act.
       (2) Criteria.--The regulation under paragraph (1) shall 
     establish relevant criteria for the medical director or an 
     appropriately licensed practitioner of an opioid treatment 
     program, to determine whether a patient is stable and may 
     qualify for unsupervised use, which criteria may allow for 
     consideration of each of the following:
       (A) Whether the benefits of providing unsupervised doses to 
     a patient outweigh the risks.
       (B) The patient's demonstrated adherence to their treatment 
     plan.
       (C) The patient's history of negative toxicology tests.
       (D) Whether there is an absence of serious behavioral 
     problems.
       (E) The patient's stability in living arrangements and 
     social relationships.
       (F) Whether there is an absence of substance misuse-related 
     behaviors.
       (G) Whether there is an absence of recent diversion 
     activity.
       (H) Whether there is an assurance that the medication can 
     be safely stored by the patient.
       (I) Any other criterion the Secretary of Health and Human 
     Services determines appropriate.
       (3) Prohibited sole consideration.--The regulation under 
     paragraph (1) shall prohibit the medical director of an 
     opioid treatment program from considering, as the sole 
     consideration in determining whether a patient is 
     sufficiently responsible in handling opioid drugs for 
     unsupervised use, whether the patient has an absence of 
     recent misuse of drugs (whether narcotic or nonnarcotic), 
     including alcohol.

   Subtitle F--Additional Provisions Relating to Addiction Treatment

     SEC. 261. PROHIBITION.

       Notwithstanding any provision of this Act and the 
     amendments made by this Act, no funds

[[Page H5765]]

     made available to carry out this Act or any amendment made by 
     this Act shall be used to purchase, procure, or distribute 
     pipes or cylindrical objects intended to be used to smoke or 
     inhale illegal scheduled substances.

     SEC. 262. ELIMINATING ADDITIONAL REQUIREMENTS FOR DISPENSING 
                   NARCOTIC DRUGS IN SCHEDULE III, IV, AND V FOR 
                   MAINTENANCE OR DETOXIFICATION TREATMENT.

       (a) In General.--Section 303(g) of the Controlled 
     Substances Act (21 U.S.C. 823(g)) is amended--
       (1) by striking paragraph (2);
       (2) by striking ``(g)(1) Except as provided in paragraph 
     (2), practitioners who dispense narcotic drugs to individuals 
     for maintenance treatment or detoxification treatment'' and 
     inserting ``(g) Practitioners who dispense narcotic drugs 
     (other than narcotic drugs in schedule III, IV, or V) to 
     individuals for maintenance treatment or detoxification 
     treatment'';
       (3) by redesignating subparagraphs (A), (B), and (C) as 
     paragraphs (1), (2), and (3), respectively; and
       (4) in paragraph (2), as so redesignated--
       (A) by striking ``(i) security of stocks'' and inserting 
     ``(A) security of stocks''; and
       (B) by striking ``(ii) the maintenance of records'' and 
     inserting ``(B) the maintenance of records''.
       (b) Conforming Changes.--
       (1) Subsections (a) and (d)(1) of section 304 of the 
     Controlled Substances Act (21 U.S.C. 824) are each amended by 
     striking ``303(g)(1)'' each place it appears and inserting 
     ``303(g)''.
       (2) Section 309A(a)(2) of the Controlled Substances Act (21 
     U.S.C. 829a) is amended--
       (A) in the matter preceding subparagraph (A), by striking 
     ``the controlled substance is to be administered for the 
     purpose of maintenance or detoxification treatment under 
     section 303(g)(2)'' and inserting ``the controlled substance 
     is a narcotic drug in schedule III, IV, or V to be 
     administered for the purpose of maintenance or detoxification 
     treatment''; and
       (B) by striking ``and--'' and all that follows through ``is 
     to be administered by injection or implantation;'' and 
     inserting ``and is to be administered by injection or 
     implantation;''.
       (3) Section 520E-4(c) of the Public Health Service Act (42 
     U.S.C. 290bb-36d(c)) is amended by striking ``information on 
     any qualified practitioner that is certified to prescribe 
     medication for opioid dependency under section 303(g)(2)(B) 
     of the Controlled Substances Act'' and inserting 
     ``information on any practitioner who prescribes narcotic 
     drugs in schedule III, IV, or V of section 202 of the 
     Controlled Substances Act for the purpose of maintenance or 
     detoxification treatment''.
       (4) Section 544(a)(3) of the Public Health Service Act (42 
     U.S.C. 290dd-3), as added by section 219(a)(2), is amended by 
     striking ``any practitioner dispensing narcotic drugs 
     pursuant to section 303(g) of the Controlled Substances Act'' 
     and inserting ``any practitioner dispensing narcotic drugs 
     for the purpose of maintenance or detoxification treatment''.
       (5) Section 1833(bb)(3)(B) of the Social Security Act (42 
     U.S.C. 1395l(bb)(3)(B)) is amended by striking ``first 
     receives a waiver under section 303(g) of the Controlled 
     Substances Act on or after January 1, 2019'' and inserting 
     ``first begins prescribing narcotic drugs in schedule III, 
     IV, or V of section 202 of the Controlled Substances Act for 
     the purpose of maintenance or detoxification treatment on or 
     after January 1, 2021''.
       (6) Section 1834(o)(3)(C)(ii) of the Social Security Act 
     (42 U.S.C. 1395m(o)(3)(C)(ii)) is amended by striking ``first 
     receives a waiver under section 303(g) of the Controlled 
     Substances Act on or after January 1, 2019'' and inserting 
     ``first begins prescribing narcotic drugs in schedule III, 
     IV, or V of section 202 of the Controlled Substances Act for 
     the purpose of maintenance or detoxification treatment on or 
     after January 1, 2021''.
       (7) Section 1866F(c)(3) of the Social Security Act (42 
     U.S.C. 1395cc-6(c)(3)) is amended--
       (A) in subparagraph (A), by adding ``and'' at the end;
       (B) in subparagraph (B), by striking ``; and'' and 
     inserting a period; and
       (C) by striking subparagraph (C).
       (8) Section 1903(aa)(2)(C) of the Social Security Act (42 
     U.S.C. 1396b(aa)(2)(C)) is amended--
       (A) in clause (i), by adding ``and'' at the end;
       (B) by striking clause (ii); and
       (C) by redesignating clause (iii) as clause (ii).

     SEC. 263. REQUIRING PRESCRIBERS OF CONTROLLED SUBSTANCES TO 
                   COMPLETE TRAINING.

       Section 303 of the Controlled Substances Act (21 U.S.C. 
     823) is amended by adding at the end the following:
       ``(l) Required Training for Prescribers.--
       ``(1) Training required.--As a condition on registration 
     under this section to dispense controlled substances in 
     schedule II, III, IV, or V, the Attorney General shall 
     require any qualified practitioner, beginning with the first 
     applicable registration for the practitioner, to meet the 
     following:
       ``(A) If the practitioner is a physician is a physician (as 
     defined under section 1861(r) of the Social Security Act), 
     the practitioner meets one ore more of the following 
     conditions:
       ``(i) The physician holds a board certification in 
     addiction psychiatry or addiction medicine from the American 
     Board of Medical Specialties.
       ``(ii) The physician holds a board certification from the 
     American Board of Addiction Medicine.
       ``(iii) The physician holds a board certification in 
     addiction medicine from the American Osteopathic Association.
       ``(iv) The physician has, with respect to the treatment and 
     management of patients with opioid or other substance use 
     disorders, of the safe pharmacological management of dental 
     pain and screening, brief intervention, and referral for 
     appropriate treatment of patients with or at risk of 
     developing opioid or other substance use disorders, completed 
     not less than 8 hours of training (through classroom 
     situations, seminars at professional society meetings, 
     electronic communications, or otherwise that is provided by--

       ``(I) the American Society of Addiction Medicine, the 
     American Academy of Addiction Psychiatry, the American 
     Medical Association, the American Osteopathic Association, 
     the American Dental Association, the American Association of 
     Oral and Maxillofacial Surgeons, the American Psychiatric 
     Assocation, or any other organization accredited by the 
     Accreditation Council for Continuing Medical Education 
     (commonly known as the `ACCME') or the Commission on Dental 
     Accreditation;
       ``(II) any organization accredited by a State medical 
     society accreditor that is recognized by the ACCME or the 
     Commission on Dental Accreditation;
       ``(III) any organization accredited by the American 
     Osteopathic Association to provide continuing medical 
     education; or
       ``(IV) any organization approved by the Assistant Secretary 
     for Mental Health and Substance Abuse or the ACCME, of the 
     Commission on Dental Accreditation.

       ``(v) The physician graduated in good standing from an 
     accredited school of allopathic medicine or osteopathic 
     medicine, dental surgery, or dental medicine in the United 
     States during the 5-year period immediately preceding the 
     date on which the physician first registers or renews under 
     this section and has successfully completed a comprehensive 
     allopathic or osteopathic medicine curriculum or accredited 
     medical residency or dental surgery or dental medicine 
     curriculum that included not less than 8 hours of training 
     on--hat included not less than 8 hours of training on 
     treating and managing patients with opioid and other 
     substance use disorders, including the appropriate clinical 
     use of all drugs approved by the Food and Drug Administration 
     for the treatment of a substance use disorder.

       ``(I) treating and managing patents with opioid and other 
     substance use disorders, including the appropriate clinical 
     use of all drugs approved by the Food and Drug Administration 
     for the treatment of a substance use disorder; or
       ``(II) the safe pharmacological management of dental pain 
     and screening, brief intervention, and referral for 
     appropriate treatment of patients with or at risk of 
     developing opioid and other substance us disorders.

       ``(B) If the practitioner is not a physician (as defined 
     under section 1861(r) of the Social Security Act), the 
     practitioner meets one or more of the following conditions:
       ``(i) The practitioner has completed not fewer than 8 hours 
     of training with respect to the treatment and management of 
     patients with opioid or other substance use disorders 
     (through classroom situations, seminars at professional 
     society meetings, electronic communications, or otherwise) 
     provided by the American Society of Addiction Medicine, the 
     American Academy of Addiction Psychiatry, the American 
     Medical Association, the American Osteopathic Association, 
     the American Nurses Credentialing Center, the American 
     Psychiatric Association, the American Association of Nurse 
     Practitioners, the American Academy of Physician Associates, 
     or any other organization approved or accredited by the 
     Assistant Secretary for Mental Health and Substance Abuse or 
     the or the Accreditation Council for Continuing Medical 
     Education.
       ``(ii) The practitioner has graduated in good standing from 
     an accredited physician assistant school or accredited school 
     of advanced practice nursing in the United States during the 
     5-year period immediately preceding the date on which the 
     practitioner first registers or renews under this section and 
     has successfully completed a comprehensive physician 
     assistant or advanced practice nursing curriculum that 
     included not fewer than 8 hours of training on treating and 
     managing patients with opioid and other substance use 
     disorders, including the appropriate clinical use of all 
     drugs approved by the Food and Drug Administration for the 
     treatment of a substance use disorder.
       ``(2) One-time training.--
       ``(A) In general.--The Attorney General shall not require 
     any qualified practitioner to complete the training described 
     in clause (iv) or (v) of paragraph (1)(A) or clause (i) or 
     (ii) of paragraph (1)(B) more than once.
       ``(B) Notification.--Not later than 90 days after the date 
     of the enactment of the Restoring Hope for mental health and 
     Well-Being Act of 2022, the Attorney General shall provide to 
     qualified practitioners a single written, electronic 
     notification of the training described in clauses (i) and 
     (ii) of paragraph (1)(B).
       ``(3) Rule of construction.--Nothing in this subsection 
     shall be construed to preclude the use, by a qualified 
     practitioner, of training received pursuant to this 
     subsection to satisfy registration requirements of a State or 
     for some other lawful purpose.
       ``(4) Definitions.--In this section:
       ``(A) First applicable registration.--The term `first 
     applicable registration' means the first registration or 
     renewal of registration by a qualified practitioner under 
     this section that occurs on or after the date that is 180 
     days after the date of enactment of the Restoring Hope for 
     Mental Health and Well-Being Act of 2022.
       ``(B) Qualified practitioner.--In this subsection, the term 
     `qualified practitioner' means a practitioner who--
       ``(i) is licensed under State law to prescribe controlled 
     substances; and
       ``(ii) is not solely a veterinarian.''.

[[Page H5766]]

  


          TITLE III--ACCESS TO MENTAL HEALTH CARE AND COVERAGE

       Subtitle A--Collaborate in an Orderly and Cohesive Manner

     SEC. 301. INCREASING UPTAKE OF THE COLLABORATIVE CARE MODEL.

       Section 520K of the Public Health Service Act (42 U.S.C. 
     290bb-42) is amended to read as follows:

     ``SEC. 520K. INTEGRATION INCENTIVE GRANTS AND COOPERATIVE 
                   AGREEMENTS.

       ``(a) Definitions.--In this section:
       ``(1) Collaborative care model.--The term `collaborative 
     care model' means the evidence-based, integrated behavioral 
     health service delivery method that includes--
       ``(A) care directed by the primary care team;
       ``(B) structured care management;
       ``(C) regular assessments of clinical status using 
     developmentally appropriate, validated tools; and
       ``(D) modification of treatment as appropriate.
       ``(2) Eligible entity.--The term `eligible entity' means a 
     State, or an appropriate State agency, in collaboration 
     with--
       ``(A) 1 or more qualified community programs as described 
     in section 1913(b)(1);
       ``(B) 1 or more health centers (as defined in section 
     330(a)), a rural health clinic (as defined in section 
     1961(aa) of the Social Security Act), or a Federally 
     qualified health center (as defined in such section); or
       ``(C) 1 or more primary health care practices.
       ``(3) Integrated care; bidirectional integrated care.--
       ``(A) The term `integrated care' means models or practices 
     for coordinating and jointly delivering behavioral and 
     physical health services, which may include practices that 
     share the same space in the same facility.
       ``(B) The term `bidirectional integrated care' means the 
     integration of behavioral health care and specialty physical 
     health care, as well as the integration of primary and 
     physical health care with specialty behavioral health 
     settings, including within primary health care settings.
       ``(4) Primary health care provider.--The term `primary 
     health care provider' means a provider who--
       ``(A) provides health services related to family medicine, 
     internal medicine, pediatrics, obstetrics, gynecology, or 
     geriatrics; or
       ``(B) is a doctor of medicine or osteopathy, physician 
     assistant, or nurse practitioner, who is licensed to practice 
     medicine by the State in which such physician, assistant, or 
     practitioner primarily practices, including within primary 
     health care settings.
       ``(5) Primary health care practice.--The term `primary 
     health care practice' means a medical practice of primary 
     health care providers, including a practice within a larger 
     health care system.
       ``(6) Special population.--The term `special population', 
     for an eligible entity that is collaborating with an entity 
     described in subparagraph (A) or (B) of paragraph (3), 
     means--
       ``(A) adults with a serious mental illness who have a co-
     occurring physical health condition or chronic disease;
       ``(B) children and adolescents with a mental illness who 
     have a co-occurring physical health condition or chronic 
     disease;
       ``(C) individuals with a substance use disorder; or
       ``(D) individuals with a mental illness who have a co-
     occurring substance use disorder.
       ``(b) Grants and Cooperative Agreements.--
       ``(1) In general.--The Secretary may award grants and 
     cooperative agreements to eligible entities to support the 
     improvement of integrated care for physical and behavioral 
     health care in accordance with paragraph (2).
       ``(2) Use of funds.--A grant or cooperative agreement 
     awarded under this section shall be used--
       ``(A) in the case of an eligible entity that is 
     collaborating with an entity described in subparagraph (A) or 
     (B) of subsection (a)(2)--
       ``(i) to promote full integration and collaboration in 
     clinical practices between physical and behavioral health 
     care for special populations including each population listed 
     in subsection (a)(7);
       ``(ii) to support the improvement of integrated care models 
     for physical and behavioral health care to improve the 
     overall wellness and physical health status of--

       ``(I) adults with a serious mental illness or children with 
     a serious emotional disturbance; and
       ``(II) individuals with a substance use disorder; and

       ``(iii) to promote bidirectional integrated care services 
     including screening, diagnosis, prevention, treatment, and 
     recovery of mental and substance use disorders, and co-
     occurring physical health conditions and chronic diseases; 
     and
       ``(B) in the case of an eligible entity that is 
     collaborating with a primary health care practice, to support 
     the uptake of the collaborative care model, including by--
       ``(i) hiring staff;
       ``(ii) identifying and formalizing contractual 
     relationships with other health care providers, including 
     providers who will function as psychiatric consultants and 
     behavioral health care managers in providing behavioral 
     health integration services through the collaborative care 
     model;
       ``(iii) purchasing or upgrading software and other 
     resources needed to appropriately provide behavioral health 
     integration services through the collaborative care model, 
     including resources needed to establish a patient registry 
     and implement measurement-based care; and
       ``(iv) for such other purposes as the Secretary determines 
     to be necessary.
       ``(c) Applications.--
       ``(1) In general.--An eligible entity that is collaborating 
     with an entity described in subparagraph (A) or (B) of 
     subsection (a)(2) seeking a grant or cooperative agreement 
     under subsection (b)(2)(A) shall submit an application to the 
     Secretary at such time, in such manner, and accompanied by 
     such information as the Secretary may require, including the 
     contents described in paragraph (2).
       ``(2) Contents.--Any such application of an eligible entity 
     described in subparagraph (A) or (B) of subsection (a)(2) 
     shall include--
       ``(A) a description of a plan to achieve fully 
     collaborative agreements to provide bidirectional integrated 
     care to special populations;
       ``(B) a document that summarizes the policies, if any, that 
     are barriers to the provision of integrated care, and the 
     specific steps, if applicable, that will be taken to address 
     such barriers;
       ``(C) a description of partnerships or other arrangements 
     with local health care providers to provide services to 
     special populations;
       ``(D) an agreement and plan to report to the Secretary 
     performance measures necessary to evaluate patient outcomes 
     and facilitate evaluations across participating projects;
       ``(E) a description of how validated rating scales will be 
     implemented to support the improvement of patient outcomes 
     using measurement-based care, including those related to 
     depression screening, patient follow-up, and symptom 
     remission; and
       ``(F) a plan for sustainability beyond the grant or 
     cooperative agreement period under subsection (e).
       ``(3) Collaborative care model grants.--An eligible entity 
     that is collaborating with a primary health care practice 
     seeking a grant pursuant to subsection (b)(2)(B) shall submit 
     an application to the Secretary at such time, in such manner, 
     and accompanied by such information as the Secretary may 
     require.
       ``(d) Grant and Cooperative Agreement Amounts.--
       ``(1) Target amount.--The target amount that an eligible 
     entity may receive for a year through a grant or cooperative 
     agreement under this section shall be--
       ``(A) $2,000,000 for an eligible entity described in 
     subparagraph (A) or (B) of subsection (a)(2); or
       ``(B) $100,000 or less for an eligible entity described in 
     subparagraph (C) of subsection (a)(2).
       ``(2) Adjustment permitted.--The Secretary, taking into 
     consideration the quality of an eligible entity's application 
     and the number of eligible entities that received grants 
     under this section prior to the date of enactment of the 
     Restoring Hope for Mental Health and Well-Being Act of 2022, 
     may adjust the target amount that an eligible entity may 
     receive for a year through a grant or cooperative agreement 
     under this section.
       ``(3) Limitation.--An eligible entity that is collaborating 
     with an entity described in subparagraph (A) or (B) of 
     subsection (a)(2) receiving funding under this section--
       ``(A) may not allocate more than 20 percent of the funds 
     awarded to such eligible entity under this section to 
     administrative functions; and
       ``(B) shall allocate the remainder of such funding to 
     health facilities that provide integrated care.
       ``(e) Duration.--A grant or cooperative agreement under 
     this section shall be for a period not to exceed 5 years.
       ``(f) Report on Program Outcomes.--An eligible entity 
     receiving a grant or cooperative agreement under this 
     section--
       ``(1) that is collaborating with an entity described in 
     subparagraph (A) or (B) of subsection (a)(2) shall submit an 
     annual report to the Secretary that includes--
       ``(A) the progress made to reduce barriers to integrated 
     care as described in the entity's application under 
     subsection (c); and
       ``(B) a description of outcomes with respect to each 
     special population listed in subsection (a)(7), including 
     outcomes related to education, employment, and housing; or
       ``(2) that is collaborating with a primary health care 
     practice shall submit an annual report to the Secretary that 
     includes--
       ``(A) the progress made to improve access;
       ``(B) the progress made to improve patient outcomes; and
       ``(C) the progress made to reduce referrals to specialty 
     care.
       ``(g) Technical Assistance for Primary-Behavioral Health 
     Care Integration.--
       ``(1) Certain recipients.--The Secretary may provide 
     appropriate information, training, and technical assistance 
     to eligible entities that are collaborating with an entity 
     described in subparagraph (A) or (B) of subsection (a)(2) 
     that receive a grant or cooperative agreement under this 
     section, in order to help such entities meet the requirements 
     of this section, including assistance with--
       ``(A) development and selection of integrated care models;
       ``(B) dissemination of evidence-based interventions in 
     integrated care;
       ``(C) establishment of organizational practices to support 
     operational and administrative success; and
       ``(D) other activities, as the Secretary determines 
     appropriate.
       ``(2) Collaborative care model recipients.--The Secretary 
     shall provide appropriate information, training, and 
     technical assistance to eligible entities that are 
     collaborating with primary health care practices that receive 
     funds under this section to help such entities implement the 
     collaborative care model, including--
       ``(A) developing financial models and budgets for 
     implementing and maintaining a collaborative care model, 
     based on practice size;
       ``(B) developing staffing models for essential staff roles;
       ``(C) providing strategic advice to assist practices 
     seeking to utilize other clinicians for additional 
     psychotherapeutic interventions;
       ``(D) providing information technology expertise to assist 
     with building the collaborative care

[[Page H5767]]

     model into electronic health records, including assistance 
     with care manager tools, patient registry, ongoing patient 
     monitoring, and patient records;
       ``(E) training support for all key staff and operational 
     consultation to develop practice workflows;
       ``(F) establishing methods to ensure the sharing of best 
     practices and operational knowledge among primary health care 
     physicians and primary health care practices that provide 
     behavioral health integration services through the 
     collaborative care model; and
       ``(G) providing guidance and instruction to primary health 
     care physicians and primary health care practices on 
     developing and maintaining relationships with community-based 
     mental health and substance use disorder facilities for 
     referral and treatment of patients whose clinical 
     presentation or diagnosis is best suited for treatment at 
     such facilities.
       ``(3) Additional dissemination of technical information.--
     In addition to providing the assistance described in 
     paragraphs (1) and (2) to recipients of a grant or 
     cooperative agreement under this section, the Secretary may 
     also provide such assistance to other States and political 
     subdivisions of States, Indian Tribes and Tribal 
     organizations (as defined under the Federally Recognized 
     Indian Tribe List Act of 1994), outpatient mental health and 
     addiction treatment centers, community mental health centers 
     that meet the criteria under section 1913(c), certified 
     community behavioral health clinics described in section 223 
     of the Protecting Access to Medicare Act of 2014, primary 
     care organizations such as Federally qualified health centers 
     or rural health clinics as defined in section 1861(aa) of the 
     Social Security Act, primary health care practices, other 
     community-based organizations, and other entities engaging in 
     integrated care activities, as the Secretary determines 
     appropriate.
       ``(h) Authorization of Appropriations.--To carry out this 
     section, there is authorized to be appropriated $60,000,000 
     for each of fiscal years 2023 through 2027.''.

        Subtitle B--Helping Enable Access to Lifesaving Services

     SEC. 311. REAUTHORIZATION AND PROVISION OF CERTAIN PROGRAMS 
                   TO STRENGTHEN THE HEALTH CARE WORKFORCE.

       (a) Liability Protections for Health Professional 
     Volunteers.--Section 224(q)(6) of the Public Health Service 
     Act (42 U.S.C. 233(q)(6)) is amended by striking ``October 1, 
     2022'' and inserting ``October 1, 2027''.
       (b) Minority Fellowships in Crisis Care Management.--
     Section 597(b) of the Public Health Service Act (42 U.S.C. 
     290ll(b)) is amended by striking ``in the fields of 
     psychiatry,'' and inserting ``in the fields of crisis care 
     management, psychiatry,''.
       (c) Mental and Behavioral Health Education and Training 
     Grants.--Section 756 of the Public Health Service Act (42 
     U.S.C. 294e-1) is amended--
       (1) in subsection (a)(1), by inserting ``(which may include 
     master's and doctoral level programs)'' after ``occupational 
     therapy''; and
       (2) in subsection (f), by striking ``For each of fiscal 
     years 2019 through 2023'' and inserting ``For each of fiscal 
     years 2023 through 2027''.
       (d) Training Demonstration Program.--Section 760(g) of the 
     Public Health Service Act (42 U.S.C. 294k(g)) is amended by 
     inserting ``and $31,700,000 for each of fiscal years 2023 
     through 2027'' before the period at the end.

     SEC. 312. REAUTHORIZATION OF MINORITY FELLOWSHIP PROGRAM.

       Section 597(c) of the Public Health Service Act (42 U.S.C. 
     290ll(c)) is amended by striking ``$12,669,000 for each of 
     fiscal years 2018 through 2022'' and inserting $25,000,000 
     for each fiscal years 2023 through 2027''.

Subtitle C--Eliminating the Opt-Out for Nonfederal Governmental Health 
                                 Plans

     SEC. 321. ELIMINATING THE OPT-OUT FOR NONFEDERAL GOVERNMENTAL 
                   HEALTH PLANS.

       Section 2722(a)(2) of the Public Health Service Act (42 
     U.S.C. 300gg-21(a)(2)) is amended by adding at the end the 
     following new subparagraph:
       ``(F) Sunset of election option.--
       ``(i) In general.--Notwithstanding the preceding provisions 
     of this paragraph--

       ``(I) no election described in subparagraph (A) with 
     respect to section 2726 may be made on or after the date of 
     the enactment of this subparagraph; and
       ``(II) except as provided in clause (ii), no such election 
     with respect to section 2726 expiring on or after the date 
     that is 180 days after the date of such enactment may be 
     renewed.

       ``(ii) Exception for certain collectively bargained 
     plans.--Notwithstanding clause (i)(II), a plan described in 
     subparagraph (B)(ii) that is subject to multiple agreements 
     described in such subparagraph of varying lengths and that 
     has an election described in subparagraph (A) with respect to 
     section 2726 in effect as of the date of the enactment of 
     this subparagraph that expires on or after the date that is 
     180 days after the date of such enactment may extend such 
     election until the date on which the term of the last such 
     agreement expires.''.

      Subtitle D--Mental Health and Substance Use Disorder Parity 
                             Implementation

     SEC. 331. GRANTS TO SUPPORT MENTAL HEALTH AND SUBSTANCE USE 
                   DISORDER PARITY IMPLEMENTATION.

       (a) In General.--Section 2794(c) of the Public Health 
     Service Act (42 U.S.C. 300gg-94(c)) (as added by section 1003 
     of the Patient Protection and Affordable Care Act (Public Law 
     111-148)) is amended by adding at the end the following:
       ``(3) Parity implementation.--
       ``(A) In general.--Beginning during the first fiscal year 
     that begins after the date of enactment of this paragraph, 
     the Secretary shall, out of funds made available pursuant to 
     subparagraph (C), award grants to eligible States to enforce 
     and ensure compliance with the mental health and substance 
     use disorder parity provisions of section 2726.
       ``(B) Eligible state.--A State shall be eligible for a 
     grant awarded under this paragraph only if such State--
       ``(i) submits to the Secretary an application for such 
     grant at such time, in such manner, and containing such 
     information as specified by the Secretary; and
       ``(ii) agrees to request and review from health insurance 
     issuers offering group or individual health insurance 
     coverage the comparative analyses and other information 
     required of such health insurance issuers under subsection 
     (a)(8)(A) of section 2726 relating to the design and 
     application of nonquantitative treatment limitations imposed 
     on mental health or substance use disorder benefits.
       ``(C) Authorization of appropriations.--There are 
     authorized to be appropriated $10,000,000 for each of the 
     first five fiscal years beginning after the date of the 
     enactment of this paragraph, to remain available until 
     expended, for purposes of awarding grants under subparagraph 
     (A).''.
       (b) Technical Amendment.--Section 2794 of the Public Health 
     Service Act (42 U.S.C. 300gg-95), as added by section 6603 of 
     the Patient Protection and Affordable Care Act (Public Law 
     111-148) is redesignated as section 2795.

                      TITLE IV--CHILDREN AND YOUTH

      Subtitle A--Supporting Children's Mental Health Care Access

     SEC. 401. PEDIATRIC MENTAL HEALTH CARE ACCESS GRANTS.

       Section 330M of the Public Health Service Act (42 U.S.C. 
     254c-19) is amended--
       (1) in the section enumerator, by striking ``330M'' and 
     inserting ``330M.'';
       (2) in subsection (a)--
       (A) by striking ``Indian tribes and tribal organizations'' 
     and inserting ``Indian Tribes and Tribal organizations''; and
       (B) by inserting ``or, in the case of a State that does not 
     submit an application, a nonprofit entity that has the 
     support of the State'' after ``450b))'';
       (3) in subsection (b)--
       (A) in paragraph (1)--
       (i) in subparagraph (G), by inserting ``developmental-
     behavioral pediatricians,'' after ``adolescent 
     psychiatrists,'';
       (ii) in subparagraph (H), by striking ``; and'' at the end 
     and inserting a semicolon;
       (iii) by redesignating subparagraph (I) as subparagraph 
     (J); and
       (iv) by inserting after subparagraph (H) the following:
       ``(I) maintain an up-to-date list of community-based 
     supports for children with mental health problems; and'';
       (B) by redesignating paragraph (2) as paragraph (4);
       (C) by inserting after paragraph (1) the following:
       ``(2) Support to schools and emergency departments.--In 
     addition to the activities required by paragraph (1), a 
     pediatric mental health care telehealth access program 
     referred to in subsection (a), with respect to which a grant 
     under such subsection may be used, may provide support to 
     schools and emergency departments.
       ``(3) Priority.--In awarding grants under this section, the 
     Secretary shall give priority to applicants proposing to--
       ``(A) continue existing programs that meet the requirements 
     of paragraph (1);
       ``(B) establish a pediatric mental health care telehealth 
     access program in the jurisdiction of a State, Territory, 
     Indian Tribe, or Tribal organization that does not yet have 
     such a program; or
       ``(C) expand a pediatric mental health care telehealth 
     access program to include one or more new sites of care, such 
     as a school or emergency department.''; and
       (D) in paragraph (4), as redesignated by subparagraph (B), 
     by inserting ``Such a team may include a developmental-
     behavioral pediatrician.'' after ``mental health 
     counselor.'';
       (4) in subsections (c), (d), and (f), by striking ``Indian 
     tribe, or tribal organization'' each place it appears and 
     inserting ``Indian Tribe, Tribal organization, or nonprofit 
     entity''; and
       (5) by striking subsection (g) and inserting the following:
       ``(g) Technical Assistance.--The Secretary shall award 
     grants or contracts to one or more eligible entities (as 
     defined by the Secretary) for the purposes of providing 
     technical assistance and evaluation support to grantees under 
     subsection (a).
       ``(h) Authorization of Appropriations.--To carry out this 
     section, there are authorized to be appropriated--
       ``(1) $14,000,000 for each of fiscal years 2023 through 
     2025; and
       ``(2) $30,000,000 for each of fiscal years 2026 through 
     2027.''.

     SEC. 402. INFANT AND EARLY CHILDHOOD MENTAL HEALTH PROMOTION, 
                   INTERVENTION, AND TREATMENT.

       Section 399Z-2(f) of the Public Health Service Act (42 
     U.S.C. 280h-6(f)) is amended by striking ``$20,000,000 for 
     the period of fiscal years 2018 through 2022'' and inserting 
     ``$50,000,000 for the period of fiscal years 2023 through 
     2027''.

          Subtitle B--Continuing Systems of Care for Children

     SEC. 411. COMPREHENSIVE COMMUNITY MENTAL HEALTH SERVICES FOR 
                   CHILDREN WITH SERIOUS EMOTIONAL DISTURBANCES.

       (a) Definition of Family.--Section 565(d)(2)(B) of the 
     Public Health Service Act (42

[[Page H5768]]

     U.S.C. 290ff-4(d)(2)(B)) is amended by striking ``as 
     appropriate regarding mental health services for the child, 
     the parents of the child (biological or adoptive, as the case 
     may be) and any foster parents of the child'' and inserting 
     ``as appropriate regarding mental health services for the 
     child and the parents or kinship caregivers of the child''.
       (b) Authorization of Appropriations.--Paragraph (1) of 
     section 565(f) of the Public Health Service Act (42 U.S.C. 
     290ff-4(f)) is amended--
       (1) by moving the margin of such paragraph 2 ems to the 
     right; and
       (2) by striking ``$119,026,000 for each of fiscal years 
     2018 through 2022'' and inserting ``$125,000,000 for each of 
     fiscal years 2023 through 2027''.

     SEC. 412. SUBSTANCE USE DISORDER TREATMENT AND EARLY 
                   INTERVENTION SERVICES FOR CHILDREN AND 
                   ADOLESCENTS.

       Section 514 of the Public Health Service Act (42 U.S.C. 
     290bb-7) is amended--
       (1) in subsection (a), by striking ``Indian tribes or 
     tribal organizations'' and inserting ``Indian Tribes or 
     Tribal organizations''; and
       (2) in subsection (f), by striking ``2018 through 2022'' 
     and inserting ``2023 through 2027''.

         Subtitle C--Garrett Lee Smith Memorial Reauthorization

     SEC. 421. SUICIDE PREVENTION TECHNICAL ASSISTANCE CENTER.

       (a) Technical Amendment.--Section 520C of the Public Health 
     Service Act (42 U.S.C. 290bb-34) is amended--
       (1) by striking ``tribes'' and inserting ``Tribes''; and
       (2) by striking ``tribal'' each place it appears and 
     inserting ``Tribal''.
       (b) Authorization of Appropriations.--Section 520C(c) of 
     the Public Health Service Act (42 U.S.C. 290bb-34(c)) is 
     amended by striking ``$5,988,000 for each of fiscal years 
     2018 through 2022'' and inserting ``$9,000,000 for each of 
     fiscal years 2023 through 2027''.
       (c) Annual Report.--Section 520C(d) of the Public Health 
     Service Act (42 U.S.C. 290bb-34(d)) is amended by striking 
     ``Not later than 2 years after the date of enactment of this 
     subsection'' and inserting ``Not later than 2 years after the 
     date of enactment of the Restoring Hope for Mental Health and 
     Well-Being Act of 2022''.

     SEC. 422. YOUTH SUICIDE EARLY INTERVENTION AND PREVENTION 
                   STRATEGIES.

       Section 520E of the Public Health Service Act (42 U.S.C. 
     290bb-36) is amended--
       (1) by striking ``tribe'' and inserting ``Tribe'';
       (2) by striking ``tribal'' each place it appears and 
     inserting ``Tribal'';
       (3) in subsection (a)(1), by inserting ``pediatric health 
     programs,'' after ``foster care systems,'';
       (4) by amending subsection (b)(1)(B) to read as follows:
       ``(B) a public organization or private nonprofit 
     organization designated by a State or Indian Tribe (as 
     defined under the Federally Recognized Indian Tribe List Act 
     of 1994) to develop or direct the State-sponsored statewide 
     or Tribal youth suicide early intervention and prevention 
     strategy; or'';
       (5) in subsection (c)--
       (A) in paragraph (1), by inserting ``pediatric health 
     programs,'' after ``foster care systems,'';
       (B) in paragraph (7), by inserting ``pediatric health 
     programs,'' after ``foster care systems,'';
       (C) in paragraph (9), by inserting ``pediatric health 
     programs,'' after ``educational institutions,'';
       (D) in paragraph (13), by striking ``and'' at the end;
       (E) in paragraph (14), by striking the period at the end 
     and inserting ``; and''; and
       (F) by adding at the end the following:
       ``(15) provide to parents, legal guardians, and family 
     members of youth, supplies to securely store means commonly 
     used in suicide, if applicable, within the household.'';
       (6) in subsection (d)--
       (A) in the heading, by striking ``Direct Services'' and 
     inserting ``Suicide Prevention Activities''; and
       (B) by striking ``direct services, of which not less than 5 
     percent shall be used for activities authorized under 
     subsection (a)(3)'' and inserting ``suicide prevention 
     activities'';
       (7) in subsection (e)(3)(A), by inserting ``and Department 
     of Education'' after ``Department of Health and Human 
     Services'';
       (8) in subsection (g)--
       (A) in paragraph (1), by striking ``18'' and inserting 
     ``24''; and
       (B) in paragraph (2), by striking ``2 years after the date 
     of enactment of Helping Families in Mental Health Crisis 
     Reform Act of 2016'' and inserting ``3 years after December 
     31, 2022'';
       (9) in subsection (l)(4), by striking ``between 10 and 24 
     years of age'' and inserting ``up to 24 years of age''; and
       (10) in subsection (m), by striking ``$30,000,000 for each 
     of fiscal years 2018 through 2022'' and inserting 
     ``$40,000,000 for each of fiscal years 2023 through 2027''.

     SEC. 423. MENTAL HEALTH AND SUBSTANCE USE DISORDER SERVICES 
                   FOR STUDENTS IN HIGHER EDUCATION.

       Section 520E-2 of the Public Health Service Act (42 U.S.C. 
     290bb-36b) is amended--
       (1) in the heading, by striking ``on campus'' and inserting 
     ``for students in higher education''; and
       (2) in subsection (i), by striking ``2018 through 2022'' 
     and inserting ``2023 through 2027''.

     SEC. 424. MENTAL AND BEHAVIORAL HEALTH OUTREACH AND EDUCATION 
                   AT INSTITUTIONS OF HIGHER EDUCATION.

       Section 549 of the Public Health Service Act (42 U.S.C. 
     290ee-4) is amended--
       (1) in the heading, by striking ``on college campuses'' and 
     inserting ``at institutions of higher education'';
       (2) in subsection (c)(2), by inserting ``, including 
     minority-serving institutions as described in section 371(a) 
     of the Higher Education Act of 1965 (20 U.S.C. 1067q) and 
     community colleges'' after ``higher education''; and
       (3) in subsection (f), by striking ``2018 through 2022'' 
     and inserting ``2023 through 2027''.

                  Subtitle D--Media and Mental Health

     SEC. 431. STUDY ON THE EFFECTS OF SMARTPHONE AND SOECIAL 
                   MEDIA USE OF ADOLESCENTS.

       (a) In general.--Not later than 1 year after the date of 
     enactment of this Act, the Secretary of Health and Human 
     Services shall conduct or support research on--
       (1) smartphone and social media use by adolescents; and
       (2) the effects of such use on--
       (A) emotional, behavioral, and physical health and 
     development; and
       (B) any disparities in the mental health outcomes of rural, 
     minority, and other under-served populations.
       (b) Report.--Not later than 5 years after the date of 
     enactment of this Act, the Secretary of Health and Human 
     Services shall submit to the Congress, and make publicly 
     available, a report on the findings of research under this 
     section.

     SEC. 432. RESEARCH ON THE HEALTH AND DEVELOPMENT EFFECTS OF 
                   MEDIA ON INFANTS, CHILDREN, AND ADOLESCENTS.

       Subpart 7 of part C of title IV of the Public Health 
     Service Act (42 U.S.C. 285g et seq.) is amended by adding at 
     the end the following:

     SEC. 452H. RESEARCH ON THE HEALTH AND DEVELOPMENT EFFECTS OF 
                   MEDIA ON INFANTS, CHILDREN, AND ADOLESCENTS.

       ``(a) In general.--The Director of the National Institutes 
     of Health, in coordination with or acting through the 
     Director of the Institute, shall conduct and support research 
     and related activities concerning the health and 
     developmental effects of media on infants, children, and 
     adolescents, which may include the positive and negative 
     effects of exposure to and use of media, such as social 
     media, applications, websites, television, motion pictures, 
     artificial intelligence, mobile devices, computers, video 
     games, virtual and augmented reality, and other media formats 
     as they become available. Such research shall attempt to 
     better understand the relationships between media and 
     technology use and individual differences and characteristics 
     of children and shall include longitudinally designed studies 
     to assess the impact of media on youth over time. Such 
     research shall include consideration of core areas of child 
     and adolescent health and development including the 
     following:
     ``(1) Cognitive.--The role and impact of media use and 
     exposure in the development children and adolescents within 
     such cognitive areas as language development, executive 
     functioning, attention, creative program solving skills, 
     visual and spatial skills, literacy, critical thinking, and 
     other learning abilities, and the impact of early technology 
     use on developmental trajectories.
     ``(2) Physical--The role and impact of media use and exposure 
     on children's and adolescent's physical development and 
     health behaviors, including diet, exercise, sleeping and 
     eating routines, and other areas of physical development.
     ``(3) Socio-Emotional.--The role and impact of media use and 
     exposure on children's and adolescents' social-emotional 
     competencies, including self-awareness, self-regulation, 
     social awareness, relationship skills, empathy, distress 
     tolerance, perception of social cues, awareness of one's 
     relationship with the media, and decision-making, as well as 
     outcomes such as violations of privacy, perpetration of or 
     exposure to violence, bullying or other forms of aggression, 
     depression, anxiety, substance use, misuse or disorder, and 
     suicidal ideation/behavior and self-harm.
       ``(b) Developing Research Agenda.--The Director of the 
     National Institutes of Health, in consultation with the 
     Director of the Institute, other appropriate national 
     research institutes, academies, and centers, the Trans-NIH 
     Pediatric Research Consortium, and non-Federal exports as 
     needed, shall develop a research agenda on the health and 
     development effects of media on infants, children, and 
     adolescents to inform research activities under subsection 
     (a). In developing such research agenda, the Director may use 
     whatever means necessary (such as scientific workshops and 
     literature reviews) to assess current knowledge and research 
     gaps in this area.
       ``(c) Research Program.--In coordination with the Institute 
     and other national research institutes and centers, and 
     utilizing the National Institutes of Health's process of 
     scientific peer review, the Director of the National 
     Institutes of Health shall fund an expanded research program 
     on the health and developmental effects of media on infants, 
     children, and adolescents.
       ``(d) Report to Congress.--Not later than 1 year after the 
     date of enactment o this Act, the Director of the National 
     Institutes of Health shall submit a report to Congress on the 
     progress made in gathering data and expanding research on the 
     health and developmental effects of media on infants, 
     children, and adolescents in accordance with this section. 
     Such report shall summarize the grants and research funded, 
     by year, under this section''.

                       TITLE V--MEDICAID AND CHIP

     SEC. 501. MEDICAID AND CHIP REQUIREMENTS FOR HEALTH 
                   SCREENINGS AND REFERRALS FOR ELIGIBLE JUVENILES 
                   IN PUBLIC INSTITUTIONS.

       (a) Medicaid State Plan Requirement.--Section 1902 of the 
     Social Security Act (42 U.S.C. 1396a) is amended--

[[Page H5769]]

       (1) in subsection (a)(84)--
       (A) in subparagraph (A), by inserting ``, subject to 
     subparagraph (D),'' after ``but'';
       (B) in subparagraph (B), by striking ``and'' at the end;
       (C) in subparagraph (C), by adding ``and'' at the end; and
       (D) by adding at the end the following new subparagraph:
       ``(D) beginning on the first day of the first calendar 
     quarter that begins two years after the date of enactment of 
     this subparagraph, in the case of individuals who are 
     eligible juveniles described in subsection (nn)(2), are 
     within 30 days of the date on which such eligible juvenile is 
     scheduled to be released from a public institution following 
     adjudication, the State shall have in place a plan to ensure, 
     and in accordance with such plan, provide--
       ``(i) for, in the 30 days prior to the release of such an 
     eligible juvenile from such public institution (or not later 
     than one week after release from the public institution), and 
     in coordination with such institution--

       ``(I) any screening or diagnostic service which meets 
     reasonable standards of medical and dental practice, as 
     determined by the State, or as indicated as medically 
     necessary, in accordance with paragraphs (1)(A) and (5) of 
     section 1905(r); and
       ``(II) a mental health or other behavioral health screening 
     that is a screening service described under section 
     1905(r)(1), or a diagnostic service described under paragraph 
     (5) of such section, if such screening or diagnostic service 
     was not otherwise conducted pursuant to this clause;

       ``(ii) for, not later than one week after release from the 
     public institution, referrals for such eligible juvenile to 
     the appropriate care and services available under the State 
     plan (or waiver of such plan) in the geographic region of the 
     home or residence of such eligible juvenile, based on such 
     screenings; and
       ``(iii) for, following the release of such eligible 
     juvenile from such institution, not less than 30 days of 
     targeted case management services furnished by a provider in 
     the geographic region of the home or residence of such 
     eligible juvenile.''; and
       (2) in subsection (nn)(3), by striking ``(30)'' and 
     inserting ``(31)''.
       (b) Authorization of Federal Financial Participation.--The 
     subdivision (A) of section 1905(a) of the Social Security Act 
     (42 U.S.C. 1396d(a)) following paragraph (31) of such section 
     is amended by inserting ``, or in the case of an eligible 
     juvenile described in section 1902(a)(84)(D) with respect to 
     the screenings, diagnostic services, referrals, and case 
     management required under such subparagraph (D)'' after 
     ``(except as a patient in a medical institution''.
       (c) CHIP Conforming Amendments.--
       (1) Section 2103(c) of the Social Security Act (42 U.S.C. 
     1397cc(c)) is amended by adding at the end the following new 
     paragraph:
       ``(12) Required coverage of screenings, diagnostic 
     services, referrals, and case management for certain inmates 
     pre-release.--With respect to individuals described in 
     section 2110(b)(7), the State shall provide screenings, 
     diagnostic services, referrals, and case management otherwise 
     covered under the State child health plan (or waiver of such 
     plan) during the period described in such section with 
     respect to such screenings, services, referrals, and case 
     management.''.
       (2) Section 2110(b) of the Social Security Act (42 U.S.C. 
     1397jj(b)) is amended--
       (A) in paragraph (2)(A), by inserting ``except as provided 
     in paragraph (7),'' before ``a child who is an inmate of a 
     public institution''; and
       (B) by adding at the end the following new paragraph:
       ``(7) Exception to exclusion of children who are inmates of 
     a public institution.--A child shall not be considered to be 
     described in paragraph (2)(A) if such child is an eligible 
     juvenile (as described in section 1902(a)(84)(D)) with 
     respect to the screenings, diagnostic services, referrals, 
     and case management otherwise covered under the State child 
     health plan (or waiver of such plan) during the period with 
     respect to which such screenings, services, referrals, and 
     case management is respectively required under such 
     section.''.

     SEC. 502. GUIDANCE ON REDUCING ADMINISTRATIVE BARRIERS TO 
                   PROVIDING HEALTH CARE SERVICES IN SCHOOLS.

       (a) In General.--Not later than 12 months after the date of 
     enactment of this Act, the Secretary of Health and Human 
     Services shall issue guidance to State Medicaid agencies, 
     elementary and secondary schools, and school-based health 
     centers on reducing administrative barriers to such schools 
     and centers furnishing medical assistance and obtaining 
     payment for such assistance under titles XIX and XXI of the 
     Social Security Act (42 U.S.C. 1396 et seq., 1397aa et seq.).
       (b) Contents of Guidance.--The guidance issued pursuant to 
     subsection (a) shall--
       (1) include revisions to the May 2003 Medicaid School-Based 
     Administrative Claiming Guide, the 1997 Medicaid and Schools 
     Technical Assistance Guide, and other relevant guidance in 
     effect on the date of enactment of this Act;
       (2) provide information on payment under titles XIX and XXI 
     of the Social Security Act (42 U.S.C. 1396 et seq., 1397aa et 
     seq.) for the provision of medical assistance, including such 
     assistance provided in accordance with an individualized 
     education program or under the policy described in the State 
     Medicaid Director letter on payment for services issued on 
     December 15, 2014 (#14-006);
       (3) take into account reasons why small and rural local 
     education agencies may not provide medical assistance and 
     provide information on best practices to encourage such 
     agencies to provide such assistance; and
       (4) include best practices and examples of methods that 
     State Medicaid agencies and local education agencies have 
     used to pay for, and increase the availability of, medical 
     assistance.
       (c) Definitions.--In this Act:
       (1) Individualized education program.--The term 
     ``individualized education program'' has the meaning given 
     such term in section 602(14) of the Individuals with 
     Disabilities Education Act (20 U.S.C. 1401(14)).
       (2) School-based health center.--The term ``school-based 
     health center'' has the meaning given such term in section 
     2110(c)(9) of the Social Security Act (42 U.S.C. 
     1397jj(c)(9)), and includes an entity that provides Medicaid-
     covered services in school-based settings for which Federal 
     financial participation is permitted.

     SEC. 503. GUIDANCE TO STATES ON SUPPORTING PEDIATRIC 
                   BEHAVIORAL HEALTH SERVICES UNDER MEDICAID AND 
                   CHIP.

       Not later than 18 months after the date of enactment of 
     this Act, the Secretary of Health and Human Services shall 
     issue guidance to States on how to expand the provision of, 
     and access to, behavioral health services, including mental 
     health services, for children covered under State plans (or 
     waivers of such plans) under title XIX of the Social Security 
     Act (42 U.S.C. 1396 et seq.), or State child health plans (or 
     waivers of such plans) under title XXI of such Act (42 U.S.C. 
     1397aa et seq.), including a description of best practices 
     for--
       (1) expanding access to such services;
       (2) expanding access to such services in underserved 
     communities;
       (3) flexibilities that States may offer for pediatric 
     hospitals and other pediatric behavioral health providers to 
     expand access to services; and
       (4) recruitment and retention of providers of such 
     services.

     SEC. 504. ENSURING CHILDREN RECEIVE TIMELY ACCESS TO CARE.

       (a) Guidance to States on Flexibilities to Ensure Provider 
     Capacity to Provide Pediatric Behavioral Health, Including 
     Mental Health, Crisis Care.--Not later than 18 months after 
     the date of enactment of this Act, the Secretary of Health 
     and Human Services shall provide guidance to States on 
     existing flexibilities under State plans (or waivers of such 
     plans) under title XIX of the Social Security Act (42 U.S.C. 
     1396 et seq.), or State child health plans under title XXI of 
     such Act (42 U.S.C. 1397aa et seq.), to support children 
     experiencing a behavioral health crisis or in need of 
     intensive behavioral health, including mental health, 
     services.
       (b) Ensuring Consistent Review and State Implementation of 
     Early and Periodic Screening, Diagnostic, and Treatment 
     Services.--Section 1905(r) of the Social Security Act (42 
     U.S.C. 1396d(r)) is amended by adding at the end the 
     following: ``Not later than January 1, 2025, and every 5 
     years thereafter, the Secretary shall review implementation 
     of the requirements of this subsection by States, including 
     such requirements relating to services provided by managed 
     care organizations, prepaid inpatient health plans, prepaid 
     ambulatory health plans, and primary care case managers, to 
     identify and disseminate best practices for ensuring 
     comprehensive coverage of services, to identify gaps and 
     deficiencies in meeting Federal requirements, and to provide 
     guidance to States on addressing identified gaps and 
     disparities and meeting Federal coverage requirements in 
     order to ensure children have access to health services.''.

     SEC. 505. STRATEGIES TO INCREASE ACCESS TO TELEHEALTH UNDER 
                   MEDICAID AND CHIP.

       Not later than 1 year after the date of the enactment of 
     this Act, and in the event updates are available, once every 
     five years thereafter, the Secretary of Health and Human 
     Services shall update guidance issued by the Centers for 
     Medicare & Medicaid Services to States, the State Medicaid & 
     CHIP Telehealth Toolkit, or any successor guidance, to 
     describe strategies States may use to overcome existing 
     barriers and increase access to telehealth services under the 
     Medicaid program under title XIX of the Social Security Act 
     (42 U.S.C. 1396 et seq.) and the Children's Health Insurance 
     Program under title XXI of such Act (42 U.S.C. 1397aa et 
     seq.). Such updated guidance shall include examples of and 
     promising practices regarding--
       (1) telehealth delivery of covered services;
       (2) recommended voluntary billing codes, modifiers, and 
     place-of-service designations for telehealth and other 
     virtual health care services;
       (3) strategies States can use for the simplification or 
     alignment of provider credentialing and enrollment protocols 
     with respect to telehealth across States, State Medicaid 
     plans under title XIX, State child health plans under title 
     XXI, Medicaid managed care organizations, prepaid inpatient 
     health plans, prepaid ambulatory health plans, and primary 
     care case managers, including during national public health 
     emergencies; and
       (4) strategies States can use to integrate telehealth and 
     other virtual health care services into value-based health 
     care models.

     SEC. 506. REMOVAL OF LIMITATIONS ON FEDERAL FINANCIAL 
                   PARTICIPATION FOR INMATES WHO ARE ELIGIBLE 
                   JUVENILES PENDING DISPOSITION OF CHARGES.

       (a) Medicaid.--
       (1) In general.--The subdivision (A) of section 1905(a) of 
     the Social Security Act (42 U.S.C. 1396d(a)) following 
     paragraph (31) of such section, as amended by section 501(b), 
     is further amended by inserting ``, or, at the option of the 
     State, for an individual who is an eligible juvenile (as 
     defined in section 1902(nn)(2)), while such individual is an 
     inmate of a public institution (as defined in section 
     1902(nn)(3)) pending disposition of charges'' after ``or in 
     the case of an eligible juvenile described in section

[[Page H5770]]

     1902(a)(84)(D) with respect to the screenings, diagnostic 
     services, referrals, and case management required under such 
     subparagraph (D)''.
       (2) Conforming.--Section 1902(a)(84)(A) of the Social 
     Security Act (42 U.S.C. 1396a(a)(84)(A)) is amended by 
     inserting ``(or in the case of a State electing the option 
     described in the subdivision (A) following paragraph (31) of 
     section 1905(a), during such period beginning after the 
     disposition of charges with respect to such individual)'' 
     after ``is such an inmate''.
       (b) CHIP.--Section 2110(b)(7) of the Social Security Act 
     (42 U.S.C. 13977jj(b)(7)), as added by section 501(c)(2)(B), 
     is further amended by inserting ``or, at the option of the 
     State, for an individual who is a juvenile, while such 
     individual is an inmate of a public institution pending 
     disposition of charges'' after ``if such child is an eligible 
     juvenile (as described in section 1902(a)(84)(D)) with 
     respect to screenings, diagnostic services, referrals, and 
     case management otherwise covered under the State child 
     health plan (or waiver of such plan)''.
       (c) Effective Date.--The amendments made by this section 
     shall take effect on the first day of the first calendar 
     quarter that begins after the date that is 18 months after 
     the date of enactment of this Act and shall apply to items 
     and services furnished for periods beginning on or after such 
     date.

                   TITLE VI--MISCELLANEOUS PROVISIONS

     SEC. 601. DETERMINATION OF BUDGETARY EFFECTS.

       The budgetary effects of this Act, for the purpose of 
     complying with the Statutory Pay-As-You-Go Act of 2010, shall 
     be determined by reference to the latest statement titled 
     ``Budgetary Effects of PAYGO Legislation'' for this Act, 
     submitted for printing in the Congressional Record by the 
     Chairman of the House Budget Committee, provided that such 
     statement has been submitted prior to the vote on passage.

     SEC. 602. OVERSIGHT OF PHARMACY BENEFIT MANAGER SERVICES.

       (a) PHSA.--Title XXVII of the Public Health Service Act (42 
     U.S.C. 300gg et seq.) is amended--
       (1) in part D (42 U.S.C. 300gg-111 et seq.), by adding at 
     the end the following new section:

     ``SEC. 2799A-11. OVERSIGHT OF PHARMACY BENEFIT MANAGER 
                   SERVICES.

       ``(a) In General.--For plan years beginning on or after 
     January 1, 2024, a group health plan or health insurance 
     issuer offering group health insurance coverage or an entity 
     or subsidiary providing pharmacy benefits management services 
     on behalf of such a plan or issuer shall not enter into a 
     contract with a drug manufacturer, distributor, wholesaler, 
     subcontractor, rebate aggregator, or any associated third 
     party that limits the disclosure of information to plan 
     sponsors in such a manner that prevents the plan or issuer, 
     or an entity or subsidiary providing pharmacy benefits 
     management services on behalf of a plan or issuer, from 
     making the reports described in subsection (b).
       ``(b) Reports.--
       ``(1) In general.--For plan years beginning on or after 
     January 1, 2024, not less frequently than once every 6 
     months, a health insurance issuer offering group health 
     insurance coverage or an entity providing pharmacy benefits 
     management services on behalf of a group health plan or an 
     issuer providing group health insurance coverage shall submit 
     to the plan sponsor (as defined in section 3(16)(B) of the 
     Employee Retirement Income Security Act of 1974) of such 
     group health plan or health insurance coverage a report in 
     accordance with this subsection and make such report 
     available to the plan sponsor in a machine-readable format. 
     Each such report shall include, with respect to the 
     applicable group health plan or health insurance coverage--
       ``(A) as applicable, information collected from drug 
     manufacturers by such issuer or entity on the total amount of 
     copayment assistance dollars paid, or copayment cards 
     applied, that were funded by the drug manufacturer with 
     respect to the participants and beneficiaries in such plan or 
     coverage;
       ``(B) a list of each drug covered by such plan, issuer, or 
     entity providing pharmacy benefit management services that 
     was dispensed during the reporting period, including, with 
     respect to each such drug during the reporting period--
       ``(i) the brand name, chemical entity, and National Drug 
     Code;
       ``(ii) the number of participants and beneficiaries for 
     whom the drug was filled during the plan year, the total 
     number of prescription fills for the drug (including original 
     prescriptions and refills), and the total number of dosage 
     units of the drug dispensed across the plan year, including 
     whether the dispensing channel was by retail, mail order, or 
     specialty pharmacy;
       ``(iii) the wholesale acquisition cost, listed as cost per 
     days supply and cost per pill, or in the case of a drug in 
     another form, per dose;
       ``(iv) the total out-of-pocket spending by participants and 
     beneficiaries on such drug, including participant and 
     beneficiary spending through copayments, coinsurance, and 
     deductibles; and
       ``(v) for any drug for which gross spending of the group 
     health plan or health insurance coverage exceeded $10,000 
     during the reporting period--

       ``(I) a list of all other drugs in the same therapeutic 
     category or class, including brand name drugs and biological 
     products and generic drugs or biosimilar biological products 
     that are in the same therapeutic category or class as such 
     drug; and
       ``(II) the rationale for preferred formulary placement of 
     such drug in that therapeutic category or class, if 
     applicable;

       ``(C) a list of each therapeutic category or class of drugs 
     that were dispensed under the health plan or health insurance 
     coverage during the reporting period, and, with respect to 
     each such therapeutic category or class of drugs, during the 
     reporting period--
       ``(i) total gross spending by the plan, before manufacturer 
     rebates, fees, or other manufacturer remuneration;
       ``(ii) the number of participants and beneficiaries who 
     filled a prescription for a drug in that category or class;
       ``(iii) if applicable to that category or class, a 
     description of the formulary tiers and utilization mechanisms 
     (such as prior authorization or step therapy) employed for 
     drugs in that category or class;
       ``(iv) the total out-of-pocket spending by participants and 
     beneficiaries, including participant and beneficiary spending 
     through copayments, coinsurance, and deductibles; and
       ``(v) for each therapeutic category or class under which 3 
     or more drugs are included on the formulary of such plan or 
     coverage--

       ``(I) the amount received, or expected to be received, from 
     drug manufacturers in rebates, fees, alternative discounts, 
     or other remuneration--

       ``(aa) that has been paid, or is to be paid, by drug 
     manufacturers for claims incurred during the reporting 
     period; or
       ``(bb) that is related to utilization of drugs, in such 
     therapeutic category or class;

       ``(II) the total net spending, after deducting rebates, 
     price concessions, alternative discounts or other 
     remuneration from drug manufacturers, by the health plan or 
     health insurance coverage on that category or class of drugs; 
     and
       ``(III) the net price per course of treatment or single 
     fill, such as a 30-day supply or 90-day supply, incurred by 
     the health plan or health insurance coverage and its 
     participants and beneficiaries, after manufacturer rebates, 
     fees, and other remuneration for drugs dispensed within such 
     therapeutic category or class during the reporting period;

       ``(D) total gross spending on prescription drugs by the 
     plan or coverage during the reporting period, before rebates 
     and other manufacturer fees or remuneration;
       ``(E) total amount received, or expected to be received, by 
     the health plan or health insurance coverage in drug 
     manufacturer rebates, fees, alternative discounts, and all 
     other remuneration received from the manufacturer or any 
     third party, other than the plan sponsor, related to 
     utilization of drug or drug spending under that health plan 
     or health insurance coverage during the reporting period;
       ``(F) the total net spending on prescription drugs by the 
     health plan or health insurance coverage during the reporting 
     period; and
       ``(G) amounts paid directly or indirectly in rebates, fees, 
     or any other type of remuneration to brokers, consultants, 
     advisors, or any other individual or firm who referred the 
     group health plan's or health insurance issuer's business to 
     the pharmacy benefit manager.
       ``(2) Privacy requirements.--Health insurance issuers 
     offering group health insurance coverage and entities 
     providing pharmacy benefits management services on behalf of 
     a group health plan shall provide information under paragraph 
     (1) in a manner consistent with the privacy, security, and 
     breach notification regulations promulgated under section 
     264(c) of the Health Insurance Portability and Accountability 
     Act of 1996, and shall restrict the use and disclosure of 
     such information according to such privacy regulations.
       ``(3) Disclosure and redisclosure.--
       ``(A) Limitation to business associates.--A group health 
     plan receiving a report under paragraph (1) may disclose such 
     information only to business associates of such plan as 
     defined in section 160.103 of title 45, Code of Federal 
     Regulations (or successor regulations).
       ``(B) Clarification regarding public disclosure of 
     information.--Nothing in this section prevents a health 
     insurance issuer offering group health insurance coverage or 
     an entity providing pharmacy benefits management services on 
     behalf of a group health plan from placing reasonable 
     restrictions on the public disclosure of the information 
     contained in a report described in paragraph (1), except that 
     such issuer or entity may not restrict disclosure of such 
     report to the Department of Health and Human Services, the 
     Department of Labor, the Department of the Treasury, or 
     applicable State agencies.
       ``(C) Limited form of report.--The Secretary shall define 
     through rulemaking a limited form of the report under 
     paragraph (1) required of plan sponsors who are drug 
     manufacturers, drug wholesalers, or other direct participants 
     in the drug supply chain, in order to prevent anti-
     competitive behavior.
       ``(4) Report to gao.--A health insurance issuer offering 
     group health insurance coverage or an entity providing 
     pharmacy benefits management services on behalf of a group 
     health plan shall submit to the Comptroller General of the 
     United States each of the first 4 reports submitted to a plan 
     sponsor under paragraph (1) with respect to such coverage or 
     plan, and other such reports as requested, in accordance with 
     the privacy requirements under paragraph (2), the disclosure 
     and redisclosure standards under paragraph (3), the standards 
     specified pursuant to paragraph (5), and such other 
     information that the Comptroller General determines necessary 
     to carry out the study under section 602(d) of the Restoring 
     Hope for Mental Health and Well-Being Act of 2022.
       ``(5) Standard format.--Not later than June 1, 2023, the 
     Secretary shall specify through rulemaking standards for 
     health insurance issuers and entities required to submit 
     reports under paragraph (4) to submit such reports in a 
     standard format.
       ``(c) Enforcement.--
       ``(1) In general.--The Secretary, in consultation with the 
     Secretary of Labor and the Secretary of the Treasury, shall 
     enforce this section.

[[Page H5771]]

       ``(2) Failure to provide timely information.--A health 
     insurance issuer or an entity providing pharmacy benefit 
     management services that violates subsection (a) or fails to 
     provide information required under subsection (b), or a drug 
     manufacturer that fails to provide information under 
     subsection (b)(1)(A) in a timely manner, shall be subject to 
     a civil monetary penalty in the amount of $10,000 for each 
     day during which such violation continues or such information 
     is not disclosed or reported.
       ``(3) False information.--A health insurance issuer, entity 
     providing pharmacy benefit management services, or drug 
     manufacturer that knowingly provides false information under 
     this section shall be subject to a civil money penalty in an 
     amount not to exceed $100,000 for each item of false 
     information. Such civil money penalty shall be in addition to 
     other penalties as may be prescribed by law.
       ``(4) Procedure.--The provisions of section 1128A of the 
     Social Security Act, other than subsection (a) and (b) and 
     the first sentence of subsection (c)(1) of such section shall 
     apply to civil monetary penalties under this subsection in 
     the same manner as such provisions apply to a penalty or 
     proceeding under section 1128A of the Social Security Act.
       ``(5) Waivers.--The Secretary may waive penalties under 
     paragraph (2), or extend the period of time for compliance 
     with a requirement of this section, for an entity in 
     violation of this section that has made a good-faith effort 
     to comply with this section.
       ``(d) Rule of Construction.--Nothing in this section shall 
     be construed to permit a health insurance issuer, group 
     health plan, or other entity to restrict disclosure to, or 
     otherwise limit the access of, the Department of Health and 
     Human Services to a report described in subsection (b)(1) or 
     information related to compliance with subsection (a) by such 
     issuer, plan, or entity.
       ``(e) Definition.--In this section, the term `wholesale 
     acquisition cost' has the meaning given such term in section 
     1847A(c)(6)(B) of the Social Security Act.''; and
       (2) in section 2723 (42 U.S.C. 300gg-22)--
       (A) in subsection (a)--
       (i) in paragraph (1), by inserting ``(other than 
     subsections (a) and (b) of section 2799A-11)'' after ``part 
     D''; and
       (ii) in paragraph (2), by inserting ``(other than 
     subsections (a) and (b) of section 2799A-11)'' after ``part 
     D''; and
       (B) in subsection (b)--
       (i) in paragraph (1), by inserting ``(other than 
     subsections (a) and (b) of section 2799A-11)'' after ``part 
     D'';
       (ii) in paragraph (2)(A), by inserting ``(other than 
     subsections (a) and (b) of section 2799A-11)'' after ``part 
     D''; and
       (iii) in paragraph (2)(C)(ii), by inserting ``(other than 
     subsections (a) and (b) of section 2799A-11)'' after ``part 
     D''.
       (b) ERISA.--
       (1) In general.--Subtitle B of title I of the Employee 
     Retirement Income Security Act of 1974 (29 U.S.C. 1021 et 
     seq.) is amended--
       (A) in subpart B of part 7 (29 U.S.C. 1185 et seq.), by 
     adding at the end the following:

     ``SEC. 726. OVERSIGHT OF PHARMACY BENEFIT MANAGER SERVICES.

       ``(a) In General.--For plan years beginning on or after 
     January 1, 2024, a group health plan (or health insurance 
     issuer offering group health insurance coverage in connection 
     with such a plan) or an entity or subsidiary providing 
     pharmacy benefits management services on behalf of such a 
     plan or issuer shall not enter into a contract with a drug 
     manufacturer, distributor, wholesaler, subcontractor, rebate 
     aggregator, or any associated third party that limits the 
     disclosure of information to plan sponsors in such a manner 
     that prevents the plan or issuer, or an entity or subsidiary 
     providing pharmacy benefits management services on behalf of 
     a plan or issuer, from making the reports described in 
     subsection (b).
       ``(b) Reports.--
       ``(1) In general.--For plan years beginning on or after 
     January 1, 2024, not less frequently than once every 6 
     months, a health insurance issuer offering group health 
     insurance coverage or an entity providing pharmacy benefits 
     management services on behalf of a group health plan or an 
     issuer providing group health insurance coverage shall submit 
     to the plan sponsor (as defined in section 3(16)(B)) of such 
     group health plan or group health insurance coverage a report 
     in accordance with this subsection and make such report 
     available to the plan sponsor in a machine-readable format. 
     Each such report shall include, with respect to the 
     applicable group health plan or health insurance coverage--
       ``(A) as applicable, information collected from drug 
     manufacturers by such issuer or entity on the total amount of 
     copayment assistance dollars paid, or copayment cards 
     applied, that were funded by the drug manufacturer with 
     respect to the participants and beneficiaries in such plan or 
     coverage;
       ``(B) a list of each drug covered by such plan, issuer, or 
     entity providing pharmacy benefit management services that 
     was dispensed during the reporting period, including, with 
     respect to each such drug during the reporting period--
       ``(i) the brand name, chemical entity, and National Drug 
     Code;
       ``(ii) the number of participants and beneficiaries for 
     whom the drug was filled during the plan year, the total 
     number of prescription fills for the drug (including original 
     prescriptions and refills), and the total number of dosage 
     units of the drug dispensed across the plan year, including 
     whether the dispensing channel was by retail, mail order, or 
     specialty pharmacy;
       ``(iii) the wholesale acquisition cost, listed as cost per 
     days supply and cost per pill, or in the case of a drug in 
     another form, per dose;
       ``(iv) the total out-of-pocket spending by participants and 
     beneficiaries on such drug, including participant and 
     beneficiary spending through copayments, coinsurance, and 
     deductibles; and
       ``(v) for any drug for which gross spending of the group 
     health plan or health insurance coverage exceeded $10,000 
     during the reporting period--

       ``(I) a list of all other drugs in the same therapeutic 
     category or class, including brand name drugs and biological 
     products and generic drugs or biosimilar biological products 
     that are in the same therapeutic category or class as such 
     drug; and
       ``(II) the rationale for preferred formulary placement of 
     such drug in that therapeutic category or class, if 
     applicable;

       ``(C) a list of each therapeutic category or class of drugs 
     that were dispensed under the health plan or health insurance 
     coverage during the reporting period, and, with respect to 
     each such therapeutic category or class of drugs, during the 
     reporting period--
       ``(i) total gross spending by the plan, before manufacturer 
     rebates, fees, or other manufacturer remuneration;
       ``(ii) the number of participants and beneficiaries who 
     filled a prescription for a drug in that category or class;
       ``(iii) if applicable to that category or class, a 
     description of the formulary tiers and utilization mechanisms 
     (such as prior authorization or step therapy) employed for 
     drugs in that category or class;
       ``(iv) the total out-of-pocket spending by participants and 
     beneficiaries, including participant and beneficiary spending 
     through copayments, coinsurance, and deductibles; and
       ``(v) for each therapeutic category or class under which 3 
     or more drugs are included on the formulary of such plan or 
     coverage--

       ``(I) the amount received, or expected to be received, from 
     drug manufacturers in rebates, fees, alternative discounts, 
     or other remuneration--

       ``(aa) that has been paid, or is to be paid, by drug 
     manufacturers for claims incurred during the reporting 
     period; or
       ``(bb) that is related to utilization of drugs, in such 
     therapeutic category or class;

       ``(II) the total net spending, after deducting rebates, 
     price concessions, alternative discounts or other 
     remuneration from drug manufacturers, by the health plan or 
     health insurance coverage on that category or class of drugs; 
     and
       ``(III) the net price per course of treatment or single 
     fill, such as a 30-day supply or 90-day supply, incurred by 
     the health plan or health insurance coverage and its 
     participants and beneficiaries, after manufacturer rebates, 
     fees, and other remuneration for drugs dispensed within such 
     therapeutic category or class during the reporting period;

       ``(D) total gross spending on prescription drugs by the 
     plan or coverage during the reporting period, before rebates 
     and other manufacturer fees or remuneration;
       ``(E) total amount received, or expected to be received, by 
     the health plan or health insurance coverage in drug 
     manufacturer rebates, fees, alternative discounts, and all 
     other remuneration received from the manufacturer or any 
     third party, other than the plan sponsor, related to 
     utilization of drug or drug spending under that health plan 
     or health insurance coverage during the reporting period;
       ``(F) the total net spending on prescription drugs by the 
     health plan or health insurance coverage during the reporting 
     period; and
       ``(G) amounts paid directly or indirectly in rebates, fees, 
     or any other type of remuneration to brokers, consultants, 
     advisors, or any other individual or firm who referred the 
     group health plan's or health insurance issuer's business to 
     the pharmacy benefit manager.
       ``(2) Privacy requirements.--Health insurance issuers 
     offering group health insurance coverage and entities 
     providing pharmacy benefits management services on behalf of 
     a group health plan shall provide information under paragraph 
     (1) in a manner consistent with the privacy, security, and 
     breach notification regulations promulgated under section 
     264(c) of the Health Insurance Portability and Accountability 
     Act of 1996, and shall restrict the use and disclosure of 
     such information according to such privacy regulations.
       ``(3) Disclosure and redisclosure.--
       ``(A) Limitation to business associates.--A group health 
     plan receiving a report under paragraph (1) may disclose such 
     information only to business associates of such plan as 
     defined in section 160.103 of title 45, Code of Federal 
     Regulations (or successor regulations).
       ``(B) Clarification regarding public disclosure of 
     information.--Nothing in this section prevents a health 
     insurance issuer offering group health insurance coverage or 
     an entity providing pharmacy benefits management services on 
     behalf of a group health plan from placing reasonable 
     restrictions on the public disclosure of the information 
     contained in a report described in paragraph (1), except that 
     such issuer or entity may not restrict disclosure of such 
     report to the Department of Health and Human Services, the 
     Department of Labor, the Department of the Treasury, or 
     applicable State agencies.
       ``(C) Limited form of report.--The Secretary shall define 
     through rulemaking a limited form of the report under 
     paragraph (1) required of plan sponsors who are drug 
     manufacturers, drug wholesalers, or other direct participants 
     in the drug supply chain, in order to prevent anti-
     competitive behavior.
       ``(4) Report to gao.--A health insurance issuer offering 
     group health insurance coverage or an entity providing 
     pharmacy benefits management services on behalf of a group 
     health plan shall submit to the Comptroller General of the 
     United States each of the first 4 reports submitted to a plan 
     sponsor under paragraph (1) with respect to such coverage or 
     plan, and other

[[Page H5772]]

     such reports as requested, in accordance with the privacy 
     requirements under paragraph (2), the disclosure and 
     redisclosure standards under paragraph (3), the standards 
     specified pursuant to paragraph (5), and such other 
     information that the Comptroller General determines necessary 
     to carry out the study under section 602(d) of the Restoring 
     Hope for Mental Health and Well-Being Act of 2022.
       ``(5) Standard format.--Not later than June 1, 2023, the 
     Secretary shall specify through rulemaking standards for 
     health insurance issuers and entities required to submit 
     reports under paragraph (4) to submit such reports in a 
     standard format.
       ``(c) Enforcement.--
       ``(1) In general.--The Secretary, in consultation with the 
     Secretary of Health and Human Services and the Secretary of 
     the Treasury, shall enforce this section.
       ``(2) Failure to provide timely information.--A health 
     insurance issuer or an entity providing pharmacy benefit 
     management services that violates subsection (a) or fails to 
     provide information required under subsection (b), or a drug 
     manufacturer that fails to provide information under 
     subsection (b)(1)(A) in a timely manner, shall be subject to 
     a civil monetary penalty in the amount of $10,000 for each 
     day during which such violation continues or such information 
     is not disclosed or reported.
       ``(3) False information.--A health insurance issuer, entity 
     providing pharmacy benefit management services, or drug 
     manufacturer that knowingly provides false information under 
     this section shall be subject to a civil money penalty in an 
     amount not to exceed $100,000 for each item of false 
     information. Such civil money penalty shall be in addition to 
     other penalties as may be prescribed by law.
       ``(4) Procedure.--The provisions of section 1128A of the 
     Social Security Act, other than subsection (a) and (b) and 
     the first sentence of subsection (c)(1) of such section shall 
     apply to civil monetary penalties under this subsection in 
     the same manner as such provisions apply to a penalty or 
     proceeding under section 1128A of the Social Security Act.
       ``(5) Waivers.--The Secretary may waive penalties under 
     paragraph (2), or extend the period of time for compliance 
     with a requirement of this section, for an entity in 
     violation of this section that has made a good-faith effort 
     to comply with this section.
       ``(d) Rule of Construction.--Nothing in this section shall 
     be construed to permit a health insurance issuer, group 
     health plan, or other entity to restrict disclosure to, or 
     otherwise limit the access of, the Department of Labor to a 
     report described in subsection (b)(1) or information related 
     to compliance with subsection (a) by such issuer, plan, or 
     entity.
       ``(e) Definition.--In this section, the term `wholesale 
     acquisition cost' has the meaning given such term in section 
     1847A(c)(6)(B) of the Social Security Act.''; and
       (B) in section 502(b)(3) (29 U.S.C. 1132(b)(3)), by 
     inserting ``(other than section 726)'' after ``part 7''.
       (2) Clerical amendment.--The table of contents in section 1 
     of the Employee Retirement Income Security Act of 1974 (29 
     U.S.C. 1001 et seq.) is amended by inserting after the item 
     relating to section 725 the following new item:

``Sec. 726. Oversight of pharmacy benefit manager services.''.
       (c) IRC.--
       (1) In general.--Subchapter B of chapter 100 of the 
     Internal Revenue Code of 1986 is amended by adding at the end 
     the following:

     ``SEC. 9826. OVERSIGHT OF PHARMACY BENEFIT MANAGER SERVICES.

       ``(a) In General.--For plan years beginning on or after 
     January 1, 2024, a group health plan or an entity or 
     subsidiary providing pharmacy benefits management services on 
     behalf of such a plan shall not enter into a contract with a 
     drug manufacturer, distributor, wholesaler, subcontractor, 
     rebate aggregator, or any associated third party that limits 
     the disclosure of information to plan sponsors in such a 
     manner that prevents the plan, or an entity or subsidiary 
     providing pharmacy benefits management services on behalf of 
     a plan, from making the reports described in subsection (b).
       ``(b) Reports.--
       ``(1) In general.--For plan years beginning on or after 
     January 1, 2024, not less frequently than once every 6 
     months, an entity providing pharmacy benefits management 
     services on behalf of a group health plan shall submit to the 
     plan sponsor (as defined in section 3(16)(B) of the Employee 
     Retirement Income Security Act of 1974) of such group health 
     plan a report in accordance with this subsection and make 
     such report available to the plan sponsor in a machine-
     readable format. Each such report shall include, with respect 
     to the applicable group health plan--
       ``(A) as applicable, information collected from drug 
     manufacturers by such entity on the total amount of copayment 
     assistance dollars paid, or copayment cards applied, that 
     were funded by the drug manufacturer with respect to the 
     participants and beneficiaries in such plan;
       ``(B) a list of each drug covered by such plan or entity 
     providing pharmacy benefit management services that was 
     dispensed during the reporting period, including, with 
     respect to each such drug during the reporting period--
       ``(i) the brand name, chemical entity, and National Drug 
     Code;
       ``(ii) the number of participants and beneficiaries for 
     whom the drug was filled during the plan year, the total 
     number of prescription fills for the drug (including original 
     prescriptions and refills), and the total number of dosage 
     units of the drug dispensed across the plan year, including 
     whether the dispensing channel was by retail, mail order, or 
     specialty pharmacy;
       ``(iii) the wholesale acquisition cost, listed as cost per 
     days supply and cost per pill, or in the case of a drug in 
     another form, per dose;
       ``(iv) the total out-of-pocket spending by participants and 
     beneficiaries on such drug, including participant and 
     beneficiary spending through copayments, coinsurance, and 
     deductibles; and
       ``(v) for any drug for which gross spending of the group 
     health plan exceeded $10,000 during the reporting period--

       ``(I) a list of all other drugs in the same therapeutic 
     category or class, including brand name drugs and biological 
     products and generic drugs or biosimilar biological products 
     that are in the same therapeutic category or class as such 
     drug; and
       ``(II) the rationale for preferred formulary placement of 
     such drug in that therapeutic category or class, if 
     applicable;

       ``(C) a list of each therapeutic category or class of drugs 
     that were dispensed under the health plan during the 
     reporting period, and, with respect to each such therapeutic 
     category or class of drugs, during the reporting period--
       ``(i) total gross spending by the plan, before manufacturer 
     rebates, fees, or other manufacturer remuneration;
       ``(ii) the number of participants and beneficiaries who 
     filled a prescription for a drug in that category or class;
       ``(iii) if applicable to that category or class, a 
     description of the formulary tiers and utilization mechanisms 
     (such as prior authorization or step therapy) employed for 
     drugs in that category or class;
       ``(iv) the total out-of-pocket spending by participants and 
     beneficiaries, including participant and beneficiary spending 
     through copayments, coinsurance, and deductibles; and
       ``(v) for each therapeutic category or class under which 3 
     or more drugs are included on the formulary of such plan--

       ``(I) the amount received, or expected to be received, from 
     drug manufacturers in rebates, fees, alternative discounts, 
     or other remuneration--

       ``(aa) that has been paid, or is to be paid, by drug 
     manufacturers for claims incurred during the reporting 
     period; or
       ``(bb) that is related to utilization of drugs, in such 
     therapeutic category or class;

       ``(II) the total net spending, after deducting rebates, 
     price concessions, alternative discounts or other 
     remuneration from drug manufacturers, by the health plan on 
     that category or class of drugs; and
       ``(III) the net price per course of treatment or single 
     fill, such as a 30-day supply or 90-day supply, incurred by 
     the health plan and its participants and beneficiaries, after 
     manufacturer rebates, fees, and other remuneration for drugs 
     dispensed within such therapeutic category or class during 
     the reporting period;

       ``(D) total gross spending on prescription drugs by the 
     plan during the reporting period, before rebates and other 
     manufacturer fees or remuneration;
       ``(E) total amount received, or expected to be received, by 
     the health plan in drug manufacturer rebates, fees, 
     alternative discounts, and all other remuneration received 
     from the manufacturer or any third party, other than the plan 
     sponsor, related to utilization of drug or drug spending 
     under that health plan during the reporting period;
       ``(F) the total net spending on prescription drugs by the 
     health plan during the reporting period; and
       ``(G) amounts paid directly or indirectly in rebates, fees, 
     or any other type of remuneration to brokers, consultants, 
     advisors, or any other individual or firm who referred the 
     group health plan's business to the pharmacy benefit manager.
       ``(2) Privacy requirements.--Entities providing pharmacy 
     benefits management services on behalf of a group health plan 
     shall provide information under paragraph (1) in a manner 
     consistent with the privacy, security, and breach 
     notification regulations promulgated under section 264(c) of 
     the Health Insurance Portability and Accountability Act of 
     1996, and shall restrict the use and disclosure of such 
     information according to such privacy regulations.
       ``(3) Disclosure and redisclosure.--
       ``(A) Limitation to business associates.--A group health 
     plan receiving a report under paragraph (1) may disclose such 
     information only to business associates of such plan as 
     defined in section 160.103 of title 45, Code of Federal 
     Regulations (or successor regulations).
       ``(B) Clarification regarding public disclosure of 
     information.--Nothing in this section prevents an entity 
     providing pharmacy benefits management services on behalf of 
     a group health plan from placing reasonable restrictions on 
     the public disclosure of the information contained in a 
     report described in paragraph (1), except that such entity 
     may not restrict disclosure of such report to the Department 
     of Health and Human Services, the Department of Labor, the 
     Department of the Treasury, or applicable State agencies.
       ``(C) Limited form of report.--The Secretary shall define 
     through rulemaking a limited form of the report under 
     paragraph (1) required of plan sponsors who are drug 
     manufacturers, drug wholesalers, or other direct participants 
     in the drug supply chain, in order to prevent anti-
     competitive behavior.
       ``(4) Report to gao.--An entity providing pharmacy benefits 
     management services on behalf of a group health plan shall 
     submit to the Comptroller General of the United States each 
     of the first 4 reports submitted to a plan sponsor under 
     paragraph (1) with respect to such plan, and other such 
     reports as requested, in accordance with the privacy 
     requirements under paragraph (2), the disclosure and 
     redisclosure standards under paragraph (3), the standards 
     specified pursuant to paragraph (5), and such other

[[Page H5773]]

     information that the Comptroller General determines necessary 
     to carry out the study under section 602(d) of the Restoring 
     Hope for Mental Health and Well-Being Act of 2022.
       ``(5) Standard format.--Not later than June 1, 2023, the 
     Secretary shall specify through rulemaking standards for 
     entities required to submit reports under paragraph (4) to 
     submit such reports in a standard format.
       ``(c) Enforcement.--
       ``(1) In general.--The Secretary, in consultation with the 
     Secretary of Labor and the Secretary of Health and Human 
     Services, shall enforce this section.
       ``(2) Failure to provide timely information.--An entity 
     providing pharmacy benefit management services that violates 
     subsection (a) or fails to provide information required under 
     subsection (b), or a drug manufacturer that fails to provide 
     information under subsection (b)(1)(A) in a timely manner, 
     shall be subject to a civil monetary penalty in the amount of 
     $10,000 for each day during which such violation continues or 
     such information is not disclosed or reported.
       ``(3) False information.--An entity providing pharmacy 
     benefit management services, or drug manufacturer that 
     knowingly provides false information under this section shall 
     be subject to a civil money penalty in an amount not to 
     exceed $100,000 for each item of false information. Such 
     civil money penalty shall be in addition to other penalties 
     as may be prescribed by law.
       ``(4) Procedure.--The provisions of section 1128A of the 
     Social Security Act, other than subsection (a) and (b) and 
     the first sentence of subsection (c)(1) of such section shall 
     apply to civil monetary penalties under this subsection in 
     the same manner as such provisions apply to a penalty or 
     proceeding under section 1128A of the Social Security Act.
       ``(5) Waivers.--The Secretary may waive penalties under 
     paragraph (2), or extend the period of time for compliance 
     with a requirement of this section, for an entity in 
     violation of this section that has made a good-faith effort 
     to comply with this section.
       ``(d) Rule of Construction.--Nothing in this section shall 
     be construed to permit a group health plan or other entity to 
     restrict disclosure to, or otherwise limit the access of, the 
     Department of the Treasury to a report described in 
     subsection (b)(1) or information related to compliance with 
     subsection (a) by such plan or entity.
       ``(e) Definition.--In this section, the term `wholesale 
     acquisition cost' has the meaning given such term in section 
     1847A(c)(6)(B) of the Social Security Act.''.
       (2) Clerical amendment.--The table of sections for 
     subchapter B of chapter 100 of the Internal Revenue Code of 
     1986 is amended by adding at the end the following new item:

``Sec. 9826. Oversight of pharmacy benefit manager services.''.
       (d) GAO Study.--
       (1) In general.--Not later than 3 years after the date of 
     enactment of this Act, the Comptroller General of the United 
     States shall submit to Congress a report on--
       (A) pharmacy networks of group health plans, health 
     insurance issuers, and entities providing pharmacy benefit 
     management services under such group health plan or group or 
     individual health insurance coverage, including networks that 
     have pharmacies that are under common ownership (in whole or 
     part) with group health plans, health insurance issuers, or 
     entities providing pharmacy benefit management services or 
     pharmacy benefit administrative services under group health 
     plan or group or individual health insurance coverage;
       (B) as it relates to pharmacy networks that include 
     pharmacies under common ownership described in subparagraph 
     (A)--
       (i) whether such networks are designed to encourage 
     enrollees of a plan or coverage to use such pharmacies over 
     other network pharmacies for specific services or drugs, and 
     if so, the reasons the networks give for encouraging use of 
     such pharmacies; and
       (ii) whether such pharmacies are used by enrollees 
     disproportionately more in the aggregate or for specific 
     services or drugs compared to other network pharmacies;
       (C) whether group health plans and health insurance issuers 
     offering group or individual health insurance coverage have 
     options to elect different network pricing arrangements in 
     the marketplace with entities that provide pharmacy benefit 
     management services, the prevalence of electing such 
     different network pricing arrangements;
       (D) pharmacy network design parameters that encourage 
     enrollees in the plan or coverage to fill prescriptions at 
     mail order, specialty, or retail pharmacies that are wholly 
     or partially-owned by that issuer or entity; and
       (E) the degree to which mail order, specialty, or retail 
     pharmacies that dispense prescription drugs to an enrollee in 
     a group health plan or health insurance coverage that are 
     under common ownership (in whole or part) with group health 
     plans, health insurance issuers, or entities providing 
     pharmacy benefit management services or pharmacy benefit 
     administrative services under group health plan or group or 
     individual health insurance coverage receive reimbursement 
     that is greater than the median price charged to the group 
     health plan or health insurance issuer when the same drug is 
     dispensed to enrollees in the plan or coverage by other 
     pharmacies included in the pharmacy network of that plan, 
     issuer, or entity that are not wholly or partially owned by 
     the health insurance issuer or entity providing pharmacy 
     benefit management services.
       (2) Requirement.--The Comptroller General of the United 
     States shall ensure that the report under paragraph (1) does 
     not contain information that would allow a reader to identify 
     a specific plan or entity providing pharmacy benefits 
     management services or otherwise contain commercial or 
     financial information that is privileged or confidential.
       (3) Definitions.--In this subsection, the terms ``group 
     health plan'', ``health insurance coverage'', and ``health 
     insurance issuer'' have the meanings given such terms in 
     section 2791 of the Public Health Service Act (42 U.S.C. 
     300gg-91).

     SEC. 603. MEDICARE IMPROVEMENT FUND.

       Section 1898(b)(1) of the Social Security Act (42 U.S.C. 
     1395iii(b)(1)) is amended by striking ``$5,000,000'' and 
     inserting ``$1,029,000,000''.

     SEC. 604. LIMITATIONS ON AUTHORITY.

       In carrying out any program of the Substance Abuse and 
     Mental Health Services Administration whose statutory 
     authorization is enacted or amended by this Act, the 
     Secretary of Health and Human Services shall not allocate 
     funding, or require award recipients to prioritize, dedicate, 
     or allocate funding, without consideration of the incidence, 
     prevalence, or determinants of mental health or substance use 
     issues, unless such allocation or requirement is consistent 
     with statute, regulation, or other Federal law.

  The SPEAKER pro tempore. The bill, as amended, shall be debatable for 
1 hour equally divided and controlled by the chair and ranking minority 
member of the Committee on Energy and Commerce or their respective 
designees.
  The gentleman from New Jersey (Mr. Pallone) and the gentlewoman from 
Washington (Mrs. Rodgers) each will control 30 minutes.
  The Chair recognizes the gentleman from New Jersey.


                             General Leave

  Mr. PALLONE. Mr. Speaker, I ask unanimous consent that all Members 
may have 5 legislative days in which to revise and extend their remarks 
and add extraneous material on H.R. 7666.
  The SPEAKER pro tempore. Is there objection to the request of the 
gentleman from New Jersey?
  There was no objection.
  Mr. PALLONE. Mr. Speaker, I yield myself such time as I may consume.
  Mr. Speaker, I rise today in support of H.R. 7666, the Restoring Hope 
for Mental Health and Well-Being Act of 2022, and I thank Ranking 
Member Rodgers for working with me these past few months to develop 
this comprehensive legislation that will help address the mental health 
and substance use disorder crisis facing millions of Americans.
  This bill is needed today more than ever. Americans report rising 
anxiety and depression and increased use of alcohol, opiates, and other 
substances. One in five adults are battling a mental illness. Suicide 
is now the second leading cause of death for children ages 10 to 14, 
and earlier this year the Centers for Disease Control and Prevention 
released a report finding that 4 in 10 high school students said they 
felt persistently sad or hopeless during the COVID-19 pandemic. The 
opioid crisis also continues to devastate families and communities all 
around the Nation. 108,000 people lost their lives due to drug 
overdoses just last year alone.
  The Restoring Hope for Mental Health and Well-Being Act will help 
restore hope for millions of Americans. The bill strengthens and 
expands more than 30 critical programs that collectively support mental 
health care and substance use disorder prevention, care, treatment, and 
recovery support services in communities across the Nation.
  As the Nation prepares for the launch of the 988 National Suicide 
Prevention Lifeline dialing code next month, H.R. 7666 provides key 
crisis response efforts, establishing the Substance Abuse and Mental 
Health Services Behavioral Health Crisis Coordination Office and 
requiring the development of crisis response best practices. The 
legislation also continues investments in critical mental health and 
substance use services block grant funding to States, territories, and 
Tribes.
  The Restoring Hope Act includes crucial provisions to meet the 
challenges of the Nation's opioid epidemic, expanding and ensuring 
timely patient access to lifesaving treatment for opioid use disorders 
through the elimination of barriers to treatment. It includes 
Representative Tonko's MAT Act, which eliminates the X-waiver, a 
burdensome registration requirement that establishes arbitrary caps on 
the number of patients a provider can treat for opioid use disorder 
using buprenorphine.
  This bill also establishes a one-time, 8-hour training requirement on 
treating and identifying substance use disorders that providers must 
complete

[[Page H5774]]

before their first registration or renewal of a license to dispense 
controlled substances.
  H.R. 7666 also helps bolster the behavioral health workforce capacity 
and training. It also increases access to mental health and substance 
use disorder care and coverage by applying the mental health parity law 
to State and local government workers, such as teachers and frontline 
workers.
  The legislation also supports the mental health of children and young 
people. It continues investment in the integration of behavioral health 
into pediatric primary care through Pediatric Mental Health Access 
Grants and enhances research at the National Institutes of Health on 
the cognitive, physical, and socioemotional impacts of modern 
technology and multimedia on infants, children, and adolescents.
  I can't stress enough that this is an epidemic that focuses a lot on 
children and adolescents. Older youth need help with suicide prevention 
and other mental health support and substance use disorder services. 
Students in higher education need that help, and they get it through a 
program called the Garrett Lee Smith Memorial Act.
  The bill also ensures that State Medicaid programs have resources to 
implement and strengthen school-based mental health services while 
preserving the continuity of coverage for justice-involved youth. These 
important provisions will increase children's access to care.
  Mr. Speaker, the scope and reach of this bipartisan legislation--and 
I stress that. This was reported out of the Energy and Commerce 
Committee unanimously, Mr. Speaker. It is truly bipartisan. It is going 
to help to support the mental health and well-being of millions of 
Americans, their families, and communities for years to come.
  I thank Members on both sides of the aisle, not only Ranking Member 
Rodgers, but the subcommittee leadership as well, both Democrat and 
Republican.
  The reason that we try to do this on a bipartisan level and get 
everybody's support is because we have a good chance of passing this in 
the Senate, which is also acting on similar legislation. We are hopeful 
that as a result of a large vote today, that will spur the Senate into 
action, and we can actually get this bill signed into law.
  Mr. Speaker, I urge my colleagues to support the bill, and I reserve 
the balance of my time.
                                         House of Representatives,


                                   Committee on the Judiciary,

                                    Washington, DC, June 10, 2022.
     Hon. Frank Pallone, Jr.,
     Chairman, Committee on Energy and Commerce, House of 
         Representatives, Washington, DC.
       Dear Chairman Pallone: This letter is to advise you that 
     the Committee on the Judiciary has now had an opportunity to 
     review the provisions in H.R. 7666, the ``Restoring Hope for 
     Mental Health and Well-Being Act of 2022,'' that fall within 
     our Rule X jurisdiction. I appreciate your consulting with us 
     on those provisions. The Judiciary Committee has no objection 
     to your including them in the bill for consideration on the 
     House floor, and to expedite that consideration is willing to 
     forgo action on H.R. 7666, with the understanding that we do 
     not thereby waive any future jurisdictional claim over those 
     provisions or their subject matters.
       In the event a House-Senate conference on this or similar 
     legislation is convened, the Judiciary Committee reserves the 
     right to request an appropriate number of conferees to 
     address any concerns with these or similar provisions that 
     may arise in conference.
       Please place this letter into the Congressional Record 
     during consideration of the measure on the House floor. Thank 
     you for the cooperative spirit in which you have worked 
     regarding this matter and others between our committees.
           Sincerely,
                                                   Jerrold Nadler,
     Chairman.
                                  ____

                                         House of Representatives,


                             Committee on Energy and Commerce,

                                    Washington, DC, June 13, 2022.
     Hon. Jerrold Nadler,
     Chairman, Committee on Judiciary,
     Washington, DC.
       Dear Chairman Nadler: Thank you for consulting with the 
     Committee on Energy and Commerce and agreeing to be 
     discharged from further consideration of H.R. 7666, the 
     ``Restoring Hope for Mental Health and Well-Being Act of 
     2022,'' so that the bill may proceed expeditiously to the 
     House floor.
       I agree that your forgoing further action on this measure 
     does not in any way diminish or alter the jurisdiction of 
     your committee or prejudice its jurisdictional prerogatives 
     on this measure or similar legislation in the future. I would 
     support your effort to seek appointment of an appropriate 
     number of conferees from your committee to any House-Senate 
     conference on this legislation.
       I will ensure our letters on H.R. 7666 are included in the 
     report for this bill and entered into the Congressional 
     Record during floor consideration of the bill. I appreciate 
     your cooperation regarding this legislation and look forward 
     to continuing to work together as this measure moves through 
     the legislative process.
           Sincerely,
                                               Frank Pallone, Jr.,
                                                         Chairman.
  Mrs. RODGERS of Washington. Mr. Speaker, I yield myself such time as 
I may consume.
  Mr. Speaker, I rise today in support of H.R. 7666, the Restoring Hope 
for Mental Health and Well-Being Act.
  We are taking urgent action to help States and communities provide 
lifesaving mental health care to people in need, especially for our 
children and those suffering from severe mental illness.
  I think about Austin, a 9-year-old boy who struggled to cope when his 
school was shut down, and his parents were going through a divorce. He 
was socially isolated and didn't know where to turn. When he confessed 
suicidal thoughts to his mom, they faced long waiting lists and no beds 
for the care that he needed.
  Cases like Austin's can't be ignored. Parents, teachers, and medical 
professionals are talking about this everywhere I go.
  In Spokane, Washington, we are seeing more violence in our schools 
and rising crime. Drug overdose deaths and fentanyl poisoning were up 
300 percent last year. There is an overwhelming sense of despair, 
anxiety, fear, and isolation. This has been heightened by the horrific 
shootings in Uvalde and Buffalo. Especially for our children, we need 
to deliver hope and healing in every community in our country.
  This bill will help children in crisis and improve school safety. For 
example, Congresswoman Ashley Hinson is leading with Richard Hudson on 
a provision that will expand access to behavioral and mental health 
services to kids in schools.
  It also includes a solution I led on with Congresswoman Young Kim to 
reauthorize the Garrett Lee Smith Memorial Act, which supports 
community-based youth and young adult suicide prevention programs.
  Like with Representative French Hill's solution in this, we are 
removing red tape, boosting treatment access, and making sure 
communities have resources to combat the substance use disorder 
epidemic in America.
  More than 100,000 people are dying a year, and our communities are in 
desperate need of help to prevent, treat, and rescue people from 
overdoses and despair.
  The priorities in this bill are targeted to responsibly address our 
most urgent needs so we can build stronger families, communities, and a 
brighter future. We are accomplishing this by stopping duplicative 
programs and cutting the deficit by $200 million. The bulk of the 
programs in this bill are block grants that have been successful in 
providing our States and communities with the resources and 
flexibilities to meet the specific and unique needs in combating mental 
illness and addiction while keeping the Federal Government out of the 
decisionmaking process for treatments and care.
  By protecting charitable choice, we are also making sure faith-based 
and religious organizations are competing on an equal footing. This is 
a victory for conscience protections.
  The provisions in this bill also support care for maternal mental 
health and substance use disorders, which are among the leading causes 
of death for pregnant and postpartum women. We are saving lives and 
caring for women at every stage of pregnancy and beyond.
  Mr. Speaker, I again urge support for this legislation. I thank 
Chairman Pallone for his leadership and for working with us on 
solutions from our colleagues on both sides of the aisle.
  While families and communities will lead the way to address the root 
causes of despair, isolation, violence, and overdose deaths that are 
tearing nearly every community apart and destroying people's lives, 
this bill takes an important step forward to help them in these 
efforts.
  We are taking action to turn this despair into hope. Children like 
Austin in communities like mine in eastern Washington are counting on 
it. Let's

[[Page H5775]]

deliver today and keep building on this work.
  Mr. Speaker, I reserve the balance of my time.
  Mr. PALLONE. Mr. Speaker, I yield 2 minutes to the gentlewoman from 
Illinois (Ms. Schakowsky), who chairs our Subcommittee on Consumer 
Protection and Commerce.
  Ms. SCHAKOWSKY. Mr. Speaker, I am so happy about this bipartisan 
legislation and really excited about the changes that are going to be 
made, because for all 24 years that I have been in Congress, I have not 
had a townhall meeting or a meeting with my constituents where the 
issue of access and affordability of mental health services has not 
come up.
  Right now, our country is facing a mental health crisis like we have 
not seen before. We are seeing that families are losing loved ones to 
COVID, to suicide, and to overdoses.
  This bill will provide vital services in substance abuse and mental 
health, four things mainly. We will see a strengthening of parity. We 
voted for parity a long time ago, and now we are going to make sure 
that mental health and physical health are on the same page.
  We are going to have 30 programs that are going to strengthen and 
reauthorize mental health services. We are going to have more education 
for doctors. We are going to have doctors be able to have more patients 
for certain mental assistance treatment.

  This is a great bill. We should all be proud to vote for it.
  Mrs. RODGERS of Washington. Mr. Speaker, I yield 2 minutes to the 
gentleman from Minnesota (Mr. Emmer), who has led on important 
provisions for children in this bill.
  Mr. EMMER. Mr. Speaker, I thank the ranking member, soon to be chair, 
for yielding.
  I rise in support of H.R. 7666, the Restoring Hope for Mental Health 
and Well-Being Act.
  After years of lockdowns and social isolation, the mental health of 
our Nation's citizens, and especially our youth, is at an all-time low. 
But H.R. 7666 begins to return us to a better path, so I thank the 
chairman and ranking member for all their hard work to make this a 
reality.
  I am especially pleased that portions of two bills that I had the 
pleasure of working on with my colleague from Maryland were included in 
this legislation. One such provision would amend the Medicaid Inmate 
Exclusion Policy to allow incarcerated juveniles who have been detained 
pending trial to continue to receive Medicaid coverage. Pretrial 
detainees are, by definition, presumed innocent. As a matter of due 
process, we should not be denying critical health benefits to anyone 
who has not been convicted of a crime.
  From a practical standpoint, reforms to the Medicaid Inmates 
Exclusion Policy will help our local law enforcement better manage the 
shockingly high percentage of inmates who suffer from mental illness.
  H.R. 7666 also includes language to create a behavioral health 
coordinating office, another issue that I have had the pleasure of 
working on. Many Federal programs to address the mental health crisis 
currently lack clear, unified direction and coordination, which is a 
recipe for redundancy and waste.

                              {time}  1415

  The reforms in today's bill will bring all the major agencies into 
the room, including the Secretary of Education, the Secretary of Health 
and Human Services, and the Director of National Drug Control Policy to 
develop a unified approach to addressing topics ranging from substance 
abuse care to delivery of better telehealth.
  There is always more work to be done to improve the mental health of 
our Nation, but H.R. 7666 is an important step, and one we need now 
more than ever.
  Madam Speaker, I once again urge my colleagues to support this 
critical legislation.
  Mr. PALLONE. Mr. Speaker, I yield 2 minutes to the gentleman from 
Maryland (Mr. Sarbanes), who has been involved with these health and 
behavioral issues for a long time.
  Mr. SARBANES. Mr. Speaker, I thank the gentleman for yielding.
  Mr. Speaker, I, too, rise today in support of H.R. 7666, the 
Restoring Hope for Mental Health and Well-Being Act of 2022.
  Our Nation, as you know, is facing a continuing mental health and 
substance use crisis that has only been exacerbated by the COVID-19 
pandemic. This crisis touches the lives of individuals in each and 
every corner of our country and has a particularly acute impact on 
children and teens.
  Recognizing this, last October, the American Academy of Pediatrics, 
the American Academy of Child and Adolescent Psychiatry, and the 
Children's Hospital Association declared a national emergency in child 
and adolescent mental health.
  To wrap our arms as a society around children facing mental and 
behavioral health challenges, I recently joined in introducing H.R. 
7248, the Continuing Systems of Care for Children Act, with my 
colleagues Representatives Joyce, Underwood, and Gimenez, a bipartisan 
bill that I am proud is included in H.R. 7666 today.
  This legislation would reauthorize for 5 years two important grant 
programs; one that provides comprehensive community mental health 
services for children with serious emotional disturbances, as well as 
the Youth and Family TREE Program.
  These programs connect children and teenagers to services that meet 
their individual needs and have a sustained positive impact on their 
well-being.
  As we confront the compounding challenges posed by our mental health 
and behavioral health crisis and our national gun violence crisis, 
Congress must provide our children every resource they need to lead 
safe and healthy lives.
  That is why it is so important that we pass the Restoring Hope for 
Mental Health and Well-Being Act today to bolster mental health 
services and better support our communities now and into the future.
  Mr. Speaker, I urge my colleagues to vote ``yes'' on this 
legislation.
  Mrs. RODGERS of Washington. Mr. Speaker, I yield 3 minutes to the 
gentleman from Kentucky (Mr. Guthrie), our lead on the Subcommittee on 
Health.
  Mr. GUTHRIE. Mr. Speaker, I thank the gentlewoman for yielding.
  Mr. Speaker, H.R. 7666 the Restoring Hope for Mental Health and Well-
Being Act is a significant bill that will help support our mental 
health workforce, increase access to pediatric mental health treatment, 
and help make schools safer.
  This bill will bolster substance use disorder prevention, treatment, 
and recovery resources. The Committee on Energy and Commerce has worked 
on this for many months, held hearings, and reported it out by a voice 
vote in May.
  Recognizing children's mental health has been negatively impacted by 
school closures, ineffective lockdowns, and increased violence. This 
bill provides specific resources to help communities respond to the 
children's mental health crisis. This legislation also supports 
community mental health services for children with serious emotional 
disturbances through crisis-care service and early intervention 
activities.
  The need to strengthen resources for children's mental health has 
been further heightened after the horrific school violence we have seen 
in Uvalde.
  This bill also works to reauthorize the Garrett Lee Smith Suicide 
Prevention Program, provide funding for a suicide prevention lifeline, 
and update a major block grant that States use to provide support to 
those with serious mental illness.
  In addition to supporting those with mental illness, the legislation 
helps those with substance use disorders. Kentucky has seen a drastic 
rise in overdoses throughout the pandemic and, nationally, the CDC 
estimates that drug overdoses exceeded 107,000 between November 2020 
and November 2021.
  Many of these drug overdoses have been caused by synthetic opioids, 
like illicit fentanyl poisoning, which were involved in about 70 
percent of all Kentucky overdoses in 2021.
  Ultimately, fighting the drug overdose epidemic will require a two-
pronged approach: Equipping our law enforcement with the tools they 
need to keep these deadly poisons off our streets and providing 
recovery and treatment resources.
  Through the passage of this bill, we are advancing the second part of 
this

[[Page H5776]]

approach by increasing access to critical treatment and recovery 
resources for people from all walks of life and every stage of life. 
This includes resources for moms and pregnant women by supporting care 
for maternal health and substance use disorders, which are among the 
leading cause of death for pregnant and postpartum women.
  In addition, this legislation also has a provision led by 
Representative Bucshon, alongside Representatives Miller-Meeks, Axne, 
and Pappas, to remove unnecessary regulatory barriers to help those 
with opioid use disorder seek the care that they need as quickly as 
possible.
  The Timely Treatment for Opioid Use Disorder Act removes a Federal 
requirement of having to live with opioid disorder for more than 1 year 
to be admitted for in-person treatment. I am proud that my bill, the 
Substance Use Prevention, Treatment, and Recovery Services Block Grant 
Act of 2022, which I have worked together with my colleagues, Messrs. 
Tonko, McKinley, and Ms. Wild, is also included in this bill.

  The legislation would deliver more coordinated substance use disorder 
care as well as explicitly reauthorizing funding for recovery support 
services, which include workforce training and others.
  Mr. Speaker, I encourage my colleagues to vote for this bill.
  Mr. PALLONE. Mr. Speaker, I yield 2 minutes to the gentleman from New 
York (Mr. Tonko), who chairs our Environment and Climate Change 
Subcommittee.
  Mr. TONKO. Mr. Speaker, I rise in strong support of the Restoring 
Hope for Mental Health and Well-Being Act.
  I offer my thanks to Chairman Pallone and Ranking Member Rodgers and 
their staffs for their tireless work on this bill. It is yet another 
example of the profound good our committee can produce when we work 
together in a collaborative and bipartisan fashion.
  This strongly bipartisan legislation will take several steps to 
improve mental health and substance use care.
  Importantly, H.R. 7666 includes my Mainstreaming Addiction Treatment 
Act, which will eliminate outdated barriers that prevent more people in 
need from having access to buprenorphine, a lifesaving drug. I have 
worked on this legislation for years and was pleased to see it advance 
out of committee with a strong bipartisan majority.
  By passing this legislation, we will vastly expand access to 
addiction medicine and move us toward a system of treatment on demand 
for those struggling with addiction.
  It is not hyperbole to say this is one of the most meaningful steps 
that Congress has taken to date to address the opioid epidemic. It will 
save countless lives, and I am indeed grateful for the bipartisan push 
here to get it over the finish line.
  H.R. 7666 also includes a bill that I authored to reauthorize and 
strengthen the Substance Use Prevention and Treatment Block Grant, 
which serves as the foundation for State's substance use prevention and 
treatment programs.
  We made important improvements to the block grant, including 
clarifying that recovery support services are eligible for funding 
through this program.
  We are going to keep working to increase funding levels and hopefully 
implement a recovery set-aside, ensuring that all States invest in 
critical recovery services.
  Taken together, the pieces of the Restoring Hope for Mental Health 
and Well-Being Act will truly make a difference to families and 
communities struggling with mental health and substance use challenges.
  Mr. Speaker, I urge all my colleagues to support this critically 
important legislation that delivers hope to our communities, delivers 
hope to the doorstep of our families.
  Mrs. RODGERS of Washington. Mr. Speaker, I yield 2 minutes to the 
gentleman from Arkansas (Mr. Hill), a leader on this issue, who 
sponsored the underlying bill that is incorporated in this package.
  Mr. HILL of Arkansas. Mr. Speaker, I thank Mr. Pallone and Mrs. 
McMorris Rodgers for their excellent bipartisan leadership in bringing 
these bills to the floor. It is the way Congress is supposed to work.
  Mr. Speaker, I didn't know anyone who died of a drug overdose when I 
was in high school or college. But my two sweet kids can count five or 
six of their peers who have been lost to suicide, drug overdose-
related. It is heartbreaking. Everybody in this House knows the 
horrifying 107,000 losses we have seen from opioid deaths last year.
  So I do, in fact, rise in support of H.R. 7666, and to discuss my co-
prescribing legislation that was included in this mental health 
package. My bill seeks to prevent opioid overdoses through co-
prescription. This effort was inspired by my home State of Arkansas, 
which is one of 14 States that has co-prescribing now.
  Co-prescribing is when a doctor prescribes an opioid overdose 
reversal drug like naloxone along with the prescription. My legislation 
encourages co-prescribing when medically appropriate. It also supports 
existing standing orders to increase laypersons' access to opioid 
overdose reversal drugs like naloxone.
  Statistical modeling reported to the International Journal of Drug 
Policy suggests that high rates of naloxone distribution among 
laypersons and emergency personnel could avert 21 percent of opioid 
overdose deaths. The majority of overdose death reduction would be as a 
result of that increased naloxone distribution to patients.
  Mr. Speaker, in 2021, 551 of our citizens of Arkansas are alive today 
because of a co-prescription legislation.
  Mr. Speaker, the data is clear. Co-prescribing saves lives, and that 
is why I urge my colleagues to support H.R. 7666.
  Mr. PALLONE. Mr. Speaker, I yield 2 minutes to the gentleman from 
Arizona (Mr. O'Halleran), a member of the Committee on Energy and 
Commerce.
  Mr. O'HALLERAN. Mr. Speaker, I thank the chairman for yielding.
  Mr. Speaker, I rise in support of H.R. 7666, the Restoring Hope for 
Mental Health and Well-Being Act, legislation that works to increase 
the accessibility of our mental health care system and breaks down the 
unique barriers to care for rural communities that are facing it.
  Each year, hundreds of thousands of Arizonians do not receive the 
mental health care they need. Without access to this essential care, 
our families and our communities suffer.
  In recent years, we have lost too many loved ones to opioid abuse, 
suicide, and senseless violence in our communities. It has gone on far 
too long. As a homicide investigator in Chicago, I can tell you of the 
hundreds and hundreds of these types of cases I saw day in and day out.

  Affordable, accessible mental health care plays an important role in 
holistically addressing each one of these issues. That is why I worked 
with my colleagues on the Committee on Energy and Commerce, a 
bipartisan effort, to bring this urgently needed legislation to the 
House floor for a vote.
  By investing in workforce education and training, and supporting 
critical mental health programs, the Restoring Hope for Mental Health 
and Well-Being Act works to address the provider shortage millions of 
Americans are experiencing and expands access to the care our 
vulnerable and underserved communities need.
  I am pleased to see the initiative to reauthorize and improve 
critical SAMHSA programs included in this bill. In Arizona, more than 
five people die every day from overdoses. This crisis is tearing entire 
families and communities apart.
  Our legislation would assist in developing coordinated local opioid 
response plans, expand access to medications that reverse an opioid 
overdose, and improve substance use disorder and mental health 
treatment for homeless individuals.
  Our bill also invests in mental health care for our children through 
programs that serve a wide range of ages and mental health needs, 
including suicide prevention for students.
  Mr. Speaker, it is time we fill those gaps, and I urge my colleagues 
to vote for this bill.
  Mrs. RODGERS of Washington. Mr. Speaker, I yield 2 minutes to the 
gentleman from Texas (Mr. Tony Gonzales), whose community understands 
the importance of hope and healing like no other right now.
  Mr. TONY GONZALES of Texas. Mr. Speaker, I rise today to support H.R. 
7666, the Restoring Hope for Mental Health and Well-Being Act of 2022.
  One month ago, a gunman fired on Robb Elementary School in Uvalde,

[[Page H5777]]

Texas, 38 miles from where I grew up. This despicable crime led to the 
death of 19 innocent children and two teachers. As a father of six, I 
am absolutely heartbroken.
  As a Congressman who represents Uvalde, I am focusing on delivering 
change. The change starts with addressing the serious lack of mental 
health resources in our country.

                              {time}  1430

  In a 2022 report by Mental Health America, Texas was ranked as the 
worst State for access to mental health care. In rural communities, 
that gap is felt even more intensely.
  It is in places like Uvalde that mental health clinicians are few and 
far between, and parents have to drive more than 4 hours roundtrip for 
access to inpatient care. Communities like Uvalde are desperately in 
need of mental health resources now and well into the future.
  That is why I am proud to support this bipartisan package that will 
commit significant resources to mental health awareness, training, and 
treatment.
  It is time for Congress to address the solution to the mental health 
crisis in America, and that starts with supporting H.R. 7666.
  Mr. PALLONE. Mr. Speaker, I yield 2 minutes to the gentlewoman from 
New Hampshire (Ms. Kuster), a member of the Energy and Commerce 
Committee.
  Ms. KUSTER. Mr. Speaker, I rise today in support of H.R. 7666, the 
Restoring Hope for Mental Health and Well-Being Act of 2022.
  It has never been more urgent to pass this comprehensive legislation 
that will help deliver essential mental health and substance use 
disorder treatment and support to communities across this country.
  Americans continue to lose loved ones to addiction and mental health 
struggles every day. Mr. Speaker, 2021 marked the deadliest year yet, 
with nearly 108,000 overdose deaths here in the United States. In 
Nashua, New Hampshire, in my district, the rate of fatal overdoses 
doubled from March to April just this year, and it is on track to reach 
the highest number of opioid deaths since the epidemic began.
  We cannot wait another day to pass this critical legislation.
  As founder and co-chair of the Bipartisan Addiction and Mental Health 
Task Force, I am pleased to see the Restoring Hope for Mental Health 
and Well-Being Act include many of the bills from our task force 
agenda, bills like the Mainstreaming Addiction Treatment Act to remove 
outdated barriers that prevent healthcare providers from prescribing 
essential treatment for substance use disorder.
  I am also pleased to see the Restoring Hope for Mental Health and 
Well-Being Act include the KIDS CARE Act, legislation I introduced with 
Congressman Hudson to improve Medicaid in schools and provide mental 
health screenings for justice-involved youth.
  Importantly, H.R. 7666 addresses the many unmet needs of communities 
that have suffered because of inadequate mental health resources, from 
bolstering grants for depression screening and suicide prevention to 
strengthening the behavioral health workforce.
  I support this legislation because it responds to the urgency of 
today's crisis and will improve mental health and addiction care all 
across the country.
  Mr. Speaker, I thank Chairman Pallone and his staff for his 
leadership on this bill and the Speaker for giving us the opportunity 
to discuss this legislation. I urge a ``yes'' vote.
  Mrs. RODGERS of Washington. Mr. Speaker, I yield 2 minutes to the 
gentlemen from North Dakota (Mr. Armstrong), a leader on the committee.
  Mr. ARMSTRONG. Mr. Speaker, I rise today in strong support of the 
Restoring Hope for Mental Health and Well-Being Act.
  This bipartisan mental health package includes my legislation, the 
Summer Barrow Prevention, Treatment, and Recovery Act. This bill 
reauthorizes several substance use disorder programs administered by 
SAMHSA that help local communities provide substance use disorder and 
mental health services to those most in need.
  This is particularly important for rural States like North Dakota, 
where individuals struggle to access all treatment options that may 
work for them.
  The package also includes the Mainstreaming Addiction Treatment Act, 
or MAT Act. The MAT Act would remove the burdensome requirement that a 
healthcare practitioner apply for a separate waiver, known as the X 
waiver, through the Drug Enforcement Agency to prescribe certain drugs 
for substance use disorder treatment.
  The X waiver requirement limits access to lifesaving treatment, which 
is particularly painful considering recent news that drug overdose 
deaths hit a record high of more than 107,000 in 2021.
  Lastly, I offer my support for an amendment I offered with my friend 
Congressman Trone of Maryland that will come to the floor soon. Our 
amendment would add the State Opioid Response Grants Act to this 
program.
  This amendment will provide $8.75 billion over 5 years in flexible 
financing for State Opioid Response grants and Tribal Opioid Response 
grants, providing States and Tribes certainty and stability to 
implement prevention, treatment, and recovery.
  Mr. PALLONE. Mr. Speaker, I yield 1 minute to the gentleman from 
Maryland (Mr. Hoyer), the House majority leader.
  Mr. HOYER. Mr. Speaker, I thank the chairman and ranking member for 
the work they have done together and with the committee to bring this 
very important bipartisan bill to the floor. I thank them both for 
their hard work, and the committee for its hard work, in compiling this 
bipartisan package to combat two of the most important issues, Mr. 
Speaker, facing communities today: mental health and drug addiction.
  The COVID-19 pandemic exacerbated mental health and addiction 
challenges that were already present in our communities. For those 
already experiencing severe depression, anxiety, or even substance 
abuse and addiction disorders, the pandemic made it harder to access 
mental health care and essential help and resources, and it created, of 
course, much greater anxiety.
  This bill would reauthorize key mental health and addiction programs 
while helping to strengthen communities' crisis response.
  There are many important programs included, but I will highlight just 
a few.
  Mr. Speaker, among them is legislation from my friend Representative  
 David Trone to help States expand the availability of high-quality 
recovery housing for treatment from substance abuse. Representative 
Trone has been a leader on this issue as co-chair of the Bipartisan 
Addiction and Mental Health Task Force.

  Mr. Speaker, also included is legislation from my friends 
Representatives Cindy Axne and Chris Pappas to revise opioid treatment 
program criteria to help those in need of treatment access it more 
quickly.
  Our in-house pediatrician, Representative Kim Schrier, authored a 
provision to help children and teens who have had their lives upended 
by the pandemic access the mental health care and services that they so 
badly need.
  Mr. Speaker, I also mention a critical section added by 
Representative Susie Lee to provide important resources for virtual 
peer support programs. Representative Lee knows how much her 
constituents have benefited from these types of programs and how much 
more good they can do if given the proper resources.
  Representative Tonko from New York, included legislation to expand 
access to prescription medications that help patients overcome 
addiction disorders.
  Mr. Speaker, these are just a few of the very beneficial policies 
included in this legislation that will improve lives and, indeed, save 
lives.
  I am so proud of the Energy and Commerce Committee and all the 
Members whose legislation is included in this bipartisan package, which 
demonstrates how we can join together, Democrats and Republicans, to 
pass important legislation and show those we serve they are not alone 
in facing these challenges.
  Mr. Speaker, I hope this strong vote today will help move these 
critical policies through the Senate and see them quickly enacted into 
law.
  Mr. Speaker, I urge a ``yes'' vote.
  Mrs. RODGERS of Washington. Mr. Speaker, I reserve the balance of my 
time.
  Mr. PALLONE. Mr. Speaker, I yield 2 minutes to the gentlewoman from

[[Page H5778]]

Washington (Ms. Schrier), a member of the Energy and Commerce 
Committee.
  Ms. SCHRIER. Mr. Speaker, I express my support for H.R. 7666, the 
Restoring Hope for Mental Health and Well-Being Act of 2022.
  In over 20 years as a pediatrician, I saw steadily escalating levels 
of mental illness in my patients. There was a big uptick after 2007 
that many associate with ubiquitous social media use. Of course, the 
pandemic further accelerated rates of depression, anxiety, eating 
disorders, and self-harm. We are seeing 9-year-olds with eating 
disorders and 10-year-olds with suicidal ideation. This is alarming.
  We all agree that our children need help, but resources are limited. 
There just aren't enough behavioral health specialists out there to 
meet the need, particularly in rural areas like some of those I 
represent.
  There are ways to extend the reach of people who have dedicated their 
lives to supporting our mental health, to leverage those resources so 
they stretch a little further. One example is the Partnership Access 
Line, or PAL, that I was able to access as a pediatrician. If I was 
seeing a patient with a more complicated behavioral health concern, 
something really beyond the scope of a general pediatrician, I could 
get a psychiatrist on the line and in-the-moment advice on how to treat 
that patient.
  Another example is integrative care, where a mental worker works 
alongside physicians and other healthcare providers, providing support 
as needed throughout the day for patients who are struggling with 
mental illness.
  These programs and more are supported in the package of bills we will 
be voting on this week, including mine, the Supporting Children's 
Mental Health Care Access Act.
  Mr. Speaker, I encourage my colleagues to vote ``yes'' on this 
excellent bill.
  Mrs. RODGERS of Washington. Mr. Speaker, I reserve the balance of my 
time.
  Mr. PALLONE. Mr. Speaker, I yield 2 minutes to the gentlewoman from 
Michigan (Mrs. Dingell), a member of the committee.
  Mrs. DINGELL. Mr. Speaker, I rise in support of the Restoring Hope 
for Mental Health and Well-Being Act of 2022.
  I thank all of my committee members on both sides for months of work 
on this important bipartisan legislation, which reauthorizes and 
strengthens critical mental and behavioral health programs that will 
help address public health issues like the opioid epidemic, which 
claimed over 107,000 lives in the United States last year alone.
  The mental health package before us contains strong mental health 
parity provisions that my colleague Congresswoman Katie Porter and I 
led. This will close a critical gap in healthcare coverage for mental 
health and substance abuse treatment for thousands of frontline workers 
across the country.
  It also includes a provision I worked on with my friend and 
colleague, Congressman French Hill, that provides incentives for co-
prescribing when a doctor pairs an opioid prescription with a 
prescription of an opioid overdose reversal drug like naloxone. This is 
a proven method to reduce overdose deaths.
  Finally, it is good to see consideration of an amendment I coauthored 
with Congressman McKinley cracking down on suspicious orders of 
opioids, which will help further curb abuses and save lives.
  Mr. Speaker, all of us have had family members or know someone who 
has had a mental health crisis or issue or suffered from depression. 
For too long, people have been afraid to even acknowledge it, to seek 
help, or to get help. There has been a stigma associated with it. 
Today, all of us on both sides of this aisle need to help remove that 
stigma.
  My sister died of a drug overdose, and my father was a drug addict. 
Perhaps we wouldn't have suffered some of the traumas had people not 
been afraid to speak of it.
  Mr. Speaker, this is a strong package that will improve our national 
response, and I urge my colleagues to support this bill.
  Mrs. RODGERS of Washington. Mr. Speaker, I yield 2 minutes to the 
gentleman from Florida (Mr. Bilirakis), a leader on the committee and 
on this legislation.
  Mr. BILIRAKIS. Mr. Speaker, I thank the ranking member and the 
chairman for this very important bill.
  I rise in strong support of H.R. 7666, the Restoring Hope for Mental 
Health and Well-Being Act, which reauthorizes and improves key SAMHSA 
block grant programs for mental health and substance use disorder 
prevention and treatment services. These are all targeted toward 
helping our constituents who have struggled with anxiety, stress, and 
isolation.
  Sadly, our Nation is experiencing an unprecedented mental health 
crisis, particularly among our children and teens. It has only gotten 
worse during the COVID pandemic, Mr. Speaker. We have seen a disturbing 
spike in rates of depression, self-harm, suicide attempts, and death 
among teens. Teen depression, in particular, has risen by 60 percent.
  We cannot afford to wait any longer to address this mental health and 
addiction crisis, and this package presents much-needed solutions that 
will enact meaningful changes to help combat the trends we have seen.
  Specifically, I am very glad to see in the manager's amendment a 
provision I have long advocated for that will require HHS to conduct 
research on smartphone and social media use by adolescents and the 
effects of such use on emotional and behavioral health.

                              {time}  1445

  All of us agree on the need to better protect our children and their 
mental health from social media, and this is an excellent start. We are 
also going to consider an amendment I am proud to support with my good 
friend Rodney Davis that will contain H.R. 2355, the Opioid 
Prescription Verification Act, to help prevent opioid abuse through e-
prescribing.
  In closing, this is a strong, bipartisan package, and I urge my 
colleagues to fully support it.
  Mr. PALLONE. Mr. Speaker, I yield 2 minutes to the gentlewoman from 
Texas (Mrs. Fletcher), who is also a member of the Energy and Commerce 
Committee.
  Mrs. FLETCHER. Mr. Speaker, I thank the chairman for his leadership 
and support and making it possible for us to be here today to pass the 
Restoring Hope for Mental Health and Well-Being Act of 2022. It is an 
important effort, and I am so glad that the bipartisan bill that I 
introduced last year with Congresswoman Jaime Herrera Beutler, the 
Collaborate in an Orderly and Cohesive Manner Act, H.R. 5218, is 
included in it.
  Many people first display symptoms of a mental health condition or 
substance use disorder in the primary care setting. Often they can't 
access the necessary follow-up treatment, it is either too expensive or 
too difficult for them to find the necessary mental health professional 
or overcome other obstacles, including stigma.
  That is why enabling patients to access behavioral health treatment 
at their first point of care is critical, and that is what this bill 
does.
  The collaborative care model addresses obstacles including stigma, a 
shortage of mental health professionals, and cost by integrating 
behavioral healthcare within the primary care setting, with their 
trusted family doctors, which allows patients to access the care they 
need in a setting where they feel most comfortable.
  The collaborative care model is a measurement-based model featuring a 
primary care physician, a psychiatric consultant, and care manager all 
working together to provide mental health care for patients and 
ensuring that that care is delivered effectively.
  There are more than 90 published trials demonstrating its success in 
different settings for both adults and children. It extends the reach 
of our psychiatrists, which is essential as we work to address demand 
in the face of workforce shortages. It is covered by Medicare, most 
private insurers, and many State Medicaid programs, alleviating the 
huge financial burden that can often be associated with accessing 
mental health care.
  Despite its proven effectiveness, implementation of the collaborative 
care model remains low because of the upfront costs and lack of 
technical assistance for providers. This bill addresses this roadblock 
by providing grant funding for States to work with primary

[[Page H5779]]

care physicians and practices looking to adopt this model.
  Mr. Speaker, I thank my colleagues, Congresswomen Herrera Beutler and 
Eshoo and Chairman Pallone for addressing the mental health crisis in 
this country.
  Mrs. RODGERS of Washington. Mr. Speaker, may I inquire as to how much 
time is remaining.
  The SPEAKER pro tempore. The gentlewoman from Washington has 14\1/2\ 
minutes remaining. The gentleman from New Jersey has 8\1/2\ minutes 
remaining.
  Mrs. RODGERS of Washington. Mr. Speaker, I yield 1\1/2\ minutes to 
the gentlewoman from California (Mrs. Kim), who is a leader on a 
provision within the larger package.
  Mrs. KIM of California. Mr. Speaker, I thank Ranking Member Rodgers 
for yielding. I rise today in support of the Restoring Hope for Mental 
Health and Well-Being Act of 2022.
  The pandemic and shutdowns left many Americans, especially women and 
children, feeling isolated, anxious, and alone. Depression, self-harm, 
substance abuse, and suicide have reached crisis levels.
  I am glad we can help provide meaningful, targeted hope and healing 
to communities who need it. I am proud that two bills that I worked on, 
the Into the Light for Maternal Mental Health Act and the Garrett Lee 
Smith Memorial Act, were included in this package to prevent student 
suicide and support women facing mental health and substance abuse 
disorders during pregnancy.
  We must keep working to turn despair into hope.
  As a mom of four and a new grandma, I will always fight for the 
health and well-being of communities in southern California and across 
our Nation.
  Mr. Speaker, I urge my colleagues to pass this commonsense, 
bipartisan H.R. 7666.
  Mr. PALLONE. Mr. Speaker, I yield 1 minute to the gentleman from 
Oregon (Mr. Blumenauer).
  Mr. BLUMENAUER. Mr. Speaker, I am pleased we are taking up this 
bipartisan legislation today to reauthorize critical programs to 
address mental health.
  We cannot, however, address mental health without acknowledging and 
addressing the climate impact. Our children are experiencing twin 
crises of mental health and climate change anxiety.
  Last week, the Oregon Health Authority released a report raising the 
alarm of the effect of climate change on our youth. From the impact of 
climate-related disasters to climate anxiety, our children are facing 
stress and trauma that we need to address with them.
  If we want to invest in our youth and their mental health, we must 
acknowledge the impact and give them hope that we understand and are 
working to reduce that threat. We simply cannot leave climate out of 
the conversation.
  I appreciate the work that Chairman Pallone has done for both youth 
mental health and climate, and I look forward to working with him to 
address both these critical issues.
  Mrs. RODGERS of Washington. Mr. Speaker, I yield 1 minute to the 
gentleman from Georgia (Mr. Carter), who is a leader on the issue.
  Mr. CARTER of Georgia. Mr. Speaker, I thank the gentlewoman for 
yielding.
  Mr. Speaker, we are all witnessing the decline in America's mental 
health brought about by the COVID-19 pandemic. Between family members 
and friends, we all are either affected ourselves or we know someone 
with a mental health condition. I am a father and a grandfather, and 
there is nothing more important to me than the safety and well-being of 
my children and grandchildren.
  The urgency to address this mental health crisis has become more dire 
as we are seeing how fear, anxiety, and particularly isolation have 
compounded these issues. We owe it to our constituents to turn despair 
into hope and keep our children safe at school and in their community.
  The Restoring Hope for Mental Health and Well-Being Act will help 
communities provide much-needed lifesaving care to our children. 
America's children are our Nation's future. It is time we take action 
and protect our loved ones and pass the Restoring Hope for Mental 
Health and Well-Being Act.
  Mr. Speaker, I support this bill, and I encourage my colleagues to do 
the same.
  Mr. PALLONE. Mr. Speaker, I yield 1 minute to the gentleman from 
Virginia (Mr. Beyer).
  Mr. BEYER. Mr. Speaker, the pandemic magnified suicide risk, anxiety, 
and depression with two out of five adults reporting symptoms of 
anxiety and depression. The Kaiser Family Foundation released a report 
this morning that found that suicide death rates rose by 12 percent 
from 2010 to 2020--with rates rising fastest among people of color, 
younger people, and our good citizens in rural areas.
  Help can't come fast enough.
  I thank the Rules Committee for allowing the Katko-Napolitano-Beyer 
amendment to be included in the first en bloc today. This reauthorizes 
and ensures sufficient funding and provides oversight of the National 
Suicide Prevention Lifeline.
  As the House and Senate finalize any mental health package to be 
signed into law, I want to flag my bill with Adam Kinzinger--the 
Campaign to Prevent Suicide--which was passed by the committee and the 
House last year. It would help educate the American public both on the 
new 988 suicide lifeline number and also change the culture from one in 
crisis and avoidance to one that connects to resources.
  SAMHSA has stated that the campaign is crucial to the success of 988. 
We can save an untold number of lives. 988 can be among the most 
important bipartisan success we have ever had.
  Mr. Speaker, I thank Chair Pallone, Cathy McMorris Rodgers, and the 
committee staff for their commitment to tackling mental health. It is 
2022, and we know far, far more than ever before in human history. It 
is time to put our healing knowledge to work.
  Mrs. RODGERS of Washington. Mr. Speaker, I yield 1\1/2\ minutes to 
the gentlewoman from Iowa (Mrs. Miller-Meeks).
  Mrs. MILLER-MEEKS. Mr. Speaker, I thank Ranking Member McMorris 
Rodgers for yielding time.
  Mr. Speaker, I rise today in support of H.R. 7666, the Restoring Hope 
for Mental Health and Well-Being Act.
  This bill takes serious action to address mental health and substance 
use disorder, especially as we are coming out of the COVID-19 pandemic. 
I am pleased that the House was able to come together to create a 
bipartisan solution to deliver real results to the American people, 
both adults and children.
  I also thank Ms. Schrier for partnering with me as we introduced the 
Supporting Children's Mental Health Care Access Act, which is included 
in this bipartisan package. This bill reauthorizes two grant programs 
that support pediatric mental and behavioral health services and 
interventions. Reauthorizing the pediatric mental health care access 
grant program is an important step in ensuring that our students have 
equal access to quality mental health care.
  I would also like to thank Representatives Axne, Bucshon, and Pappas 
for joining me to introduce the Timely Treatment for Opioid Use 
Disorder Act which is also included in H.R. 7666. This bill increases 
access to treatment for individuals suffering from opioid use disorder. 
Opioid addiction does not have a timeline and does not discriminate. 
Patients should be able to begin treatment for opioid addiction as soon 
as possible.
  I strongly encourage all of my colleagues to join me in supporting 
H.R. 7666, the bipartisan, results driven, and commonsense Restoring 
Hope for Mental Health and Well-Being Act.
  Mr. PALLONE. Mr. Speaker, I yield 2 minutes to the gentlewoman from 
Texas (Ms. Jackson Lee).
  Ms. JACKSON LEE. Mr. Speaker, I thank the chairman for yielding. As I 
begin--I am going to ask the chairman to enter into a colloquy--but, 
first, let me express my strong support for H.R. 7666 and the work that 
has been done in a bipartisan manner by both the chairman and the 
ranking member, and the importance of the issue of dealing with opioid 
addictions and other addictions that require this additional work. I am 
gratified to rise to support that.
  I thank Chairman Pallone, and ask, as I said, that he engages in a 
colloquy with me on the need to support the mental health needs of 
trauma victims impacted by trauma and, yes, mass

[[Page H5780]]

shootings. I think I have been here in the United States Congress 
during Columbine, Virginia Tech, Sandy Hook, Mother Emanuel, Santa Fe, 
Parkland--and the list goes on--and tragically Uvalde with 19 children, 
2 adults, and 1 individual who died of heartbreak. I was in Uvalde, and 
I saw the impact on our children, to see 9-year-olds--9-year-olds--
crying and saying that because I spoke to them, they said you are 
making me happy because you spoke to me, and you said you care. Out of 
the mouth of a 9-year-old.
  So we know there is a mental health crisis as relates to the trauma 
of those who certainly are survivors and those who are in the 
community.
  We also know that too many families and children in this country are 
hurting from the preventable epidemic of gun violence, shootings, and 
mass casualty events. These tragic events have lasting scars on the 
families, friends, and communities. I have seen this pain with my own 
eyes. And so I am interested in--as my amendment that I withdrew 
indicated--is there a prioritization of those children who are impacted 
by trauma?
  Madam Speaker, I would like to be able to work with Chairman Pallone 
on this issue. Will the gentleman yield for the purpose of a colloquy?
  Mr. PALLONE. Madam Speaker, I just wanted to stress that H.R. 7666 
includes programs focused on supporting youth mental health.
  The SPEAKER pro tempore (Mrs. Beatty). The time of the gentlewoman 
has expired.
  Mr. PALLONE. I thank the gentlewoman for her leadership on this 
issue. In fact, H.R. 7666 includes programs focused on supporting youth 
mental health including due to such traumatic events that were 
mentioned by the gentlewoman.
  The SAMHSA Garrett Lee Smith State/Tribal Youth Suicide Prevention 
and Early Intervention Program, for instance, and HRSA's Pediatric 
Mental Health Care Access program, which helps integrate behavioral 
health into pediatric primary care, extends resources to support 
Project AWARE, building student, families, and school behavioral health 
resiliency. Further, the bill provides support to complement SAMHSA's 
launch of the new 988 National Suicide Prevention Lifeline dialing code 
next month that will expand access to crisis care support through call, 
text, or chat functions for millions of Americans.
  Madam Speaker, I yield an additional 1 minute to the gentlewoman from 
Texas (Ms. Jackson Lee).
  Ms. JACKSON LEE. I thank the chairman for answering my questions 
regarding the Restoring Hope Act that there will be provisions for 
mental health care and services for children, families, and communities 
who experience these traumatic and violent events.
  I look forward working with the chairman on these vital resources. 
With your partnership I would like to continue to work with you and the 
administration to ensure that when this legislation is enacted, the 
needs of the vulnerable victims and those closest to them are in the 
front of our minds.
  Will the gentleman commit to working with me on this matter?
  The SPEAKER pro tempore. The time of the gentlewoman has again 
expired.
  Mr. PALLONE. Let me just add, I am pleased to work with the 
gentlewoman from Texas on this critical matter.
  I thank her for her support in ensuring children and families have 
access to the mental health support and services they need to lead 
healthy and hopeful lives.
  Madam Speaker, I yield an additional 30 seconds to the gentlewoman 
from Texas.
  Ms. JACKSON LEE. Madam Speaker, I thank the chairman for his support. 
I will support this legislation.
  Mr. Speaker, I rise as a staunch advocate for mental health services 
to speak in favor of the Restoring Hope for Mental Health and Well-
Being Act of 2022.
  This bill amends the Public Health Service Act to reauthorize 
critical mental health programs for those dealing with mental health or 
substance abuse disorders.
  H.R. 7666 works to mitigate some of the most pressing issues of our 
time by designating grants, expanding the availability of high-quality 
recovery housing, reauthorizing treatment programs, and combatting 
substance abuse.
  In 2019, an estimated 10.1 million people in the U.S. aged 12 or 
older misused opioids in the past year. Specifically, 9.7 million 
people misused prescription pain relievers and 745,000 people used 
heroin.
  The bill eliminates a key restrictive classification of opioid 
addiction so that access to treatment programs is expanded.
  These issues disproportionately impact tribal communities. According 
to the American Addiction Centers, 10% of Native Americans have a 
substance use disorder.
  H.R. 7666 specifically funds the prevention and treatment of mental 
health and substance use disorders for tribal populations.
  This is a needed step in protecting a community with a history of 
being mistreated by the Federal government.
  This bill's expansion of access to mental health care services, most 
importantly of all, would make these services much more available to 
children and adolescents, who must always be our top priority.
  For example, this bill increases mental health services for our youth 
by integrating behavioral health into public education in primary 
schools and creating a grant for pediatric mental health services.
  This legislation also addresses another pressing issue that afflicts 
young Americans: eating disorders. As many as 10 in 100 young women 
suffer from an eating disorder.
  H.R. 7666 provides federal funding for the identification and 
treatment of eating disorders.
  But, above all, Mr. Speaker, who among all of our children, need 
mental health services more than those who have just experienced the 
unconscionable? Senseless shootings leave our students, some as young 
as five years old, devastated and vulnerable.
  As adults, the thought of having our peers murdered in front of us is 
disturbing. How much more traumatizing would that be for pre-school 
students?
  This bill acts as a conduit for protecting children who are victims 
of a mass shooting or mass casualty event.
  Mass shootings, especially school shootings, can leave lethal and 
obvious physical wounds on victims.
  However, the long-lasting and subtle mental trauma is the invisible 
scar left on many survivors. Friends, family, and classmates often 
suffer with extreme guilt and sadness.
  There have been 278 mass shooting in this year alone. Firearms are 
now the leading cause of death for children and teens.
  In addition to those tragically killed, millions more are left 
behind, coping with these deaths. An estimated 3 million children in 
the US are exposed to shootings per year.
  Since Columbine, there have been 337 school shootings and 311,000 
students have experienced gun violence at school. Even more disturbing, 
just since Uvalde, there have been 65 mass shootings.
  This is not a one-state issue. From the 28 killed at Sandy Hook in 
Connecticut, to the 17 killed at Marjorie Stoneman-Douglas in Florida, 
to the 10 killed at Red Lake in Minnesota, to the 22 killed at Robb 
Elementary in my home state of Texas, school shootings have become a 
disgusting norm.
  Children exposed to violence, crime, and abuse are more likely to 
abuse drugs and alcohol; suffer from depression, anxiety, and 
posttraumatic stress disorder; fail or have difficulties in school; and 
engage in criminal activity.
  These children don't stay children forever. These mental health 
struggles translate to a life of pain and suffering where crime, drug 
use, and suicide are more likely.
  This trauma has real consequences: in the year following the 2018 
massacre at Stoneman-Douglas High school, two students took their own 
life after suffering with the mental anguish of the events they had 
lived through.
  Passage of this bill will not solve the gun crisis or mass shootings 
in this country. Only common-sense gun-control will do that.
  However, this bill will set a foundation for the government to 
address the toll of gun violence on children's mental health.
  Additionally, enactment of this legislation demonstrates Congress' 
support of victims of mass casualty events by prioritizing access to 
mental health services.
  Children are the future of our country. Far too many of them have 
their hopes and dreams stripped away by senseless shootings.

                              {time}  1500

  Mrs. RODGERS of Washington. Madam Speaker, I yield 1\1/2\ minutes to 
the gentleman from Kentucky (Mr. Comer).
  Mr. COMER. Madam Speaker, I have become increasingly concerned that 
the consolidation and monopolistic nature of pharmacy benefit managers, 
or PBMs has negatively impacted competition in the pharmaceutical 
marketplace, leading Americans to spend more on prescription drugs than 
any

[[Page H5781]]

other country. These PBMs not only raise patient costs but are 
potentially engaged in anticompetitive behavior.
  The legislation before us today includes language requiring PBMs to 
issue reports to employer sponsors of health plans outlining 
information that they have been unwilling to provide to their 
customers, including copays applied by insurers to drug manufacturer 
costs, rebates received from manufacturers, and the PBM's rationale for 
choosing certain brand name drugs over more affordable biosimilars, 
generics, or therapeutics for their formularies.
  Simply providing this information to the participants in group health 
plans is expected to save over $2 billion over 10 years. These 
biannual, employer or sponsor-specific reports will allow participants 
in group health plans to make informed decisions about the services 
their PBM is providing and reduce patient costs for prescription drugs.
  We cannot have a serious conversation about lowering drug prices in 
America without examining PBMs' ever-growing influence.
  Mr. PALLONE. Madam Speaker, I yield 1 minute to the gentleman from 
California (Mr. Levin).
  Mr. LEVIN of California. Madam Speaker, I thank the gentleman for 
yielding.
  Madam Speaker, the substance use disorder crisis has touched almost 
every American in one way or another. Too many families have felt the 
extraordinary pain of burying a son or daughter, a father or a mother 
who struggled with the disease of addiction.
  Tragically, many families have also experienced the heartbreak and 
deep frustration that comes after a loved one enters a residential 
recovery home that ultimately doesn't provide them with adequate care 
to get and stay on the path toward recovery.
  We must ensure that residential recovery homes meet a high standard 
of care and provide those who are struggling with the support they need 
to recover.
  We can and must do better. That is why I introduced the SOBER Homes 
Act, parts of which are included in H.R. 7666, the legislation we are 
voting on today. It includes $1.5 million for a Federal study of the 
effectiveness of recovery housing and to identify recommendations 
promoting the availability of high-quality recovery housing.
  This legislation will help us better understand where these 
facilities are falling short and how we can improve them to ensure 
everyone in recovery housing receives the help they need and deserve.
  Finally, I thank all the advocates who have been fighting so hard on 
this issue. The information from this effort will save lives, which is 
why I implore my colleagues to support this bill and vote ``aye.''
  Mrs. RODGERS of Washington. Madam Speaker, I yield 3 minutes to the 
gentleman from Pennsylvania (Mr. Joyce), a member of the Committee on 
Energy and Commerce.
  Mr. JOYCE of Pennsylvania. Madam Speaker, I thank the gentlewoman for 
yielding.
  Right now, today, as we all are here in the Halls of Congress, our 
Nation is facing a mental health crisis. And this crisis followed 2 
years of lockdowns and remote learning that have left so many Americans 
feeling isolated, lost, and, in some cases, hopeless. Particularly, our 
young Americans feel all of these emotions.
  I rise today in support of this legislation that would help to 
address this crisis head-on by helping to ensure that those who are 
struggling can receive the help that they so desperately need, that 
they need, and they need our attention to it right now.
  The Restoring Hope for Mental Health and Well-Being Act of 2022 
expands access to care for millions of Americans, including children 
and teenagers who are desperately in need of this assistance.
  As a doctor, I have treated patients who have later lost their lives 
to mental illness. Just last week, we had physicians here on the Hill, 
pediatricians, family doctors, telling us that they have seen the shift 
of the pendulum; that they see on a daily basis more and more cases in 
their patients, specifically involving mental health.
  And there is not a single American who has not in some way been 
impacted by the effects that mental illness is having today.
  In the past year, over 107,000 Americans have lost their lives to 
drug overdoses. Far too many grandparents, far too many fathers, 
mothers, sons, and daughters are dying. We cannot wait to act any 
longer. We need to act and vote on this legislation.
  To help address the tragedy of addiction, this bill increases support 
for opioid recovery programs that will help people who are struggling 
to receive the care that they need.
  This bill would go on to make mental health screenings a part of each 
person's annual physical exam and evaluation and help to ensure that 
everyone who sees a doctor is able to have a conversation frankly, 
concisely, clearly, about their mental health and the mental health 
issues that they are facing.
  Most importantly, this bill would provide a whole-of-care approach 
that would fund prevention, treatment, and recovery services for the 
people who are suffering with addiction. We have worked as a committee, 
as a conference addressing these important issues.
  I urge all of my colleagues to vote to pass this important piece of 
legislation.
  Mr. PALLONE. Madam Speaker, I yield 1 minute to the gentleman from 
Rhode Island (Mr. Cicilline).
  Mr. CICILLINE. Madam Speaker, for too long, Americans, including 
children, struggling with mental illness and substance abuse, have 
suffered in silence, intimidated by stigma and unable to access 
treatment.

  The 2019 Rhode Island Youth Risk Behavior Survey found that 15 
percent of Rhode Island high school students reported attempting 
suicide one or more times in the previous 12 months. That is 4 students 
in a class of 25.
  There is a mental health crisis in Rhode Island and throughout our 
country, and we have to address it now.
  The Restoring Hope for Mental Health and Well-Being Act will save 
lives by expanding access to mental health and substance abuse disorder 
treatment through: Establishing the Behavioral Health Crisis 
Coordination Office; reauthorizing critical public health programs to 
prevent suicide and expand access to mental health and substance use 
disorder treatment; and eliminating unnecessary limits on providers' 
ability to prescribe treatments for opioid use disorder.
  I urge my colleagues to join with me in support of this critical 
legislation to save lives and to help us address addiction all across 
our country.
  Mrs. RODGERS of Washington. Madam Speaker, I yield 1 minute to the 
gentleman from Ohio (Mr. Balderson).
  Mr. BALDERSON. Madam Speaker, I thank Ranking Member Rodgers for this 
work.
  Madam Speaker, I rise today in support of H.R. 7666, the Restoring 
Hope for Mental Health and Well-Being Act.
  Lockdowns, isolations, economic instability, disruptions to learning 
and daily routines. For well over a year, school closures, mask 
mandates, and online learning became the new normal for far too many 
young Americans.
  As a result, a new crisis is afoot in our country, one with 
potentially dire consequences for our future, a mental health crisis 
among younger Americans.
  Today, nearly 7 in 10 parents of young children in Ohio are worried 
about their kids' mental or emotional health. Drug overdose is now the 
leading cause of death of Americans ages 18 to 45. Our kids are 
counting on us, and we are counting on them.
  Madam Speaker, I urge a ``yes'' vote on H.R. 7666.
  Mr. PALLONE. Madam Speaker, I have no additional speakers. I am 
prepared to close. I reserve the balance of my time.
  Mrs. RODGERS of Washington. Madam Speaker, I yield 2 minutes to the 
gentleman from Indiana (Mr. Bucshon).
  Mr. BUCSHON. Madam Speaker, I rise today in support of H.R. 7666, the 
Restore Hope for Mental Health and Well-Being Act of 2022.
  I am proud to be a member of a committee that works in a bipartisan 
way to help solve the problems facing our constituents every day. Right 
now, that means addressing the Nation's mental health crisis.

[[Page H5782]]

  Though many challenges existed before the start of the COVID-19 
pandemic, 2\1/2\ years of widespread fear, social isolation, and 
financial uncertainty has further increased Americans' need for mental 
health support systems.
  This bill reauthorizes many of the critical mental health programs 
Americans currently rely on, but also provides for new measures.
  Especially important to me is the inclusion of the TRIUMPH for New 
Moms Act, a bipartisan bill I coauthored with Representative Barragan. 
It aims to establish a no-cost, interdepartmental task force to address 
the U.S. maternal mental health crisis by eliminating duplication and 
coordinating Federal resources toward maternal mental health.
  This task force would also work closely with State Governors to 
alleviate the maternal mental health challenges in their States.
  Current Federal efforts to support women suffering from maternal 
mental health conditions lack coordinated action and organization 
toward this issue. And, as a result, 50 percent of these new moms never 
receive treatment.
  This bill will increase mental health support for pregnant and new 
mothers by offering targeted solutions that have proven success, a fact 
that is particularly important to me, given Indiana's maternal 
mortality rate, which is one of the highest in the Nation.
  Passing this bill will help provide better support for future 
generations of mothers and children.
  Again, I thank the chair and ranking member of the Energy and 
Commerce Committee for their dedication to these issues, and I look 
forward to passage of H.R. 7666.
  Mr. PALLONE. Madam Speaker, I reserve the balance of my time.
  Mrs. RODGERS of Washington. Madam Speaker, I yield myself the balance 
of my time.
  Madam Speaker, I want to again just express appreciation to the 
chairman of the committee, all the Members that have participated in 
helping bring this package of very important mental health proposals to 
the House today. I urge a strong ``yes'' vote.
  As many have said, we have a mental health crisis. At a time when 
there is so much fear and anxiety and stress, we see increased suicide. 
We see drug overdoses, and it is time that we act, and act in a way 
that is really going to make a difference for America's families and 
our youth in particular.
  Madam Speaker, I urge support, and I yield back the balance of my 
time.
  Mr. PALLONE. Madam Speaker, I yield myself the balance of my time.
  Let me just reiterate what the ranking member said. This was really a 
bipartisan bill. I thank Mrs. Rodgers, Mr. Guthrie, Ms. Anna Eshoo, and 
all the staff that worked so hard on this legislation.
  It is important that we have as big a vote as possible because this 
bill has a real chance of passing the Senate and getting to the 
President's desk and will really address the mental health and 
substance abuse concerns that we have and the crisis that we have. So I 
urge everyone to vote ``yes.''
  Madam Speaker, I yield back the balance of my time.
  Mrs. NAPOLITANO. Madam Speaker, I rise today in strong support of 
H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act. I 
am honored to have my bill, H.R. 721, the Mental Health Services for 
Students Act, included in this package. Today is a historic day in 
recognizing the need for more comprehensive school-based mental health 
resources.
  The COVID-19 pandemic has upended the lives of our nation's children 
and youth and added additional stressors that have significantly 
strained and continues to strain their mental health and well-being. 
Children and youth across the nation continue to confront the traumatic 
challenges of this pandemic, including disruptions to their lives, fear 
and anxiety about the virus, and the tragic death of loved ones. 
According to the Centers for Disease Control and Prevention (CDC), 
mental health disorders are chronic conditions that, without proper 
diagnosis and treatment, can lead to problems for children at home and 
in school, interfering with their health and future development.
  H.R. 721 acknowledges this problem by providing $130 million in 
competitive grants for school-based mental health programs nationwide. 
It expands the scope of the Project AWARE program by providing onsite 
licensed mental health professionals in schools across the country.
  H.R. 721 is based on the successful Youth Suicide Prevention Program 
that I helped establish with Pacific Clinics in Los Angeles County in 
2001, after learning 1 in 3 Latina adolescents, age 9 to 11, had 
contemplated suicide. We need to secure the long-term availability of 
mental health services to ensure a bright future for our students, 
which my bill would help accomplish.
  I would like to thank the many advocates in and outside of Congress 
who have played an integral role in this legislation. H.R. 721 has 86 
bipartisan co-sponsors and has the support of over 50 mental health 
organizations, as well as local governments and teacher unions. I would 
also like to thank my co-lead Rep. John Katko, Chairman Pallone and his 
staff, and my own staff who contributed toward today's passage.
  Madam Speaker, I ask my colleagues to support the underlying bill, 
H.R. 7666, which will help address our ongoing mental health crisis. it 
is now time to act on this bill and provide the necessary funding and 
resources to reach children and youth early on in life.
  Ms. ROYBAL-ALLARD. Madam Speaker, I rise in support of this bill, 
which seeks to address our national mental health and substance use 
crisis. I thank Congressman Pallone for this package of bills, which 
includes my bill, H.R. 7105, known as the STOP Act.
  The STOP Act advances a comprehensive and effective national effort 
on underage drinking prevention, which includes a national adult-
oriented media campaign and grants for community-based prevention 
coalitions.
  The legislation recognizes the importance of alcohol regulation and 
the fact that alcohol is different than other consumer products and is 
best regulated by states, consistent with the 21st Amendment.
  Since the passage of the original STOP Act in 2006, we have witnessed 
a 12.7 percent decrease in alcohol use amongst 12-to-20-year-olds. Yet, 
alcohol continues to be the most widely used substance amongst youth, 
accounting for 3,900 deaths and 225,000 years of potential life lost 
annually.
  We must continue to lead efforts to reduce underage alcohol use and 
ensure the safety of our youth. I urge my colleagues to vote YES on 
this bill.
  Ms. MOORE of Wisconsin. Madam Speaker, today, I rise in support of 
H.R. 7666, a bipartisan response to rising substance use disorders and 
mental health needs in our communities.
  The need for this bill is clear.
  We've heard about the growing mental health crisis, including about 
alarming rates of mental health hospitalizations, suicide rates and 
depression. The need for mental health services continues to grow, 
including among our children. In my district, the emergency department 
at Children's Wisconsin saw a 60 percent increase in young patients who 
attempted suicide between 2020 and 2021.
  Substance misuse also remains a crisis in our communities. Milwaukee 
county has among the highest rates of overdose deaths in Wisconsin and 
has seen high numbers of emergency calls related to overdoses in the 
past few years. According to Milwaukee County, from 2014 to 2020, the 
opioid overdose fatality rate in the country was 30.9 per 100,000 
persons, more than twice the rate statewide.
  This bill includes strong provisions to reauthorize and revitalize 
federal programs that support access to treatment and services, while 
boosting access to crisis services. The whole continuum of services 
needs to be strengthened to ensure that no one in need of help goes 
without.
  The bill would also reauthorize and increase funding for the Mental 
Health First Aid grant program. Mental Health First Aid is an 
evidenced-based program that teaches ordinary people how to identify, 
understand, and respond to the signs of mental illness and substance 
use disorder.
  The bill would also reauthorize the Pediatric Mental Health Care 
Access Grant, a program that supports the ability of pediatric primary 
care providers to deliver mental health care with the help of rapid 
consultation with psychiatrists, social workers, and/or psychologists. 
The program also provides training and education on early 
identification, diagnosis, and treatment of behavioral health 
condition, allowing more families to access high-quality mental health 
treatment in their pediatrician's office.
  I am pleased to offer an amendment that will improve this bill by 
ensuring that state and local officials who administer programs serving 
pregnant and postpartum individuals are consulted by those operating 
the new maternal mental health hotline. This hotline will provide free 
and confidential support before, during, and after pregnancy providing 
yet another tool for those in need.
  Through programs such as WIC, SNAP and the Maternal and Child Health 
Service Block grant, among others, the federal government reaches 
numerous pregnant and postpartum individuals. State and local officials 
are key

[[Page H5783]]

partners in the operations of those programs and often are on the 
frontlines of reaching and serving populations that would immensely 
benefit from access to this important new resource. It only makes sense 
that they be involved in efforts related to making this hotline truly 
effective and that individuals know about the resources it offers.
  I thank the chairman and Ranking Member for their support of my 
amendment. I urge my colleagues to support it and the underlying bill.
  The SPEAKER pro tempore. All time for debate has expired.
  Each further amendment printed in part E of House Report 117-381 not 
earlier considered as part of the amendments en bloc pursuant to 
section 6 of House Resolution 1191 shall be considered only in the 
order printed in the report, may be offered only by a Member designated 
in the report, shall be considered as read, shall be debatable for the 
time specified in the report equally divided and controlled by the 
proponent and an opponent, may be withdrawn by the proponent at any 
time before the question is put thereon, shall not be subject to 
amendment, and shall not be subject to a demand for division of the 
question.
  It shall be in order at any time for the chair of the Committee on 
Energy and Commerce or his designee to offer amendments en bloc 
consisting of further amendments printed in part E of House Report 117-
381, not earlier disposed of. Amendments en bloc shall be considered as 
read, shall be debatable for 20 minutes equally divided and controlled 
by the chair and ranking minority member of the Committee on Energy and 
Commerce or their respective designees, shall not be subject to 
amendment, and shall not be subject to a demand for division of the 
question.

                              {time}  1515


     amendments en bloc no. 1 offered by mr. pallone of new jersey

  Mr. PALLONE. Madam Speaker, pursuant to House Resolution No. 1191, I 
rise to offer amendments en bloc No. 1.
  The SPEAKER pro tempore. The Clerk will designate the amendments en 
bloc.
  Amendments en bloc No. 1 consisting of amendment Nos. 1, 5, 9, 10, 
13, 14, 15, and 16, printed in part E of House Report 117-381, offered 
by Mr. Pallone of New Jersey:


           amendment no. 1 offered by mr. bera of california

       After section 331, insert the following new subtitle:

   Subtitle E--Improving Emergency Department Mental Health Access, 
                        Services, and Responders

     SEC. 341. HELPING EMERGENCY RESPONDERS OVERCOME.

       (a) Data System to Capture National Public Safety Officer 
     Suicide Incidence.--The Public Health Service Act is amended 
     by inserting before section 318 of such Act (42 U.S.C. 247c) 
     the following:

     ``SEC. 317V. DATA SYSTEM TO CAPTURE NATIONAL PUBLIC SAFETY 
                   OFFICER SUICIDE INCIDENCE.

       ``(a) In General.--The Secretary, in coordination with the 
     Director of the Centers for Disease Control and Prevention 
     and other agencies as the Secretary determines appropriate, 
     may--
       ``(1) develop and maintain a data system, to be known as 
     the Public Safety Officer Suicide Reporting System, for the 
     purposes of--
       ``(A) collecting data on the suicide incidence among public 
     safety officers; and
       ``(B) facilitating the study of successful interventions to 
     reduce suicide among public safety officers; and
       ``(2) integrate such system into the National Violent Death 
     Reporting System, so long as the Secretary determines such 
     integration to be consistent with the purposes described in 
     paragraph (1).
       ``(b) Data Collection.--In collecting data for the Public 
     Safety Officer Suicide Reporting System, the Secretary shall, 
     at a minimum, collect the following information:
       ``(1) The total number of suicides in the United States 
     among all public safety officers in a given calendar year.
       ``(2) Suicide rates for public safety officers in a given 
     calendar year, disaggregated by--
       ``(A) age and gender of the public safety officer;
       ``(B) State;
       ``(C) occupation; including both the individual's role in 
     their public safety agency and their primary occupation in 
     the case of volunteer public safety officers;
       ``(D) where available, the status of the public safety 
     officer as volunteer, paid-on-call, or career; and
       ``(E) status of the public safety officer as active or 
     retired.
       ``(c) Consultation During Development.--In developing the 
     Public Safety Officer Suicide Reporting System, the Secretary 
     shall consult with non-Federal experts to determine the best 
     means to collect data regarding suicide incidence in a safe, 
     sensitive, anonymous, and effective manner. Such non-Federal 
     experts shall include, as appropriate, the following:
       ``(1) Public health experts with experience in developing 
     and maintaining suicide registries.
       ``(2) Organizations that track suicide among public safety 
     officers.
       ``(3) Mental health experts with experience in studying 
     suicide and other profession-related traumatic stress.
       ``(4) Clinicians with experience in diagnosing and treating 
     mental health issues.
       ``(5) Active and retired volunteer, paid-on-call, and 
     career public safety officers.
       ``(6) Relevant national police, and fire and emergency 
     medical services, organizations.
       ``(d) Data Privacy and Security.--In developing and 
     maintaining the Public Safety Officer Suicide Reporting 
     System, the Secretary shall ensure that all applicable 
     Federal privacy and security protections are followed to 
     ensure that--
       ``(1) the confidentiality and anonymity of suicide victims 
     and their families are protected, including so as to ensure 
     that data cannot be used to deny benefits; and
       ``(2) data is sufficiently secure to prevent unauthorized 
     access.
       ``(e) Reporting.--
       ``(1) Annual report.--Not later than 2 years after the date 
     of enactment of the Restoring Hope for Mental Health and 
     Well-Being Act of 2022, and biannually thereafter, the 
     Secretary shall submit a report to the Congress on the 
     suicide incidence among public safety officers. Each such 
     report shall--
       ``(A) include the number and rate of such suicide 
     incidence, disaggregated by age, gender, and State of 
     employment;
       ``(B) identify characteristics and contributing 
     circumstances for suicide among public safety officers;
       ``(C) disaggregate rates of suicide by--
       ``(i) occupation;
       ``(ii) status as volunteer, paid-on-call, or career; and
       ``(iii) status as active or retired;
       ``(D) include recommendations for further study regarding 
     the suicide incidence among public safety officers;
       ``(E) specify in detail, if found, any obstacles in 
     collecting suicide rates for volunteers and include 
     recommended improvements to overcome such obstacles;
       ``(F) identify options for interventions to reduce suicide 
     among public safety officers; and
       ``(G) describe procedures to ensure the confidentiality and 
     anonymity of suicide victims and their families, as described 
     in subsection (d)(1).
       ``(2) Public availability.--Upon the submission of each 
     report to the Congress under paragraph (1), the Secretary 
     shall make the full report publicly available on the website 
     of the Centers for Disease Control and Prevention.
       ``(f) Definition.--In this section, the term `public safety 
     officer' means--
       ``(1) a public safety officer as defined in section 1204 of 
     the Omnibus Crime Control and Safe Streets Act of 1968; or
       ``(2) a public safety telecommunicator as described in 
     detailed occupation 43-5031 in the Standard Occupational 
     Classification Manual of the Office of Management and Budget 
     (2018).
       ``(g) Prohibited Use of Information.--Notwithstanding any 
     other provision of law, if an individual is identified as 
     deceased based on information contained in the Public Safety 
     Officer Suicide Reporting System, such information may not be 
     used to deny or rescind life insurance payments or other 
     benefits to a survivor of the deceased individual.''.
       (b) Peer-Support Behavioral Health and Wellness Programs 
     Within Fire Departments and Emergency Medical Service 
     Agencies.--
       (1) In general.--Part B of title III of the Public Health 
     Service Act (42 U.S.C. 243 et seq.) is amended by adding at 
     the end the following:

     ``SEC. 320C. PEER-SUPPORT BEHAVIORAL HEALTH AND WELLNESS 
                   PROGRAMS WITHIN FIRE DEPARTMENTS AND EMERGENCY 
                   MEDICAL SERVICE AGENCIES.

       ``(a) In General.--The Secretary may award grants to 
     eligible entities for the purpose of establishing or 
     enhancing peer-support behavioral health and wellness 
     programs within fire departments and emergency medical 
     services agencies.
       ``(b) Program Description.--A peer-support behavioral 
     health and wellness program funded under this section shall--
       ``(1) use career and volunteer members of fire departments 
     or emergency medical services agencies to serve as peer 
     counselors;
       ``(2) provide training to members of career, volunteer, and 
     combination fire departments or emergency medical service 
     agencies to serve as such peer counselors;
       ``(3) purchase materials to be used exclusively to provide 
     such training; and
       ``(4) disseminate such information and materials as are 
     necessary to conduct the program.
       ``(c) Definition.--In this section:
       ``(1) The term `eligible entity' means a nonprofit 
     organization with expertise and experience with respect to 
     the health and life safety of members of fire and emergency 
     medical services agencies.
       ``(2) The term `member'--
       ``(A) with respect to an emergency medical services agency, 
     means an employee, regardless of rank or whether the employee 
     receives compensation (as defined in section

[[Page H5784]]

     1204(7) of the Omnibus Crime Control and Safe Streets Act of 
     1968); and
       ``(B) with respect to a fire department, means any 
     employee, regardless of rank or whether the employee receives 
     compensation, of a Federal, State, Tribal, or local fire 
     department who is responsible for responding to calls for 
     emergency service.''.
       (2) Technical correction.--Effective as if included in the 
     enactment of the Children's Health Act of 2000 (Public Law 
     106-310), the amendment instruction in section 1603 of such 
     Act is amended by striking ``Part B of the Public Health 
     Service Act'' and inserting ``Part B of title III of the 
     Public Health Service Act''.
       (c) Health Care Provider Behavioral Health and Wellness 
     Programs.--Part B of title III of the Public Health Service 
     Act (42 U.S.C. 243 et seq.), as amended by subsection (b)(1), 
     is further amended by adding at the end the following:

     ``SEC. 320D. HEALTH CARE PROVIDER BEHAVIORAL HEALTH AND 
                   WELLNESS PROGRAMS.

       ``(a) In General.--The Secretary may award grants to 
     eligible entities for the purpose of establishing or 
     enhancing behavioral health and wellness programs for health 
     care providers.
       ``(b) Program Description.--A behavioral health and 
     wellness program funded under this section shall--
       ``(1) provide confidential support services for health care 
     providers to help handle stressful or traumatic patient-
     related events, including counseling services and wellness 
     seminars;
       ``(2) provide training to health care providers to serve as 
     peer counselors to other health care providers;
       ``(3) purchase materials to be used exclusively to provide 
     such training; and
       ``(4) disseminate such information and materials as are 
     necessary to conduct such training and provide such peer 
     counseling.
       ``(c) Definitions.--In this section, the term `eligible 
     entity' means a hospital, including a critical access 
     hospital (as defined in section 1861(mm)(1) of the Social 
     Security Act) or a disproportionate share hospital (as 
     defined under section 1923(a)(1)(A) of such Act), a 
     Federally-qualified health center (as defined in section 
     1905(1)(2)(B) of such Act), or any other health care 
     facility.''.
       (d) Development of Resources for Educating Mental Health 
     Professionals About Treating Fire Fighters and Emergency 
     Medical Services Personnel.--
       (1) In general.--The Secretary of Health and Human Services 
     shall develop and make publicly available resources that may 
     be used by the Federal Government and other entities to 
     educate mental health professionals about--
       (A) the culture of Federal, State, Tribal, and local 
     career, volunteer, and combination fire departments and 
     emergency medical services agencies;
       (B) the different stressors experienced by firefighters and 
     emergency medical services personnel, supervisory 
     firefighters and emergency medical services personnel, and 
     chief officers of fire departments and emergency medical 
     services agencies;
       (C) challenges encountered by retired firefighters and 
     emergency medical services personnel; and
       (D) evidence-based therapies for mental health issues 
     common to firefighters and emergency medical services 
     personnel within such departments and agencies.
       (2) Consultation.--In developing resources under paragraph 
     (1), the Secretary of Health and Human Services shall consult 
     with national fire and emergency medical services 
     organizations.
       (3) Definitions.--In this subsection:
       (A) The term ``firefighter'' means any employee, regardless 
     of rank or whether the employee receives compensation, of a 
     Federal, State, Tribal, or local fire department who is 
     responsible for responding to calls for emergency service.
       (B) The term ``emergency medical services personnel'' means 
     any employee, regardless of rank or whether the employee 
     receives compensation, as defined in section 1204(7) of the 
     Omnibus Crime Control and Safe Streets Act of 1968 (34 U.S.C. 
     10284(7)).
       (C) The term ``chief officer'' means any individual who is 
     responsible for the overall operation of a fire department or 
     an emergency medical services agency, irrespective of whether 
     such individual also serves as a firefighter or emergency 
     medical services personnel.
       (e) Best Practices and Other Resources for Addressing 
     Posttraumatic Stress Disorder in Public Safety Officers.--
       (1) Development; updates.--The Secretary of Health and 
     Human Services shall--
       (A) develop and assemble evidence-based best practices and 
     other resources to identify, prevent, and treat posttraumatic 
     stress disorder and co-occurring disorders in public safety 
     officers; and
       (B) reassess and update, as the Secretary determines 
     necessary, such best practices and resources, including based 
     upon the options for interventions to reduce suicide among 
     public safety officers identified in the annual reports 
     required by section 317V(e)(1)(F) of the Public Health 
     Service Act, as added by subsection (a).
       (2) Consultation.--In developing, assembling, and updating 
     the best practices and resources under paragraph (1), the 
     Secretary of Health and Human Services shall consult with, at 
     a minimum, the following:
       (A) Public health experts.
       (B) Mental health experts with experience in studying 
     suicide and other profession-related traumatic stress.
       (C) Clinicians with experience in diagnosing and treating 
     mental health issues.
       (D) Relevant national police, fire, and emergency medical 
     services organizations.
       (3) Availability.--The Secretary of Health and Human 
     Services shall make the best practices and resources under 
     paragraph (1) available to Federal, State, and local fire, 
     law enforcement, and emergency medical services agencies.
       (4) Federal training and development programs.--The 
     Secretary of Health and Human Services shall work with 
     Federal departments and agencies, including the United States 
     Fire Administration, to incorporate education and training on 
     the best practices and resources under paragraph (1) into 
     Federal training and development programs for public safety 
     officers.
       (5) Definition.--In this subsection, the term ``public 
     safety officer'' means--
       (A) a public safety officer as defined in section 1204 of 
     the Omnibus Crime Control and Safe Streets Act of 1968 (34 
     U.S.C. 10284); or
       (B) a public safety telecommunicator as described in 
     detailed occupation 43-5031 in the Standard Occupational 
     Classification Manual of the Office of Management and Budget 
     (2018).


            amendment no. 5 offered by mr. feenstra of iowa

       Page 5, after line 21, insert the following new 
     subparagraph (and redesignate the subsequent subparagraphs 
     accordingly):
       ``(B) the Veterans Crisis Line;


              amendment no. 9 offered by mr. joyce of ohio

       At the end of title I, add the following new subtitle:

      Subtitle G--Military Suicide Prevention in the 21st Century

     SEC. 155. PILOT PROGRAM ON PRE-PROGRAMMING OF SUICIDE 
                   PREVENTION RESOURCES INTO SMART DEVICES ISSUED 
                   TO MEMBERS OF THE ARMED FORCES.

       (a) In General.--Commencing not later than 120 days after 
     the date of the enactment of this Act, the Secretary of 
     Defense shall carry out a pilot program under which the 
     Secretary--
       (1) pre-downloads the Virtual Hope Box application of the 
     Defense Health Agency, or such successor application, on 
     smart devices individually issued to members of the Armed 
     Forces;
       (2) pre-programs the National Suicide Hotline number and 
     Veterans Crisis Line number into the contacts for such 
     devices; and
       (3) provides training, as part of training on suicide 
     awareness and prevention conducted throughout the Department 
     of Defense, on the preventative resources described in 
     paragraphs (1) and (2).
       (b) Duration.--The Secretary shall carry out the pilot 
     program under this section for a two-year period.
       (c) Scope.--The Secretary shall determine the appropriate 
     scope of individuals participating in the pilot program under 
     this section to best represent each Armed Force and to ensure 
     a relevant sample size.
       (d) Identification of Other Resources.--In carrying out the 
     pilot program under this section, the Secretary shall 
     coordinate with the Director of the Defense Health Agency and 
     the Secretary of Veterans Affairs to identify other useful 
     technology-related resources for use in the pilot program.
       (e) Report.--Not later than 30 days after completing the 
     pilot program under this section, the Secretary shall submit 
     to the Committee on Armed Services of the Senate and the 
     Committee on Armed Services of the House of Representatives a 
     report on the pilot program.
       (f) Veterans Crisis Line Defined.--In this section, the 
     term ``Veterans Crisis Line'' means the toll-free hotline for 
     veterans established under section 1720F(h) of title 38, 
     United States Code.


           amendment no. 10 offered by mr. katko of new york

       After section 102, insert the following new section:

     SEC. 103. SUICIDE PREVENTION LIFELINE IMPROVEMENT.

       (a) Suicide Prevention Lifeline.--
       (1) Plan.--Section 520E-3 of the Public Health Service Act 
     (42 U.S.C. 290bb-36c) is amended--
       (A) by redesignating subsection (c) as subsection (e); and
       (B) by inserting after subsection (b) the following:
       ``(c) Plan.--
       ``(1) In general.--For purposes of maintaining the suicide 
     prevention hotline under subsection (b)(2), the Secretary 
     shall develop and implement a plan to ensure the provision of 
     high-quality service.
       ``(2) Contents.--The plan required by paragraph (1) shall 
     include the following:
       ``(A) Quality assurance provisions, including--
       ``(i) clearly defined and measurable performance indicators 
     and objectives to improve the responsiveness and performance 
     of the hotline, including at backup call centers; and
       ``(ii) quantifiable timeframes to track the progress of the 
     hotline in meeting such performance indicators and 
     objectives.
       ``(B) Standards that crisis centers and backup centers must 
     meet--
       ``(i) to participate in the network under subsection 
     (b)(1); and

[[Page H5785]]

       ``(ii) to ensure that each telephone call, online chat 
     message, and other communication received by the hotline, 
     including at backup call centers, is answered in a timely 
     manner by a person, consistent with the guidance established 
     by the American Association of Suicidology or other guidance 
     determined by the Secretary to be appropriate.
       ``(C) Guidelines for crisis centers and backup centers to 
     implement evidence-based practices including with respect to 
     followup and referral to other health and social services 
     resources.
       ``(D) Guidelines to ensure that resources are available and 
     distributed to individuals using the hotline who are not 
     personally in a time of crisis but know of someone who is.
       ``(E) Guidelines to carry out periodic testing of the 
     hotline, including at crisis centers and backup centers, 
     during each fiscal year to identify and correct any problems 
     in a timely manner.
       ``(F) Guidelines to operate in consultation with the State 
     department of health, local governments, Indian tribes, and 
     tribal organizations.
       ``(3) Initial plan; updates.--The Secretary shall--
       ``(A) not later than 6 months after the date of enactment 
     of the Restoring Hope for Mental Health and Well-Being Act of 
     2022, complete development of the initial version of the plan 
     required by paragraph (1), begin implementation of such plan, 
     and make such plan publicly available; and
       ``(B) periodically thereafter, update such plan and make 
     the updated plan publicly available.''.
       (2) Transmission of data to cdc.--Section 520E-3 of the 
     Public Health Service Act (42 U.S.C. 290bb-36c) is amended by 
     inserting after subsection (c) of such section, as added by 
     paragraph (1), the following:
       ``(d) Transmission of Data to CDC.--The Secretary shall 
     formalize and strengthen agreements between the National 
     Suicide Prevention Lifeline program and the Centers for 
     Disease Control and Prevention to transmit any necessary 
     epidemiological data from the program to the Centers, 
     including local call center data, to assist the Centers in 
     suicide prevention efforts.''.
       (3) Authorization of appropriations.--Subsection (e) of 
     section 520E-3 of the Public Health Service Act (42 U.S.C. 
     290bb-36c) is amended to read as follows:
       ``(e) Authorization of Appropriations.--
       ``(1) In general.--To carry out this section, there are 
     authorized to be appropriated $101,621,000 for each of fiscal 
     years 2023 through 2027.
       ``(2) Allocation.--Of the amount authorized to be 
     appropriated by paragraph (1) for each of fiscal years 2023 
     through 2027--
       ``(A) at least 80 percent shall be made available to crisis 
     centers; and
       ``(B) not more than 10 percent may be used for carrying out 
     the pilot program in section 103(b)(1) of the Restoring Hope 
     for Mental Health and Well-Being Act of 2022.''.
       (b) Pilot Program on Innovative Technologies.--
       (1) In general.--The Secretary of Health and Human 
     Services, acting through the Assistant Secretary for Mental 
     Health and Substance Use, shall carry out a pilot program to 
     research, analyze, and employ various technologies and 
     platforms of communication (including social media platforms, 
     texting platforms, and email platforms) for suicide 
     prevention in addition to the telephone and online chat 
     service provided by the Suicide Prevention Lifeline.
       (2) Report.--Not later than 24 months after the date on 
     which the pilot program under paragraph (1) commences, the 
     Secretary of Health and Human Services, acting through the 
     Assistant Secretary for Mental Health and Substance Use, 
     shall submit to the Congress a report on the pilot program. 
     With respect to each platform of communication employed 
     pursuant to the pilot program, the report shall include--
       (A) a full description of the program;
       (B) the number of individuals served by the program;
       (C) the average wait time for each individual to receive a 
     response;
       (D) the cost of the program, including the cost per 
     individual served; and
       (E) any other information the Secretary determines 
     appropriate.
       (c) HHS Study and Report.--Not later than 24 months after 
     the Secretary of Health and Human Services begins 
     implementation of the plan required by section 520E-3(c) of 
     the Public Health Service Act, as added by subsection 
     (a)(1)(B), the Secretary shall--
       (1) complete a study on--
       (A) the implementation of such plan, including the progress 
     towards meeting the objectives identified pursuant to 
     paragraph (2)(A)(i) of such section 520E-3(c) by the 
     timeframes identified pursuant to paragraph (2)(A)(ii) of 
     such section 520E-3(c); and
       (B) in consultation with the Director of the Centers for 
     Disease Control and Prevention, options to expand data 
     gathering from calls to the Suicide Prevention Lifeline in 
     order to better track aspects of usage such as repeat calls, 
     consistent with applicable Federal and State privacy laws; 
     and
       (2) submit a report to the Congress on the results of such 
     study, including recommendations on whether additional 
     legislation or appropriations are needed.
       (d) GAO Study and Report.--
       (1) In general.--Not later than 24 months after the 
     Secretary of Health and Human Services begins implementation 
     of the plan required by section 520E-3(c) of the Public 
     Health Service Act, as added by subsection (a)(1)(B), the 
     Comptroller General of the United States shall--
       (A) complete a study on the Suicide Prevention Lifeline; 
     and
       (B) submit a report to the Congress on the results of such 
     study.
       (2) Issues to be studied.--The study required by paragraph 
     (1) shall address--
       (A) the feasibility of geolocating callers to direct calls 
     to the nearest crisis center;
       (B) operation shortcomings of the Suicide Prevention 
     Lifeline;
       (C) geographic coverage of each crisis call center;
       (D) the call answer rate of each crisis call center;
       (E) the call wait time of each crisis call center;
       (F) the hours of operation of each crisis call center;
       (G) funding avenues of each crisis call center;
       (H) the implementation of the plan under section 520E-3(c) 
     of the Public Health Service Act, as added by subsection 
     (a)(1)(B), including the progress towards meeting the 
     objectives identified pursuant to paragraph (2)(A)(i) of such 
     section 520E-3(c) by the timeframes identified pursuant to 
     paragraph (2)(A)(ii) of such section 520E-3(c); and
       (I) service to individuals requesting a foreign language 
     speaker, including--
       (i) the number of calls or chats the Lifeline receives from 
     individuals speaking a foreign language;
       (ii) the capacity of the Lifeline to handle these calls or 
     chats; and
       (iii) the number of crisis centers with the capacity to 
     serve foreign language speakers, in house.
       (3) Recommendations.--The report required by paragraph (1) 
     shall include recommendations for improving the Suicide 
     Prevention Lifeline, including recommendations for 
     legislative and administrative actions.
       (e) Definition.--In this section, the term ``Suicide 
     Prevention Lifeline'' means the suicide prevention hotline 
     maintained pursuant to section 520E-3 of the Public Health 
     Service Act (42 U.S.C. 290bb-36c).


           amendment no. 13 offered by ms. moore of wisconsin

       Page 20, line 4, strike ``and''.
       Page 20, line 9, strike the period at the end and insert 
     ``; and''.
       Page 20, after line 9, add the following:
       ``(4) consult with appropriate State, local, and Tribal 
     public health officials, including officials that administer 
     programs that serve low-income pregnant and postpartum 
     individuals.''.


       amendment no. 14 offered by mrs. napolitano of california

       After section 402, insert the following new section:

     SEC. 403. SCHOOL-BASED MENTAL HEALTH; CHILDREN AND 
                   ADOLESCENTS.

       (a) Technical Amendments.--The second part G (relating to 
     services provided through religious organizations) of title V 
     of the Public Health Service Act (42 U.S.C. 290kk et seq.) is 
     amended--
       (1) by redesignating such part as part J; and
       (2) by redesignating sections 581 through 584 as sections 
     596 through 596C, respectively.
       (b) School-Based Mental Health and Children.--Section 581 
     of the Public Health Service Act (42 U.S.C. 290hh) (relating 
     to children and violence) is amended to read as follows:

     ``SEC. 581. SCHOOL-BASED MENTAL HEALTH; CHILDREN AND 
                   ADOLESCENTS.

       ``(a) In General.--The Secretary, in consultation with the 
     Secretary of Education, shall, through grants, contracts, or 
     cooperative agreements awarded to eligible entities described 
     in subsection (c), provide comprehensive school-based mental 
     health services and supports to assist children in local 
     communities and schools (including schools funded by the 
     Bureau of Indian Education) dealing with traumatic 
     experiences, grief, bereavement, risk of suicide, and 
     violence. Such services and supports shall be--
       ``(1) developmentally, linguistically, and culturally 
     appropriate;
       ``(2) trauma-informed; and
       ``(3) incorporate positive behavioral interventions and 
     supports.
       ``(b) Activities.--Grants, contracts, or cooperative 
     agreements awarded under subsection (a), shall, as 
     appropriate, be used for--
       ``(1) implementation of school and community-based mental 
     health programs that--
       ``(A) build awareness of individual trauma and the 
     intergenerational, continuum of impacts of trauma on 
     populations;
       ``(B) train appropriate staff to identify, and screen for, 
     signs of trauma exposure, mental health disorders, or risk of 
     suicide; and
       ``(C) incorporate positive behavioral interventions, family 
     engagement, student treatment, and multigenerational supports 
     to foster the health and development of children, prevent 
     mental health disorders, and ameliorate the impact of trauma;
       ``(2) technical assistance to local communities with 
     respect to the development of programs described in paragraph 
     (1);
       ``(3) facilitating community partnerships among families, 
     students, law enforcement agencies, education agencies, 
     mental health and substance use disorder service systems, 
     family-based mental health service systems, child welfare 
     agencies, health care providers (including primary care 
     physicians, mental health professionals, and other 
     professionals

[[Page H5786]]

     who specialize in children's mental health such as child and 
     adolescent psychiatrists), institutions of higher education, 
     faith-based programs, trauma networks, and other community-
     based systems to address child and adolescent trauma, mental 
     health issues, and violence; and
       ``(4) establishing mechanisms for children and adolescents 
     to report incidents of violence or plans by other children, 
     adolescents, or adults to commit violence.
       ``(c) Requirements.--
       ``(1) In general.--To be eligible for a grant, contract, or 
     cooperative agreement under subsection (a), an entity shall 
     be a partnership that includes--
       ``(A) a State educational agency, as defined in section 
     8101 of the Elementary and Secondary Education Act of 1965, 
     in coordination with one or more local educational agencies, 
     as defined in section 8101 of the Elementary and Secondary 
     Education Act of 1965, or a consortium of any entities 
     described in subparagraph (B), (C), (D), or (E) of section 
     8101(30) of such Act; and
       ``(B) at least 1 community-based mental health provider, 
     including a public or private mental health entity, health 
     care entity, family-based mental health entity, trauma 
     network, or other community-based entity, as determined by 
     the Secretary (and which may include additional entities such 
     as a human services agency, law enforcement or juvenile 
     justice entity, child welfare agency, agency, an institution 
     of higher education, or another entity, as determined by the 
     Secretary).
       ``(2) Compliance with hipaa.--Any patient records developed 
     by covered entities through activities under the grant shall 
     meet the regulations promulgated under section 264(c) of the 
     Health Insurance Portability and Accountability Act of 1996.
       ``(3) Compliance with ferpa.--Section 444 of the General 
     Education Provisions Act (commonly known as the `Family 
     Educational Rights and Privacy Act of 1974') shall apply to 
     any entity that is a member of the partnership in the same 
     manner that such section applies to an educational agency or 
     institution (as that term is defined in such section).
       ``(d) Geographical Distribution.--The Secretary shall 
     ensure that grants, contracts, or cooperative agreements 
     under subsection (a) will be distributed equitably among the 
     regions of the country and among urban and rural areas.
       ``(e) Duration of Awards.--With respect to a grant, 
     contract, or cooperative agreement under subsection (a), the 
     period during which payments under such an award will be made 
     to the recipient shall be 5 years, with options for renewal.
       ``(f) Evaluation and Measures of Outcomes.--
       ``(1) Development of process.--The Assistant Secretary 
     shall develop a fiscally appropriate process for evaluating 
     activities carried out under this section. Such process shall 
     include--
       ``(A) the development of guidelines for the submission of 
     program data by grant, contract, or cooperative agreement 
     recipients;
       ``(B) the development of measures of outcomes (in 
     accordance with paragraph (2)) to be applied by such 
     recipients in evaluating programs carried out under this 
     section; and
       ``(C) the submission of annual reports by such recipients 
     concerning the effectiveness of programs carried out under 
     this section.
       ``(2) Measures of outcomes.--The Assistant Secretary shall 
     develop measures of outcomes to be applied by recipients of 
     assistance under this section to evaluate the effectiveness 
     of programs carried out under this section, including 
     outcomes related to the student, family, and local 
     educational systems supported by this Act.
       ``(3) Submission of annual data.--An eligible entity 
     described in subsection (c) that receives a grant, contract, 
     or cooperative agreement under this section shall annually 
     submit to the Assistant Secretary a report that includes data 
     to evaluate the success of the program carried out by the 
     entity based on whether such program is achieving the 
     purposes of the program. Such reports shall utilize the 
     measures of outcomes under paragraph (2) in a reasonable 
     manner to demonstrate the progress of the program in 
     achieving such purposes.
       ``(4) Evaluation by assistant secretary.--Based on the data 
     submitted under paragraph (3), the Assistant Secretary shall 
     annually submit to Congress a report concerning the results 
     and effectiveness of the programs carried out with assistance 
     received under this section.
       ``(5) Limitation.--An eligible entity shall use not more 
     than 20 percent of amounts received under a grant under this 
     section to carry out evaluation activities under this 
     subsection.
       ``(g) Information and Education.--The Secretary shall 
     disseminate best practices based on the findings of the 
     knowledge development and application under this section.
       ``(h) Amount of Grants and Authorization of 
     Appropriations.--
       ``(1) Amount of grants.--A grant under this section shall 
     be in an amount that is not more than $2,000,000 for each of 
     the first 5 fiscal years following the date of enactment of 
     the Restoring Hope for Mental Health and Well-Being Act of 
     2022. The Secretary shall determine the amount of each such 
     grant based on the population of children up to age 21 of the 
     area to be served under the grant.
       ``(2) Authorization of appropriations.--There is authorized 
     to be appropriated to carry out this section, $130,000,000 
     for each of fiscal years 2023 through 2027.''.
       (c) Conforming Amendment.--Part G of title V of the Public 
     Health Service Act (42 U.S.C. 290hh et seq.), as amended by 
     subsection (b), is further amended by striking the part 
     designation and heading and inserting the following:

                ``PART G--SCHOOL-BASED MENTAL HEALTH''.


       amendment no. 15 offered by ms. pressley of massachusetts

       After section 402, insert the following new section:

     SEC. 403. CO-OCCURRING CHRONIC CONDITIONS AND MENTAL HEALTH 
                   IN YOUTH STUDY.

       Not later than 12 months after the date of enactment of 
     this Act, the Secretary of Health and Human Services shall--
       (1) complete a study on the rates of suicidal behaviors 
     among children and adolescents with chronic illnesses, 
     including substance use disorders, autoimmune disorders, and 
     heritable blood disorders; and
       (2) submit a report to the Congress on the results of such 
     study, including recommendations for early intervention 
     services for such children and adolescents at risk of 
     suicide, the dissemination of best practices to support the 
     emotional and mental health needs of youth, and strategies to 
     lower the rates of suicidal behaviors in children and 
     adolescents described in paragraph (1) to reduce any 
     demographic disparities in such rates.


     amendment no. 16 offered by mr. reschenthaler of pennsylvania

       At the end of subtitle C of title I, add the following new 
     section:

     SEC. 124. STUDY ON THE COSTS OF SERIOUS MENTAL ILLNESS.

       (a) In General.--The Secretary of Health and Human 
     Services, in consultation with the Assistant Secretary for 
     Mental Health and Substance Use, the Assistant Secretary for 
     Planning and Evaluation, the Attorney General of the United 
     States, the Secretary of Labor, and the Secretary of Housing 
     and Urban Development, shall conduct a study on the direct 
     and indirect costs of serious mental illness with respect 
     to--
       (1) nongovernmental entities; and
       (2) the Federal Government and State, local, and Tribal 
     governments.
       (b) Content.--The study under subsection (a) shall consider 
     each of the following:
       (1) The costs to the health care system for health 
     services, including with respect to--
       (A) office-based physician visits;
       (B) residential and inpatient treatment programs;
       (C) outpatient treatment programs;
       (D) emergency room visits;
       (E) crisis stabilization programs;
       (F) home health care;
       (G) skilled nursing and long-term care facilities;
       (H) prescription drugs and digital therapeutics; and
       (I) any other relevant health services.
       (2) The costs of homelessness, including with respect to--
       (A) homeless shelters;
       (B) street outreach activities;
       (C) crisis response center visits; and
       (D) other supportive services.
       (3) The costs of structured residential facilities and 
     other supportive housing for residential and custodial care 
     services.
       (4) The costs of law enforcement encounters and encounters 
     with the criminal justice system, including with respect to--
       (A) encounters that do and do not result in an arrest;
       (B) criminal and judicial proceedings;
       (C) services provided by law enforcement and judicial staff 
     (including public defenders, prosecutors, and private 
     attorneys); and
       (D) incarceration.
       (5) The costs of serious mental illness on employment.
       (6) With respect to family members and caregivers, the 
     costs of caring for an individual with a serious mental 
     illness.
       (7) Any other relevant costs for programs and services 
     administered by the Federal Government or State, Tribal, or 
     local governments.
       (c) Data Disaggregation.--In conducting the study under 
     subsection (a), the Secretary of Health and Human Services 
     shall (to the extent feasible)--
       (1) disaggregate data by--
       (A) costs to nongovernmental entities, the Federal 
     Government, and State, local, and Tribal governments;
       (B) types of serious mental illnesses and medical chronic 
     diseases common in patients with a serious mental illness; 
     and
       (C) demographic characteristics, including race, ethnicity, 
     sex, age (including pediatric subgroups), and other 
     characteristics determined by the Secretary; and
       (2) include an estimate of--
       (A) the total number of individuals with a serious mental 
     illness in the United States, including in traditional and 
     nontraditional housing; and
       (B) the percentage of such individuals in--
       (i) homeless shelters;
       (ii) penal facilities, including Federal prisons, State 
     prisons, and county and municipal jails; and
       (iii) nursing facilities.
       (d) Report.--Not later than 2 years after the date of the 
     enactment of this Act, the Secretary of Health and Human 
     Services shall--
       (1) submit to the Congress a report containing the results 
     of the study conducted under this section; and

[[Page H5787]]

       (2) make such report publicly available.

  The SPEAKER pro tempore. Pursuant to House Resolution 1191, the 
gentleman from New Jersey (Mr. Pallone) and the gentlewoman from 
Washington (Mrs. Rodgers) each will control 10 minutes.
  The Chair recognizes the gentleman from New Jersey.
  Mr. PALLONE. Madam Speaker, I yield myself such time as I may 
consume.
  Madam Speaker, I rise in support of the eight mental health 
amendments under this en bloc consideration. Collectively, these 
amendments further strengthen the bipartisan nature of the underlying 
comprehensive bill, the Restoring Hope for Mental Health and Well-Being 
Act of 2022.
  I thank my colleagues for their leadership and contributions to 
furthering the health of the American people and wish to speak in 
strong support of their adoption into H.R. 7666.
  Many of these amendments, Madam Speaker, include provisions from 
bills that previously passed the House this Congress on suspension that 
the Senate has yet to act upon.
  I am pleased that we have the opportunity to, once again, emphasize 
their importance by including them in this crucial legislative package.
  The amendment offered by Congressman Bera and Congressman Fitzpatrick 
is just such an amendment. Like the bill it reflects, the HERO Act, 
which passed the House last year, it will improve data collection and 
services to ensure our first responders and public safety officers 
receive the mental health care services they need.
  Additionally, Congresswoman Napolitano and Congressman Katko 
submitted an amendment which extends and revises SAMHSA's Project AWARE 
program providing school-based mental health services, including 
screening, treatment, and outreach programs, provisions that likewise 
passed the House last year in H.R. 721, the Mental Health Services for 
Students Act of 2021.
  Representatives Katko and Napolitano were also joined by Congressmen 
Beyer, Raskin, Cardenas, and Fitzpatrick in offering an additional 
amendment that includes provisions from H.R. 2981, the Suicide 
Prevention Lifeline Improvement Act of 2021, which also passed the 
House last year.
  The amendment extends funding for SAMHSA's Lifeline--crucial in this 
Nation's moment of mental health crisis, supporting crisis care 
response and support as we prepare for the launch of the new 988 
dialing code next month.
  I appreciate the additional focus on the particular needs of certain 
communities in our country that several amendments add to the 
underlying bill.
  I thank Representatives Reschenthaler, Morelle, Wild, and Dean for 
their amendment requiring a study to determine the true cost of 
untreated serious mental illness on families, healthcare systems, 
public housing, and law enforcement in America.
  In addition, we certainly cannot do enough to support the men and 
women who have valiantly served our Nation in the Armed Forces.
  I thank Congressman Joyce for his amendment that requires the 
Department of Defense to carry out a 2-year pilot program aimed at 
preventing suicides amongst Active-Duty members of the Armed Forces.
  I also appreciate and support the amendment submitted by Congressman 
Feenstra requiring the new Behavioral Health Crisis Coordinating Office 
established within SAMHSA by H.R. 7666, to provide technical assistance 
and support to the Veterans Crisis Line.
  Further, Madam Speaker, I support the mental health and well-being of 
those who are pregnant or postpartum. The amendment offered by 
Congresswoman Moore makes important improvements to the Maternal Mental 
Health Hotline authorization to ensure those implementing the hotline 
consult with appropriate State, local, and Tribal public officials and 
those working with low-income people.
  I am particularly pleased that H.R. 7666 would establish a new 
authorization for a Maternal Mental Health Hotline, and I appreciate 
Representative Moore's amendment that will serve to improve the 
underlying legislation.
  Finally, Madam Speaker, while we know children in this country are 
facing a mental health crisis, unfortunately, we know that all too many 
also experience other chronic health challenges.
  I am grateful to Representative Pressley for her amendment requiring 
the Secretary of Health and Human Services conduct a study on the rates 
and risks of suicidal behaviors among youth with chronic illnesses and 
to provide Congress with recommendations for ways to provide early 
intervention, best practices, and strategies to address disparities.
  I am pleased to support these amendments and encourage my colleagues 
to do the same.
  Madam Speaker, I reserve the balance of my time.
  Mrs. RODGERS of Washington. Madam Speaker, I yield myself such time 
as I may consume. I rise in support of the amendments offered en bloc. 
I rise today to express my strong support for this group of amendments. 
Included in this en bloc are important bills that have already 
overwhelmingly passed the House, including Representative Katko's 
Suicide Prevention Lifeline Improvement Act, which reauthorizes the 
National Suicide Prevention Lifeline program and ensures resources are 
available for the continued operation of the hotline, especially with 
9-8-8 going live next month.
  Representative Katko also has included in this en bloc the Mental 
Health Services for Students Act, which provides an authorization for 
the Substance Abuse and Mental Health Services Administration's Project 
AWARE grant.
  Project AWARE is a successful program which supports partnerships 
between the State and local systems in increasing awareness of mental 
health issues among school-aged youth; providing training for school 
personnel to detect and respond to mental health issues; and connecting 
students with behavioral health issues and their families to needed 
services.
  The en bloc also includes the Reschenthaler amendment, which would 
authorize a study on the cost of untreated serious mental illness on 
families, the health system, the justice system, and the economy.

  While very treatable, serious mental illness remains a neglected 
health issue, and I am hopeful that the data gleaned from this study 
will convince policymakers to do more to address this condition, 
including addressing the IMD exclusion.
  This group of amendments demonstrates the good work Congress can do 
when both parties come together to find meaningful solutions to address 
mental health in America.
  Madam Speaker, I urge adoption, and I reserve the balance of my time.
  Mr. PALLONE. Madam Speaker, I yield 4 minutes to the gentlewoman from 
Massachusetts (Ms. Pressley), who has one of the important amendments 
included in this en bloc.
  Ms. PRESSLEY. Madam Speaker, I rise today in support of my amendment 
to require the Secretary of Health and Human Services to study the 
suicide crises among children living with chronic illnesses and 
conditions, including autoimmune diseases like alopecia.
  Across this Nation, our children are carrying unprecedented amounts 
of trauma and grief in their emotional backpacks.
  For an entire generation of youngsters living with chronic 
conditions, the solitude, grief, and uncertainty of the past 2 years 
have only exacerbated the emotional and mental health challenges that 
already weighed so heavily.
  Like millions of Americans, I am living with the autoimmune disease 
alopecia. There are several forms of alopecia. I am living with 
alopecia universalis.
  Navigating the world as a bald woman is disruptive to many. I am 48 
years old, I am an adult, and I have built up some pretty thick skin, 
but there are days that even bring me to my knees because of the social 
stigmatization, the bullying, the taunting that I experience as an 
adult.
  Although this does not threaten my life, that does not mean that it 
does not impact it. I was a caregiver to my mother in her cancer 
battle, and her very first concern and worry--even though she was 
fighting for her life--was, am I going to lose my hair.
  This is something much more than cosmetic for all who are living with

[[Page H5788]]

this. Certainly, for women and girls, there is an added layer, in that 
this challenge defies societal norms of what is feminine, what is 
pretty, what is acceptable, and what is appropriate.
  For the millions of children--again, I am a 48-year-old adjusted 
woman, but for the millions of children living with this disease, the 
challenges may sometimes feel too much to bear.
  While there are public misconceptions that alopecia areata is purely 
cosmetic, the fact is the National Institute of Mental Health has found 
that alopecia areata has been linked to higher rates of depression, 
sadness, anxiety, and other mental challenges.
  Some have offered: Why not just wear a wig? Well, I am working on 
that, too, because many of our children can't afford a medically 
durable wig. So for children who are just beginning their journey, 
growing comfortable in their own skin and finding their place in the 
world, these challenges can feel even harder.
  Earlier this year, our alopecia community lost one of our own. She is 
not the first, but one of the most recent: Miss Rio Allred. May she 
rest in peace. She was 12 years old, and took her life by suicide 
because of the emotional turmoil and relentless bullying she faced 
every day in school due to her alopecia.
  I have spoken to Rio's mother. I have heard her express the pain no 
parent should ever know. I asked her to tell me about Rio. She was a 
great big sister, a writer, a reader, was funny, and a light to the 
world and all around her.
  Her mother has now established Rio's Rainbow, a foundation in her 
honor, and the mission of that, in Rio's honor, is that kids should 
feel safe being who they are. One life lost to the emotional distress 
associated with this disease, and any chronic condition for that 
matter, is one too many.
  I make no appeal today for sympathy, but for empathy, for support, to 
be seen. I am not here just to take up space. I am here to create it. I 
choose not to wear a wig because I know what that representation means 
to the millions of Americans that are living with alopecia.
  It is long past time that we study the troubling suicide crisis among 
children living with chronic illnesses and conditions, including those 
within our alopecia community, and invest in the early interventions 
and best practices necessary to save lives. I urge my colleagues to 
support this amendment, which would do just that.
  Mrs. RODGERS of Washington. Madam Speaker, I yield 3 minutes to the 
gentleman from Ohio (Mr. Joyce).
  Mr. JOYCE of Ohio. Madam Speaker, I rise today in support of my 
amendment to H.R. 7666 which would add the text of the Military Suicide 
Prevention in the 21st Century Act to the underlying bill.


 =========================== NOTE =========================== 

  
  June 22, 2022, on page H5788, in the first column, the following 
appeared: Mrs. RODGERS of Washington. Madam Speaker, I yield 3 
minutes to the gentleman from Ohio (Mr. Joyce). Mr. JOYCE of 
Pennsylvania. Madam Speaker, I rise today in support of my
  
  The online version has been corrected to read: Mrs. RODGERS of 
Washington. Madam Speaker, I yield 3 minutes to the gentleman from 
Ohio (Mr. Joyce). Mr. JOYCE of Ohio. Madam Speaker, I rise today 
in support of my


 ========================= END NOTE ========================= 


  The men and the women of America's Armed Forces dedicate their lives 
in service to this Nation. Unfortunately, countless servicemembers are 
left with scars that linger long after they return home.
  Rates of serious mental illness experienced by those in the Armed 
Forces are on the rise, and tragically, so too is the number of 
soldiers who ultimately take their lives.
  According to DOD's most recent report, suicide in the military 
community is at its highest rate since 1938. An estimated 7,000 
servicemembers have died in combat or training exercises since 9/11.
  During that same time, over 30,000 Active-Duty personnel and veterans 
who recently served died by suicide. Those numbers should bring pause 
to every Member in this Chamber. More importantly, they should spur us 
into action.
  That is why I introduced the Military Suicide Prevention in the 21st 
Century Act. This commonsense bill would direct the DOD to utilize 
modern technology to prevent suicides in our military community.

  In addition to requiring the National Suicide Hotline and the 
Veterans Crisis Hotline to be preprogrammed into government-issued 
smart devices such as phones, tablets, and laptops, the bill would 
require the DOD to proactively download the Virtual Hope Box app onto 
these devices.
  This app can be set up with the photos of friends and family, sound 
bites of loved ones, videos of special moments, music, relaxation 
exercises, games, and reminders of reasons for living.
  Nothing we do here in Washington will ever truly repay the sacrifices 
made by our Nation's servicemembers, but by passing this legislation, 
we can help make a meaningful difference in the lives of countless 
American heroes and their families.
  We owe an incredible debt to the men and women of our Armed Forces 
who risk their lives fighting for our freedoms and our security. It is 
past time Congress do more to fight for them here at home.
  I urge my colleagues to support my amendment so we can make real 
progress toward providing improved support for America's servicemembers 
struggling with their mental health.
  Mr. PALLONE. Madam Speaker, I have no additional speakers, and I 
yield back the balance of my time.
  Mrs. RODGERS of Washington. Madam Speaker, I yield back the balance 
of my time.
  The SPEAKER pro tempore. Pursuant to House Resolution 1191, the 
previous question is ordered on the amendments en bloc offered by the 
gentleman from New Jersey (Mr. Pallone).
  The question is on the amendments en bloc.
  The question was taken; and the Speaker pro tempore announced that 
the ayes appeared to have it.
  Mr. TIFFANY. Madam Speaker, on that I demand the yeas and nays.
  The SPEAKER pro tempore. Pursuant to section 3(s) of House Resolution 
8, the yeas and nays are ordered.
  Pursuant to clause 8 of rule XX, further proceedings on this question 
are postponed.

                              {time}  1530


     Amendments En Bloc No. 2 Offered by Mr. Pallone of New Jersey

  Mr. PALLONE. Madam Speaker, pursuant to House Resolution 1191, I rise 
to offer amendments en bloc No. 2.
  The SPEAKER pro tempore. The Clerk will designate the amendments en 
bloc.
  Amendments en bloc No. 2 consisting of amendment Nos. 2, 3, 7, 11, 
12, and 17, printed in part E of House Report 117-381, offered by Mr. 
Pallone of New Jersey:


        Amendment No. 2 Offered By Mr. Rodney Davis of Illinois

       At the end of title II, add the following new subtitle:

                  Subtitle G--Opioid Epidemic Response

     SEC. 271. OPIOID PRESCRIPTION VERIFICATION.

       (a) Materials for Training Pharmacists on Certain 
     Circumstances Under Which a Pharmacist May Decline to Fill a 
     Prescription.--
       (1) Updates to materials.--Section 3212(a) of the SUPPORT 
     for Patients and Communities Act (21 U.S.C. 829 note) is 
     amended by striking ``Not later than 1 year after the date of 
     enactment of this Act, the Secretary of Health and Human 
     Services, in consultation with the Administrator of the Drug 
     Enforcement Administration, Commissioner of Food and Drugs, 
     Director of the Centers for Disease Control and Prevention, 
     and Assistant Secretary for Mental Health and Substance Use, 
     shall develop and disseminate'' and inserting ``The Secretary 
     of Health and Human Services, in consultation with the 
     Administrator of the Drug Enforcement Administration, 
     Commissioner of Food and Drugs, Director of the Centers for 
     Disease Control and Prevention, and Assistant Secretary for 
     Mental Health and Substance Use, shall develop and 
     disseminate not later than 1 year after the date of enactment 
     of this Act, and update periodically thereafter''.
       (2) Materials included.--Section 3212(b) of the SUPPORT for 
     Patients and Communities Act (21 U.S.C. 829 note) is 
     amended--
       (A) by redesignating paragraphs (1) and (2) as paragraphs 
     (2) and (3), respectively; and
       (B) by inserting before paragraph (2), as so redesignated, 
     the following new paragraph:
       ``(1) pharmacists on how to verify the identity of the 
     patient;''.
       (3) Materials for training on patient verification .--
     Section 3212 of the SUPPORT for Patients and Communities Act 
     (21 U.S.C. 829 note) is amended by adding at the end the 
     following new subsection:
       ``(d) Materials for Training on Verification of Identity.--
     Not later than 1 year after the date of enactment of this 
     subsection, the Secretary of Health and Human Services, after 
     seeking stakeholder input in accordance with subsection (c), 
     shall--
       ``(1) update the materials developed under subsection (a) 
     to include information for pharmacists on how to verify the 
     identity the patient; and
       ``(2) disseminate, as appropriate, the updated 
     materials.''.
       (b) Incentivizing States To Facilitate Responsible, 
     Informed Dispensing of Controlled Substances.--
       (1) In general.--Section 392A of the Public Health Service 
     Act (42 U.S.C. 280b-1) is amended--

[[Page H5789]]

       (A) by redesignating subsections (c) and (d) as subsections 
     (d) and (e), respectively; and
       (B) by inserting after subsection (b) the following new 
     subsection:
       ``(c) Preference.--In determining the amounts of grants 
     awarded to States under subsections (a) and (b), the Director 
     of the Centers for Disease Control and Prevention may give 
     preference to States in accordance with such criteria as the 
     Director may specify and may choose to give preference to 
     States that--
       ``(1) maintain a prescription drug monitoring program;
       ``(2) require prescribers of controlled substances in 
     schedule II, III, or IV to issue such prescriptions 
     electronically, and make such requirement subject to 
     exceptions in the cases listed in section 1860D-4(e)(7)(B) of 
     the Social Security Act; and
       ``(3) require dispensers of such controlled substances to 
     enter certain information about the purchase of such 
     controlled substances into the respective State's 
     prescription drug monitoring program, including--
       ``(A) the National Drug Code or, in the case of compounded 
     medications, compound identifier;
       ``(B) the quantity dispensed;
       ``(C) the patient identifier; and
       ``(D) the date filled.''.
       (2) Definitions.--
       (A) In general.--Subsection (d) of section 392A of the 
     Public Health Service Act (42 U.S.C. 280b-1), as redesignated 
     by paragraph (1)(A), is amended to read as follows:
       ``(d) Definitions.--In this section:
       ``(1) Controlled substance.--The term `controlled 
     substance' has the meaning given that term in section 102 of 
     the Controlled Substances Act.
       ``(2) Dispenser.--The term `dispenser' means a physician, 
     pharmacist, or other person that dispenses a controlled 
     substance to an ultimate user.
       ``(3) Indian tribe.--The term `Indian Tribe' has the 
     meaning given that term in section 4 of the Indian Self-
     Determination and Education Assistance Act.''.
       (B) Conforming change.--Section 392A of the Public Health 
     Service Act (42 U.S.C. 280b-1) is amended by striking 
     ``Indian tribes'' each place it appears and inserting 
     ``Indian Tribes''.


          Amendment No. 3 Offered By Ms. Dean of Pennsylvania

       After section 263, insert the following new section:

     SEC. 264. INCREASE IN NUMBER OF DAYS BEFORE WHICH CERTAIN 
                   CONTROLLED SUBSTANCES MUST BE ADMINISTERED.

       Section 309A(a)(5) of the Controlled Substances Act (21 
     U.S.C. 829a(a)(5)) is amended by striking ``14 days'' and 
     inserting ``60 days''.


        Amendment No. 7 Offered By Mr. Gottheimer of new jersey

       Page 9, line 22, insert ``veterans,'' after 
     ``minorities,''.


           Amendment No. 11 Offered By Mr. kim of new jersey

       At the end of title II, add the following new subtitle:

                  Subtitle G--Opioid Epidemic Response

     SEC. 271. SYNTHETIC OPIOID DANGER AWARENESS.

       (a) Synthetic Opioids Public Awareness Campaign.--Part B of 
     title III of the Public Health Service Act is amended by 
     inserting after section 317U (42 U.S.C. 247b-23) the 
     following new section:

     ``SEC. 317V. SYNTHETIC OPIOIDS PUBLIC AWARENESS CAMPAIGN.

       ``(a) In General.--Not later than one year after the date 
     of the enactment of this section, the Secretary shall provide 
     for the planning and implementation of a public education 
     campaign to raise public awareness of synthetic opioids 
     (including fentanyl and its analogues). Such campaign shall 
     include the dissemination of information that--
       ``(1) promotes awareness about the potency and dangers of 
     fentanyl and its analogues and other synthetic opioids;
       ``(2) explains services provided by the Substance Abuse and 
     Mental Health Services Administration and the Centers for 
     Disease Control and Prevention (and any entity providing such 
     services under a contract entered into with such agencies) 
     with respect to the misuse of opioids, particularly as such 
     services relate to the provision of alternative, non-opioid 
     pain management treatments; and
       ``(3) relates generally to opioid use and pain management.
       ``(b) Use of Media.--The campaign under subsection (a) may 
     be implemented through the use of television, radio, 
     internet, in-person public communications, and other 
     commercial marketing venues and may be targeted to specific 
     age groups.
       ``(c) Consideration of Report Findings.--In planning and 
     implementing the public education campaign under subsection 
     (a), the Secretary shall take into consideration the findings 
     of the report required under section 7001 of the SUPPORT for 
     Patients and Communities Act (Public Law 115-271).
       ``(d) Consultation.--In coordinating the campaign under 
     subsection (a), the Secretary shall consult with the 
     Assistant Secretary for Mental Health and Substance Use to 
     provide ongoing advice on the effectiveness of information 
     disseminated through the campaign.
       ``(e) Requirement of Campaign.--The campaign implemented 
     under subsection (a) shall not be duplicative of any other 
     Federal efforts relating to eliminating the misuse of 
     opioids.
       ``(f) Evaluation.--
       ``(1) In general.--The Secretary shall ensure that the 
     campaign implemented under subsection (a) is subject to an 
     independent evaluation, beginning 2 years after the date of 
     the enactment of this section, and every 2 years thereafter.
       ``(2) Measures and benchmarks.--For purposes of an 
     evaluation conducted pursuant to paragraph (1), the Secretary 
     shall--
       ``(A) establish baseline measures and benchmarks to 
     quantitatively evaluate the impact of the campaign under this 
     section; and
       ``(B) conduct qualitative assessments regarding the 
     effectiveness of strategies employed under this section.
       ``(g) Report.--The Secretary shall, beginning 2 years after 
     the date of the enactment of this section, and every 2 years 
     thereafter, submit to Congress a report on the effectiveness 
     of the campaign implemented under subsection (a) towards 
     meeting the measures and benchmarks established under 
     subsection (e)(2).
       ``(h) Dissemination of Information Through Providers.--The 
     Secretary shall develop and implement a plan for the 
     dissemination of information related to synthetic opioids, to 
     health care providers who participate in Federal programs, 
     including programs administered by the Department of Health 
     and Human Services, the Indian Health Service, the Department 
     of Veterans Affairs, the Department of Defense, and the 
     Health Resources and Services Administration, the Medicare 
     program under title XVIII of the Social Security Act, and the 
     Medicaid program under title XIX of such Act.''.
       (b) Training Guide and Outreach on Synthetic Opioid 
     Exposure Prevention.--
       (1) Training guide.--Not later than 18 months after the 
     date of the enactment of this Act, the Secretary of Health 
     and Human Services shall design, publish, and make publicly 
     available on the internet website of the Department of Health 
     and Human Services, a training guide and webinar for first 
     responders and other individuals who also may be at high risk 
     of exposure to synthetic opioids that details measures to 
     prevent that exposure.
       (2) Outreach.--Not later than 18 months after the date of 
     the enactment of this Act, the Secretary of Health and Human 
     Services shall also conduct outreach about the availability 
     of the training guide and webinar published under paragraph 
     (1) to--
       (A) police and fire managements;
       (B) sheriff deputies in city and county jails;
       (C) ambulance transport and hospital emergency room 
     personnel;
       (D) clinicians; and
       (E) other high-risk occupations, as identified by the 
     Assistant Secretary for Mental Health and Substance Use.


       amendment no. 12 offered by mr. mckinley of west virginia

       After section 263, insert the following new section:

     SEC. 264. BLOCK, REPORT, AND SUSPEND SUSPICIOUS SHIPMENTS.

       (a) Clarification of Process for Registrants to Exercise 
     Due Diligence Upon Discovering a Suspicious Order.--Paragraph 
     (3) of section 312(a) of the Controlled Substances Act (21 
     U.S.C. 832(a)) is amended to read as follows:
       ``(3) upon discovering a suspicious order or series of 
     orders, and in a manner consistent with the other 
     requirements of this section--
       ``(A) exercise due diligence as appropriate;
       ``(B) establish and maintain (for not less than a period to 
     be determined by the Administrator of the Drug Enforcement 
     Administration) a record of the due diligence that was 
     performed;
       ``(C) decline to fill the order or series of orders if the 
     due diligence fails to dispel all of the indicators that give 
     rise to the suspicion that, if the order or series of orders 
     is filled, the drugs that are the subject of the order or 
     series of orders are likely to be diverted; and
       ``(D) notify the Administrator of the Drug Enforcement 
     Administration and the Special Agent in Charge of the 
     Division Office of the Drug Enforcement Administration for 
     the area in which the registrant is located or conducts 
     business of--
       ``(i) each suspicious order or series of orders discovered 
     by the registrant; and
       ``(ii) the indicators giving rise to the suspicion that, if 
     the order or series of orders is filled, the drugs that are 
     the subject of the order or series of orders are likely to be 
     diverted.''.
       (b) Resolution of Suspicious Indicators.--Section 312 of 
     the Controlled Substances Act (21 U.S.C. 832) is amended--
       (1) by redesignating subsection (b) and (c) as subsections 
     (c) and (d), respectively; and
       (2) by inserting after subsection (a) the following:
       ``(b) Resolution of Suspicious Indicators.--If a registrant 
     resolves all of the indicators giving rise to suspicion about 
     an order or series of orders under subsection (a)(3)--
       ``(1) notwithstanding subsection (a)(3)(C), the registrant 
     may choose to fill the order or series of orders; and
       ``(2) notwithstanding subsection (a)(3)(D), the registrant 
     may choose not to make the notification otherwise required by 
     such subsection.''.
       (c) Regulations.--Not later than 1 year after the date of 
     enactment of this Act, for purposes of subsections (a)(3) and 
     (b) of section 312 of the Controlled Substances Act, as

[[Page H5790]]

     amended or inserted by subsection (a), the Attorney General 
     of the United States shall promulgate a final regulation 
     specifying the indicators that give rise to a suspicion that, 
     if an order or series of orders is filled, the drugs that are 
     the subject of the order or series of orders are likely to be 
     diverted.
       (d) Applicability.--Subsections (a)(3) and (b) of section 
     312 of the Controlled Substances Act, as amended or inserted 
     by subsection (a), shall apply beginning on the day that is 1 
     year after the date of enactment of this Act. Until such day, 
     section 312(a)(3) of the Controlled Substances Act shall 
     apply as such section 312(a)(3) was in effect on the day 
     before the date of enactment of this Act.


           amendment no. 17 offered by mr. trone of maryland

       At the end of title II, add the following new subtitle:

                  Subtitle I--Opioid Epidemic Response

     SEC. 271. GRANT PROGRAM FOR STATE AND TRIBAL RESPONSE TO 
                   OPIOID AND STIMULANT USE AND MISUSE.

       Section 1003 of the 21st Century Cures Act (42 U.S.C. 
     290ee-3 note) is amended to read as follows:

     ``SEC. 1003. GRANT PROGRAM FOR STATE AND TRIBAL RESPONSE TO 
                   OPIOID AND STIMULANT USE AND MISUSE.

       ``(a) In General.--The Secretary of Health and Human 
     Services (referred to in this section as the `Secretary') 
     shall carry out the grant program described in subsection (b) 
     for purposes of addressing opioid and stimulant use and 
     misuse, within States, Indian Tribes, and populations served 
     by Tribal organizations and Urban Indian organizations.
       ``(b) Grants Program.--
       ``(1) In general.--Subject to the availability of 
     appropriations, the Secretary shall award grants to States, 
     Indian Tribes, Tribal organizations, and Urban Indian 
     organizations for the purpose of addressing opioid and 
     stimulant use and misuse, within such States, such Indian 
     Tribes, and populations served by such Tribal organizations 
     and Urban Indian organizations, in accordance with paragraph 
     (2).
       ``(2) Minimum allocations; preference.--In determining 
     grant amounts for each recipient of a grant under paragraph 
     (1), the Secretary shall--
       ``(A) ensure that each State receives not less than 
     $4,000,000; and
       ``(B) give preference to States, Indian Tribes, Tribal 
     organizations, and Urban Indian organizations whose 
     populations have an incidence or prevalence of opioid use 
     disorders or stimulant use or misuse that is substantially 
     higher relative to the populations of other States, other 
     Indian Tribes, Tribal organizations, or Urban Indian 
     organizations, as applicable.
       ``(3) Formula methodology.--
       ``(A) In general.--Before publishing a funding opportunity 
     announcement with respect to grants under this section, the 
     Secretary shall--
       ``(i) develop a formula methodology to be followed in 
     allocating grant funds awarded under this section among 
     grantees, which includes performance assessments for 
     continuation awards; and
       ``(ii) not later than 30 days after developing the formula 
     methodology under clause (i), submit the formula methodology 
     to--

       ``(I) the Committee on Energy and Commerce and the 
     Committee on Appropriations of the House of Representatives; 
     and
       ``(II) the Committee on Health, Education, Labor, and 
     Pensions and the Committee on Appropriations of the Senate.

       ``(B) Report.--Not later than two years after the date of 
     the enactment of the Restoring Hope for Mental Health and 
     Well-Being Act of 2022, the Comptroller General of the United 
     States shall submit to the Committee on Health, Education, 
     Labor, and Pensions of the Senate and the Committee on Energy 
     and Commerce of the House of Representatives a report that--
       ``(i) assesses how grant funding is allocated to States 
     under this section and how such allocations have changed over 
     time;
       ``(ii) assesses how any changes in funding under this 
     section have affected the efforts of States to address opioid 
     or stimulant use or misuse; and
       ``(iii) assesses the use of funding provided through the 
     grant program under this section and other similar grant 
     programs administered by the Substance Abuse and Mental 
     Health Services Administration.
       ``(4) Use of funds.--Grants awarded under this subsection 
     shall be used for carrying out activities that supplement 
     activities pertaining to opioid and stimulant use and misuse, 
     undertaken by the State agency responsible for administering 
     the substance abuse prevention and treatment block grant 
     under subpart II of part B of title XIX of the Public Health 
     Service Act (42 U.S.C. 300x-21 et seq.), which may include 
     public health-related activities such as the following:
       ``(A) Implementing prevention activities, and evaluating 
     such activities to identify effective strategies to prevent 
     substance use disorders.
       ``(B) Establishing or improving prescription drug 
     monitoring programs.
       ``(C) Training for health care practitioners, such as best 
     practices for prescribing opioids, pain management, 
     recognizing potential cases of substance use disorders, 
     referral of patients to treatment programs, preventing 
     diversion of controlled substances, and overdose prevention.
       ``(D) Supporting access to health care services, 
     including--
       ``(i) services provided by federally certified opioid 
     treatment programs;
       ``(ii) outpatient and residential substance use disorder 
     treatment services that utilize medication-assisted 
     treatment, as appropriate; or
       ``(iii) other appropriate health care providers to treat 
     substance use disorders.
       ``(E) Recovery support services, including--
       ``(i) community-based services that include peer supports;
       ``(ii) mutual aid recovery programs that support 
     medication-assisted treatment; or
       ``(iii) services to address housing needs and family 
     issues.
       ``(F) Other public health-related activities, as the State, 
     Indian Tribe, Tribal organization, or Urban Indian 
     organization determines appropriate, related to addressing 
     substance use disorders within the State, Indian Tribe, 
     Tribal organization, or Urban Indian organization, including 
     directing resources in accordance with local needs related to 
     substance use disorders.
       ``(c) Accountability and Oversight.--A State receiving a 
     grant under subsection (b) shall include in reporting related 
     to substance use disorders submitted to the Secretary 
     pursuant to section 1942 of the Public Health Service Act (42 
     U.S.C. 300x-52), a description of--
       ``(1) the purposes for which the grant funds received by 
     the State under such subsection for the preceding fiscal year 
     were expended and a description of the activities of the 
     State under the grant;
       ``(2) the ultimate recipients of amounts provided to the 
     State; and
       ``(3) the number of individuals served through the grant.
       ``(d) Limitations.--Any funds made available pursuant to 
     subsection (i)--
       ``(1) shall not be used for any purpose other than the 
     grant program under subsection (b); and
       ``(2) shall be subject to the same requirements as 
     substance use disorders prevention and treatment programs 
     under titles V and XIX of the Public Health Service Act (42 
     U.S.C. 290aa et seq., 300w et seq.).
       ``(e) Indian Tribes, Tribal Organizations, and Urban Indian 
     Organizations.--The Secretary, in consultation with Indian 
     Tribes, Tribal organizations, and Urban Indian organizations, 
     shall identify and establish appropriate mechanisms for 
     Indian Tribes, Tribal organizations, and Urban Indian 
     organizations to demonstrate or report the information as 
     required under subsections (b), (c), and (d).
       ``(f) Report to Congress.--Not later than September 30, 
     2024, and biennially thereafter, the Secretary shall submit 
     to the Committee on Health, Education, Labor, and Pensions of 
     the Senate and the Committee on Energy and Commerce of the 
     House of Representatives, and the Committees on 
     Appropriations of the House of Representatives and the 
     Senate, a report that includes a summary of the information 
     provided to the Secretary in reports made pursuant to 
     subsections (c) and (e), including--
       ``(1) the purposes for which grant funds are awarded under 
     this section;
       ``(2) the activities of the grant recipients; and
       ``(3) for each State, Indian Tribe, Tribal organization, 
     and Urban Indian organization that receives a grant under 
     this section, the funding level provided to such recipient.
       ``(g) Technical Assistance.--The Secretary, including 
     through the Tribal Training and Technical Assistance Center 
     of the Substance Abuse and Mental Health Services 
     Administration, shall provide States, Indian Tribes, Tribal 
     organizations, and Urban Indian organizations, as applicable, 
     with technical assistance concerning grant application and 
     submission procedures under this section, award management 
     activities, and enhancing outreach and direct support to 
     rural and underserved communities and providers in addressing 
     substance use disorders.
       ``(h) Definitions.--In this section:
       ``(1) Indian tribe.--The term `Indian Tribe' has the 
     meaning given the term `Indian tribe' in section 4 of the 
     Indian Self-Determination and Education Assistance Act (25 
     U.S.C. 5304).
       ``(2) Tribal organization.--The term `Tribal organization' 
     has the meaning given the term `tribal organization' in such 
     section 4.
       ``(3) State.--The term `State' has the meaning given such 
     term in section 1954(b) of the Public Health Service Act (42 
     U.S.C. 300x-64(b)).
       ``(4) Urban indian organization.--The term `Urban Indian 
     organization' has the meaning given such term in section 4 of 
     the Indian Health Care Improvement Act.
       ``(i) Authorization of Appropriations.--
       ``(1) In general.--For purposes of carrying out the grant 
     program under subsection (b), there is authorized to be 
     appropriated $1,750,000,000 for each of fiscal years 2023 
     through 2027, to remain available until expended.
       ``(2) Federal administrative expenses.--Of the amounts made 
     available for each fiscal year to award grants under 
     subsection (b), the Secretary shall not use more than 20 
     percent for Federal administrative expenses, training, 
     technical assistance, and evaluation.
       ``(3) Set aside.--Of the amounts made available for each 
     fiscal year to award grants under subsection (b) for a fiscal 
     year, the Secretary shall--
       ``(A) award 5 percent to Indian Tribes, Tribal 
     organizations, and Urban Indian organizations; and
       ``(B) of the amount remaining after application of 
     subparagraph (A), set aside up to 15

[[Page H5791]]

     percent for awards to States with the highest age-adjusted 
     rate of drug overdose death based on the ordinal ranking of 
     States according to the Director of the Centers for Disease 
     Control and Prevention.''.

  The SPEAKER pro tempore. Pursuant to House Resolution 1191, the 
gentleman from New Jersey (Mr. Pallone) and the gentlewoman from 
Washington (Mrs. Rodgers) each will control 10 minutes.
  The Chair recognizes the gentleman from New Jersey.
  Mr. PALLONE. Madam Speaker, I yield myself such time as I may 
consume.
  Madam Speaker, I rise in support of this en bloc amendment. This 
package includes bipartisan bills and policies that will increase 
access to substance use disorder prevention, treatment, and recovery 
support services.
  The amendment introduced by Representatives Rodney Davis, Bilirakis, 
O'Halleran, Wagner, and Kuster reflects H.R. 2355, the Opioid 
Prescription Verification Act of 2021, which has previously passed the 
House. The amendment, like the bill it is drawn from, encourages the 
use of e-prescribing for opioids and incentivizes States to maintain 
and utilize prescription drug monitoring programs.
  Likewise, the amendment offered by Representatives Andy Kim and 
Davids also reflects a previously House-passed bill, H.R. 2364, the 
Synthetic Opioid Danger Awareness Act. Their amendment requires the 
Department of Health and Human Services to conduct a public education 
campaign about synthetic opioids, including fentanyl and its analogues, 
and disseminate information about synthetic opioids to healthcare 
providers.
  Continuing the theme of bipartisanship, Representatives McKinley and 
Dingell introduced an amendment that amends the Controlled Substances 
Act to clarify the process for registrants to exercise due diligence 
upon discovering a suspicious order. Like the prior amendments, this, 
too, is drawn from a prior House-passed bill, H.R. 768, the Block, 
Report, And Suspend Suspicious Shipments Act of 2021.
  Further, the amendment offered by Representatives Trone, Armstrong, 
and Sherrill also draws from a prior House-passed bill extending a 
critical authorization for the State Opioid Response grants and Tribal 
Opioid Response grants for 5 years.
  Another amendment introduced by Representatives Dean, Spartz, 
Scanlon, and Fitzpatrick reflects H.R. 5950, the Improving Patient 
Access to Care and Treatment Act. This amendment increases the time 
from 14 to 60 days that healthcare providers can hold long-acting 
injectable buprenorphine before administering it to a patient, giving 
patients and practitioners greater flexibility when accessing opioid 
use disorder treatment.
  Finally, this amendment package includes an amendment offered by 
Representative Gottheimer that would ensure that veterans are included 
within the crisis response continuum of best practices included in H.R. 
7666.
  I thank the sponsors of these provisions. These bipartisan amendments 
provide strong tools to address the ongoing overdose crisis and will 
save lives. I urge my colleagues to support this package of amendments 
and include them in the overall bill.
  Madam Speaker, I reserve the balance of my time.
  Mrs. RODGERS of Washington. Madam Speaker, I rise in support of the 
amendments offered en bloc and yield myself such time as I may consume.
  Madam Speaker, I rise today to express my strong support for this 
group of amendments addressing substance use disorder.
  Included in this en bloc are important bills that have already passed 
with overwhelming support, including Representative Rodney Davis' 
Opioid Prescription Verification Act, which incentivizes States to use 
prescription drug monitoring programs; requires certain controlled 
substances to be prescribed electronically; and directs Federal 
agencies to develop, disseminate, and periodically update training 
materials to help pharmacists identify and report potential cases of 
bad actors who attempt to illegally buy and sell controlled substances.
  Also included is Representative   David McKinley's Block, Report, And 
Suspend Suspicious Shipments Act, which places additional obligations 
on drug manufacturers and distributors to identify and stop suspicious 
orders of controlled substances.
  We have seen a devastating increase in overdose deaths that I think 
should be called poisonings, teens buying one pill via Snapchat and 
immediately overdosing because of a small amount of fentanyl in those 
pills. Just because it looks like a pill and someone says it was from a 
pharmacy does not make it so. We need to do more to stop both diversion 
of legitimate medication and counterfeits that are devastating our 
communities.
  These amendments are a good step in that direction, and I urge 
adoption.
  Madam Speaker, I reserve the balance of my time.
  Mr. PALLONE. Madam Speaker, I reserve the balance of my time.
  Mrs. RODGERS of Washington. Madam Speaker, I yield 3 minutes to the 
gentleman from West Virginia (Mr. McKinley), who has been a longtime 
leader on the issues of substance abuse.
  Mr. McKINLEY. Madam Speaker, I rise in support of en bloc No. 2, 
which includes an amendment to report, track, and take action on 
suspicious orders.
  While the COVID-19 pandemic raged through our population and 
dominated the headlines, the opioid epidemic exploded exponentially, 
silently claiming the lives of tens of thousands of Americans every 
year. Recent CDC data shows that the overdose death rate for last year 
was over 103,000 citizens.
  In 2017, the Energy and Commerce Committee conducted a comprehensive 
bipartisan investigation into opioid dumping in West Virginia. 
Outrageous details came to light, exposing how drug shipments in rural 
West Virginia went unconstrained. For example, over 2 million opioids 
were sent to a little town of 3,000 people.
  Another example: Even after a distributor found numerous red flags 
during his site visit, nearly 1.5 million doses of opioids were still 
shipped to a single pharmacy in Kermit, West Virginia, with a 
population of 406.
  The report that was filed by the Energy and Commerce Committee 
details failures on the part of both DEA and the distributors to 
identify and halt suspicious orders. Distributors felt they didn't have 
the authority to halt suspicious orders and could have been subject to 
lawsuits.

  As recommended in the report, this amendment not only requires the 
distributors to report suspicious orders but also to investigate the 
situation and decline to fill the order if it is warranted.
  American communities deserve to be treated better. This influx of 
illegal drugs must be stopped, and this amendment is a step in the 
right direction.
  Madam Speaker, I urge Members to adopt this amendment.
  Mrs. RODGERS of Washington. Madam Speaker, I yield back the balance 
of my time.
  Mr. PALLONE. Madam Speaker, I yield back the balance of my time.
  The SPEAKER pro tempore. Pursuant to House Resolution 1191, the 
previous question is ordered on the amendments en bloc offered by the 
gentleman from New Jersey (Mr. Pallone).
  The question is on the amendments en bloc.
  The question was taken; and the Speaker pro tempore announced that 
the ayes appeared to have it.
  Mr. TIFFANY. Madam Speaker, on that I demand the yeas and nays.
  The SPEAKER pro tempore. Pursuant to section 3(s) of House Resolution 
8, the yeas and nays are ordered.
  Pursuant to clause 8 of rule XX, further proceedings on this question 
are postponed.


                Amendment No. 4 Offered by Mrs. Demings

  The SPEAKER pro tempore. It is now in order to consider amendment No. 
4 printed in part E of House Report 117-381.
  Mrs. DEMINGS. Madam Speaker, I have an amendment at the desk.
  The SPEAKER pro tempore. The Clerk will designate the amendment.
  The text of the amendment is as follows:
       At the end of title III, add the following new subtitle:

                      Subtitle E--Other Provisions

     SEC. 341. REPORT ON LAW ENFORCEMENT MENTAL HEALTH AND 
                   WELLNESS.

       (a) In General.--Not later than 270 days after the date of 
     enactment of this Act, the Attorney General, in consultation 
     with the

[[Page H5792]]

     Director of the Federal Bureau of Investigation, the Director 
     of the National Institute for Justice, and the Assistant 
     Secretary for Mental Health and Substance Abuse, shall submit 
     to the Committee on Health, Education, Labor, and Pensions 
     and the Committee on the Judiciary of the Senate and the 
     Committee on Energy and Commerce and the Committee on the 
     Judiciary of the House of Representatives a report on--
       (1) the types, frequency, and severity of mental health and 
     stress-related responses of law enforcement officers to 
     aggressive actions or other trauma-inducing incidents against 
     law enforcement officers;
       (2) mental health and stress-related resources or programs 
     that are available to law enforcement officers at the 
     Federal, State, and local level, including peer-to-peer 
     programs;
       (3) the extent to which law enforcement officers use the 
     resources or programs described in paragraph (2);
       (4) the availability of, or need for, mental health 
     screening within Federal, State, and local law enforcement 
     agencies; and
       (5) recommendations for Federal, State, and local law 
     enforcement agencies to improve the mental health and 
     wellness of their officers.
       (b) Development.--In developing the report required under 
     subsection (a), the Attorney General, the Director of the 
     Federal Bureau of Investigation, the Director of the National 
     Institute of Justice, and the Assistant Secretary for Mental 
     Health and Substance Abuse shall consult relevant 
     stakeholders, including--
       (1) Federal, State, Tribal and local law enforcement 
     agencies; and
       (2) nongovernmental organizations, international 
     organizations, academies, or other entities.

  The SPEAKER pro tempore. Pursuant to House Resolution 1191, the 
gentlewoman from Florida (Mrs. Demings) and a Member opposed each will 
control 5 minutes.
  The Chair recognizes the gentlewoman from Florida.
  Mrs. DEMINGS. Madam Speaker, I yield myself such time as I may 
consume.
  Madam Speaker, the underlying bill is a significant step forward in 
supporting community mental health efforts, which I applaud.
  As a former social worker and former law enforcement officer, I have 
seen the devastating impact when communities fall short of meeting the 
needs of persons struggling with mental health and substance addiction.
  Florida is 49th in the Nation on access to mental health care. It is 
not a position we are proud of, but many States across the Nation have 
failed to adequately address these issues.
  Law enforcement officers, as we all know, have a tough and dangerous 
job, and I was proud to co-lead the Law Enforcement Mental Health and 
Wellness Act, signed into law by President Trump, which recognizes that 
addressing mental and psychological health is just as important as good 
physical health.
  My amendment is a simple one. It will insert reporting requirements 
on available mental health and stress-related programs for law 
enforcement officers and recommend additional tools that may be helpful 
or necessary to identify, access, monitor, and improve the overall 
well-being of our law enforcement officers.
  I am proud to support this bill, as it is critical that we support 
our community by boldly addressing mental health issues. I am proud to 
offer this amendment that will support the men and women in blue who 
support, protect, and serve us.
  Madam Speaker, I urge adoption of the amendment, and I yield back the 
balance of my time.
  Mrs. RODGERS of Washington. Madam Speaker, I claim the time in 
opposition, but I urge adoption of the amendment.
  The SPEAKER pro tempore. Without objection, the gentlewoman is 
recognized for 5 minutes.
  There was no objection.
  Mrs. RODGERS of Washington. Madam Speaker, I rise to urge adoption of 
the Demings amendment, which requires a report on the mental health 
issues experienced by law enforcement and the available resources or 
programs that are available to law enforcement officers to address 
mental health and stress.
  According to the National Alliance on Mental Illness, law enforcement 
officers report high rates of depression, anxiety, and post-traumatic 
stress disorders, with nearly one in four having considered suicide. In 
fact, more officers die from suicide than do in the line of duty.
  The report will include recommendations to Federal, State, and local 
law enforcement agencies on how to improve the mental health and well-
being of our officers.
  It is a necessary first step in helping us understand what resources 
are available to improve the mental health and wellness of law 
enforcement officials. Those risking their lives to keep America safe 
deserve passage of this amendment.
  Madam Speaker, I yield back the balance of my time.
  The SPEAKER pro tempore. Pursuant to House Resolution 1191, the 
previous question is ordered on the amendment offered by the 
gentlewoman from Florida (Mrs. Demings).
  The question is on the amendment offered by the gentlewoman from 
Florida (Mrs. Demings).
  The question was taken; and the Speaker pro tempore announced that 
the ayes appeared to have it.
  Mr. PALLONE. Madam Speaker, on that I demand the yeas and nays.
  The SPEAKER pro tempore. Pursuant to section 3(s) of House Resolution 
8, the yeas and nays are ordered.
  Pursuant to clause 8 of rule XX, further proceedings on this question 
are postponed.

                              {time}  1545


         Amendment No. 6 Offered by Mrs. Rodgers of Washington

  The SPEAKER pro tempore. It is now in order to consider amendment No. 
6 printed in part E of House Report 117-381.
  Mrs. RODGERS of Washington. Madam Speaker, as the designee of the 
gentleman from Georgia (Mr. Ferguson), I have an amendment at the desk.
  The SPEAKER pro tempore. The Clerk will designate the amendment.
  The text of the amendment is as follows:

       At the end of subtitle A of title IV, add the following new 
     section:

     SEC. 403. BEST PRACTICES FOR BEHAVIORAL INTERVENTION TEAMS.

       The Public Health Service Act is amended by inserting after 
     section 520H of such Act, as added by section 151, the 
     following new section:

     ``SEC. 520I. BEST PRACTICES FOR BEHAVIORAL INTERVENTION 
                   TEAMS.

       ``(a) In General.--The Secretary shall identify and 
     facilitate the development of best practices to assist 
     elementary schools, secondary schools, and institutions of 
     higher education in establishing and using behavioral 
     intervention teams.
       ``(b) Elements.--The best practices under subsection (a)(1) 
     shall include guidance on the following:
       ``(1) How behavioral intervention teams can operate 
     effectively from an evidence-based, objective perspective 
     while protecting the constitutional and civil rights of 
     individuals.
       ``(2) The use of behavioral intervention teams to identify 
     concerning behaviors, implement interventions, and manage 
     risk through the framework of the school's or institution's 
     rules or code of conduct, as applicable.
       ``(3) How behavioral intervention teams can, when assessing 
     an individual--
       ``(A) access training on evidence-based, threat-assessment 
     rubrics;
       ``(B) ensure that such teams--
       ``(i) have trained, diverse stakeholders with varied 
     expertise; and
       ``(ii) use cross validation by a wide-range of individual 
     perspectives on the team; and
       ``(C) use violence risk assessment.
       ``(4) How behavioral intervention teams can help mitigate--
       ``(A) inappropriate use of a mental health assessment;
       ``(B) inappropriate limitations or restrictions on law 
     enforcement's jurisdiction over criminal matters;
       ``(C) attempts to substitute the behavioral intervention 
     process in place of a criminal process, or impede a criminal 
     process, when an individual's behavior has potential criminal 
     implications;
       ``(D) endangerment of an individual's privacy by failing to 
     ensure that all applicable Federal and State privacy laws are 
     fully complied with; or
       ``(E) inappropriate referrals to, or involvement of, law 
     enforcement when an individual's behavior does not warrant a 
     criminal response.
       ``(c) Consultation.--In carrying out subsection (a)(1), the 
     Secretary shall consult with--
       ``(1) the Secretary of Education;
       ``(2) the Director of the National Threat Assessment Center 
     of the United States Secretary Service;
       ``(3) the Attorney General and the Director of the Bureau 
     of Justice Assistance;
       ``(4) teachers and other educators, principals, school 
     administrators, school board members, school psychologists, 
     mental health professionals, and parents of students;
       ``(5) local law enforcement agencies and campus law 
     enforcement administrators;

[[Page H5793]]

       ``(6) privacy experts; and
       ``(7) other education and mental health professionals as 
     the Secretary deems appropriate.
       ``(d) Publication.--Not later than 2 years after the date 
     of enactment of this section, the Secretary shall publish the 
     best practices under subsection (a)(1) on the internet 
     website of the Department of Health and Human Services.
       ``(e) Technical Assistance.--The Secretary shall provide 
     technical assistance to institutions of higher education, 
     elementary schools, and secondary schools to assist such 
     institutions and schools in implementing the best practices 
     under subsection (a).
       ``(f) Definitions.--In this section:
       ``(1) The term `behavioral intervention team' means a team 
     of qualified individuals who--
       ``(A) are responsible for identifying and assessing 
     individuals exhibiting concerning behaviors, experiencing 
     distress, or who are at risk of harm to self or others;
       ``(B) develop and facilitate implementation of evidence-
     based interventions to mitigate the threat of harm to self or 
     others posed by an individual and address the mental and 
     behavioral health needs of individuals to reduce risk; and
       ``(C) provide information to students, parents, and school 
     employees on recognizing behavior described in this 
     subsection.
       ``(2) The terms `elementary school', `parent', and 
     `secondary school' have the meanings given to such terms in 
     section 8101 of the Elementary and Secondary Education Act of 
     1965.
       ``(3) The term `institution of higher education' has the 
     meaning given to such term in section 102 of the Higher 
     Education Act of 1965.
       ``(4) The term `mental health assessment' means an 
     evaluation, primarily focused on diagnosis, determining the 
     need for involuntary commitment, medication management, and 
     on-going treatment recommendations.
       ``(5) The term `violence risk assessment' means a broad 
     determination of the potential risk of violence based on 
     evidence-based literature.''.

  The SPEAKER pro tempore. Pursuant to House Resolution 1191, the 
gentlewoman from Washington (Mrs. Rodgers) and a Member opposed each 
will control 5 minutes.
  The Chair recognizes the gentlewoman from Washington.
  Mrs. RODGERS of Washington. Mr. Speaker, I yield myself such time as 
I may consume.
  I rise to express my strong support for the Ferguson amendment, which 
would incorporate the language of the bipartisan, House-passed 
Behavioral Intervention Guidelines Act to the underlying package.
  This important amendment authorizes the Substance Abuse and Mental 
Health Services Administration to develop best practices for 
establishing and appropriately using behavioral intervention teams in 
schools.
  Behavioral intervention teams are multidisciplinary teams that 
support students' mental health and wellness by identifying students 
experiencing stress, anxiety, or other behavioral disturbances, and 
conducting intervention and outreach to these students to help manage 
risk.
  These teams are already active in some educational settings, such as 
Texas Tech and the University of California, Los Angeles.
  By acting in a proactive manner to assist students and connecting 
them with needed resources, behavioral intervention teams help schools 
create a safe environment for their students and improve mental health 
outcomes in young people.
  It is more important now than ever that schools and communities have 
guidance on how to provide behavioral health resources and 
interventions for their students to facilitate the early intervention 
and treatment of mental health conditions.
  This amendment will help children get help before their conditions 
worsen or reach a crisis level. I strongly urge a ``yes'' vote on this 
amendment, and I reserve the balance of my time.
  Mr. PALLONE. Madam Speaker, I claim the time in opposition to the 
amendment, but I do not oppose the amendment.
  The SPEAKER pro tempore. Without objection, the gentleman from New 
Jersey is recognized for 5 minutes.
  There was no objection.
  Mr. PALLONE. Madam Speaker, I yield myself such time as I may 
consume.
  Madam Speaker, I rise in support of this amendment. Like the bill 
that passed the House last year, H.R. 2877, and other House-passed 
provisions we hope to include through amendment into the Restoring Hope 
Act, this bipartisan amendment is part of the bipartisan approach 
Ranking Member Rodgers and I have taken since day one with this 
critical bill.
  This amendment requires the Secretary to consult with a range of 
experts, including mental health and education professionals, to 
develop best practices for schools and universities to establish 
behavioral intervention teams to identify concerning behaviors and 
manage risks among students. The guidance must determine how these 
teams can operate effectively while relying on evidence-based, 
objective protection of the constitutional and civil rights of students 
and staff.
  Madam Speaker, I understand that some disability and civil rights 
organizations have concerns about the provisions of this amendment and 
opposed the original bill. I agree that we must be sensitive to the 
concerns of these organizations and not inadvertently perpetuate a 
false association of psychiatric disability and gun violence, nor 
promote the preemptive use of law enforcement to address problematic 
student behaviors, particularly among students with disabilities and/or 
students of color, who are already disproportionately excessively 
disciplined compared to their peers.
  At the same time, I think there is merit to the idea of teams of 
behavioral health specialists working in concert with educators to 
identify youth and college students who may be at risk of harming 
themselves or others and making sure they get the support they need.
  This bill has passed the full House twice, as I said, on suspension, 
both this Congress and last Congress. My understanding is that the 
bill's sponsors have made changes when reintroducing the bill this 
Congress to address some of the stakeholders' concerns by including 
more robust privacy protections and inappropriate referral protections. 
I think these changes improve the bill.
  I understand the stakeholders would like to see additional changes, 
and as I have indicated in the past, I am committed to examining ways 
to address these concerns and add additional guardrails as the bill 
progresses through negotiations with our Senate counterparts, including 
this amendment for consideration for adoption into H.R. 7666, but we 
need to pass the amendment to allow those kinds of negotiations with 
the Senate.
  I look forward to working closely with stakeholders, Congressman 
Ferguson, and the other original leads of H.R. 2877, and, of course, 
our ranking member, to strike the right balance that protects the 
health, privacy, and rights of all students.
  Madam Speaker, I yield back the balance of my time.
  Mrs. RODGERS of Washington. Madam Speaker, I yield back the balance 
of my time.
  The SPEAKER pro tempore. Pursuant to House Resolution 1191, the 
previous question is ordered on the amendment offered by the 
gentlewoman from Washington (Mrs. Rodgers).
  The question is on the amendment offered by the gentlewoman from 
Washington (Mrs. Rodgers).
  The question was taken; and the Speaker pro tempore announced that 
the ayes appeared to have it.
  Mr. PALLONE. Madam Speaker, on that I demand the yeas and nays.
  The SPEAKER pro tempore. Pursuant to section 3(s) of House Resolution 
8, the yeas and nays are ordered.
  Pursuant to clause 8 of rule XX, further proceedings on this question 
are postponed.


                Amendment No. 8 Offered by Mr. Griffith

  The SPEAKER pro tempore. It is now in order to consider amendment No. 
8 printed in part E of House Report 117-381.
  Mr. GRIFFITH. Madam Speaker, I rise to offer my amendment.
  The SPEAKER pro tempore. The Clerk will designate the amendment.
  The text of the amendment is as follows:

       Page 130, after line 3, insert the following:
       (c) Applicability.--The amendments made by this section 
     shall not apply until January 1, 2024.

  The SPEAKER pro tempore. Pursuant to House Resolution 1191, the 
gentleman from Virginia (Mr. Griffith) and a Member opposed each will 
control 5 minutes.
  The Chair recognizes the gentleman from Virginia.
  Mr. GRIFFITH. Madam Speaker, I yield myself such time as I may 
consume.

[[Page H5794]]

  I appreciate the opportunity to present this amendment. This 
amendment would delay the implementation of the MAT Act, section 262, 
until January of 2024.
  Currently, the Act would eliminate the patient cap on the number of 
patients a single healthcare provider can provide buprenorphine to. 
This cap was created originally in 2000 in the Drug Addiction Treatment 
Act, which initially set the cap at 30 patients. Since 2000, the cap 
has been increased several times, and the current law is 275 patients 
per healthcare practitioner.
  This patient cap has never been lifted before or even studied as to 
what the effects would be if it was lifted. This is a complex treatment 
area. Patients don't just need buprenorphine, or its less addictive 
form known by the trade name Suboxone. They need behavioral healthcare 
treatment. They need hands-on, detailed guidance. They need to do a 
long, step-down process, slowly reducing and then eliminating all of 
the opioids that they are using or have used.
  Buprenorphine is also an opioid. It is better than heroin or 
fentanyl, and it can be used as a treatment very effectively. But it 
still can be addictive. There are reports of its sale on the street. 
With no cap on the number of patients, I fear we could see abuse.
  But if we feel this should be a matter for the States to define 
through their medical processes, their medical boards, or their 
legislatures, we need to give them time to take that action. Most State 
legislatures are not currently in session, so the amendment gives the 
States time to take action if they choose to do so.
  The overall bill is good, but I don't want us to be inadvertently 
creating more problems down the road related to buprenorphine.
  Delaying the implementation of the new MAT language until 2024 will 
allow States to analyze what they think is a good cap for their 
population, if they choose to do so at all, but they need the time in 
order to make that decision.
  Accordingly, Madam Speaker, I would ask that we vote ``yes'' on this 
important amendment, and I reserve the balance of my time.
  Mr. PALLONE. Madam Speaker, I claim the time in opposition to the 
amendment.
  The SPEAKER pro tempore. The gentleman from New Jersey is recognized 
for 5 minutes.
  Mr. PALLONE. Madam Speaker, I yield myself 2 minutes.
  Madam Speaker, I thank the gentleman from Virginia for expressing his 
concerns relating to the MAT Act, but I respectfully disagree with his 
proposal.
  First of all, I take issue with some of his characterizations 
regarding buprenorphine. Buprenorphine is not broadly available to all 
Americans who need it. In fact, only 1 in 10 individuals with opioid 
use disorder receive medications for their condition, including 
buprenorphine.
  Over half of all rural counties in the United States do not have a 
single waivered buprenorphine provider, and 40 percent of all counties 
in the United States don't have a single waivered provider, according 
to the HHS-OIG.
  This is a huge treatment gap. A treatment gap for opioid use 
disorders means lives are lost every day unnecessarily when there is 
treatment available. This is tragic and not acceptable.
  Second, the gentleman has made the argument that buprenorphine is not 
effective against fentanyl, but that is not accurate. Buprenorphine is 
proven to reduce fentanyl use and overdose deaths, according to the 
National Academies of Sciences Consensus Report on Medications for 
Opioid Use Disorders and the United States Commission on Combating 
Synthetic Opioid Trafficking.
  Delaying the elimination of the X waiver to 2024 means extending the 
time in which a barrier to treatment is in place, leading to an 
increased risk of overdose and death.
  It is clear that we are experiencing record numbers of overdose 
deaths in America. This is a public health emergency and needs to be 
addressed immediately.
  Buprenorphine is a proven, evidence-based treatment for opioid use 
disorder. Buprenorphine prevents painful withdrawal symptoms, reduces 
opioid cravings, and cuts the risk of overdose in half. This is due to 
buprenorphine's ceiling effect, which makes it nearly impossible to 
overdose on the medication. For these reasons, it is considered safer 
than commonly prescribed medications like insulin and blood thinners.
  Madam Speaker, eliminating the X waiver is a cornerstone of the 
Restoring Hope Act. The MAT Act amendment to this package was adopted 
at markup by a vote of 45-10. It received support from the majority of 
Republicans and Democrats on the committee.

  Further, nothing in this bill limits the ability of States to prepare 
and act on the overdose crisis.
  The SPEAKER pro tempore. The time of the gentleman has expired.
  Mr. PALLONE. Madam Speaker, I yield myself an additional 30 seconds.
  To the contrary, this legislation empowers States to determine the 
appropriate training, licensing requirements, and tools for providers 
who dispense controlled substances and treat patients with substance 
use disorders. All the MAT Act does is remove an unnecessary and 
outdated Federal barrier to States effectively addressing the opioid 
overdose crisis.
  If we don't act now, we risk tens of thousands of additional 
overdoses and unnecessary loss of life. I urge my colleagues to reject 
this amendment, and I reserve the balance of my time.
  Mr. GRIFFITH. Madam Speaker, I yield such time as he may consume to 
the gentleman from Georgia (Mr. Ferguson).
  Mr. FERGUSON. Madam Speaker, I thank my colleague from Virginia for 
yielding.
  Madam Speaker, while I do, in fact, support his amendment, I would 
also like to speak for just a minute on the previous amendment offered 
to H.R. 7666, the BIG Act.
  We have seen over the past couple of years a significant rise in 
mental health issues with our students, whether it is in high school, 
whether it is in middle school, or whether it is in college. We have 
seen the effects of the pandemic, but there are a lot of other things 
that have created this mental health crisis for our children around 
America.
  What our children need are resources, and they need resources at a 
very early age. So what the BIG Act does is it accumulates best 
practices from different schools around the country, and it makes sure 
that we intervene with students early. We want to get these young 
people the resources that they need.

                              {time}  1600

  There are a couple of things about this that we think are very 
important:
  Number one, early intervention has been proven to show that we can 
prevent a catastrophic event. We want students to be healthy and happy 
and functioning. What we would also like to do is limit the interaction 
with law enforcement. We want to make sure that the students are 
getting these resources across the board.
  So this body passed the BIG Act last year, and they did it with wide 
bipartisan support; however, the Senate did not take this bill up. So I 
say, let's do it again. Let's pass it as part of this important 
package.
  Madam Speaker, I thank the chairman and our ranking members for 
making such an effort to get this important piece of legislation across 
the finish line.
  Mr. GRIFFITH. Madam Speaker, may I inquire how much time is 
remaining?
  The SPEAKER pro tempore. The gentleman has 1 minute remaining.
  Mr. GRIFFITH. Mr. Speaker, I reserve the balance of my time.
  Mr. PALLONE. Madam Speaker, I yield such time as he may consume to 
the gentleman from New York (Mr. Tonko).
  Mr. TONKO. Madam Speaker, I rise in strong opposition to the Griffith 
amendment. Not only does this amendment needlessly delay the 
implementation of the MAT Act by another year, it does so with the 
intent of encouraging States to enact more restrictions on 
buprenorphine in the interim, running directly contrary to the intent 
of the underlying bill.
  Let's remember the facts here. We are in the middle of an 
unprecedented crisis. Last year alone, 107,000 were taken from us too 
early by drug overdoses. One all-too-common theme in these deaths is a 
lack of access to

[[Page H5795]]

treatment. Despite being recognized as the gold standard of care that 
can cut the risk of overdose in half, only about 1 in 10 individuals 
with opioid use disorder received medications like buprenorphine to 
treat their addiction. That is a glaring systemic failure.
  H.R. 7666 takes a strong step to address that failure by expanding 
access to safe and effective addiction treatment through eliminating 
the outdated and redundant requirement that healthcare providers obtain 
a special waiver from the DEA to prescribe buprenorphine for the 
treatment of addiction.
  Despite the lifesaving potential this legislation can bring, this 
amendment raises concerns about the impact the MAT Act will have on 
safety, abuse, and diversion, and I would take a moment to directly 
address these concerns.
  Let's start with the basic facts on safety.
  Unlike heroin and fentanyl that are causing overdose deaths, 
buprenorphine is a safe medication that is highly effective at 
protecting people from overdose.
  Due to its ceiling effect, buprenorphine does not cause people to 
feel high and is unlikely to result in substance use disorder or be a 
cause of overdose deaths.
  With regard to diversion and abuse, the DEA, which is responsible for 
policing illicit diversion, has specifically looked at this issue and 
found that the primary reason for buprenorphine diversion is the 
failure to access legitimate treatment, and that increasing, not 
limiting, buprenorphine treatment may be an effective response to 
diversion.
  Indeed, as buprenorphine access has increased over the last 5 years 
through legislation passed by this Congress, misuse of the medication 
has decreased.
  So I would say that it is important for us to be responsible here. We 
are in the midst of a pandemic, an epidemic that is causing great pain, 
great suffering, great death, every day, every week. Every moment we 
circumvent our responsibilities, someone is paying the price for that.
  Madam Speaker, I strongly oppose this amendment.
  Mr. PALLONE. Madam Speaker, I yield back the balance of my time.
  Mr. GRIFFITH. Madam Speaker, I yield 1 minute to the gentlewoman from 
Washington (Mrs. Rodgers).
  Mrs. RODGERS of Washington. Madam Speaker, I appreciate the gentleman 
for yielding.
  Madam Speaker, I rise in support of the Griffith amendment which 
provides additional time for implementation of the provisions of the 
Mainstreaming Addiction Treatment Act included in this bill.
  I supported the inclusion of this language at committee, as I believe 
it will help increase access to substance use disorder treatment, the 
underlying language. However, enacting this language will be a huge 
policy change from the status quo.
  Furthermore, States do regulate the practice of medicine, and each 
State has unique, individual regulations and procedures regarding the 
dispensing and the prescribing of scheduled narcotics. States could use 
the additional time to update their laws with any changes they may want 
now that Federal restrictions will be removed.
  This is exactly what Mr. Griffith's amendment does. It sets the 
implementation date for removing the X waiver requirement to take 
effective on January 1, 2024.
  Madam Speaker, I support this commonsense amendment that will ensure 
that the Mainstreaming Addiction Treatment Act gets appropriately 
implemented.
  Mr. GRIFFITH. Madam Speaker, I yield back the balance of my time.
  The SPEAKER pro tempore. Pursuant to House Resolution Number 1191, 
the previous question is ordered on the amendment offered by the 
gentleman from Virginia (Mr. Griffith).
  The question is on the amendment.
  The question was taken; and the Speaker pro tempore announced that 
the noes appeared to have it.
  Mr. GRIFFITH. Madam Speaker, on that I demand the yeas and nays.
  The SPEAKER pro tempore. Pursuant to section 3(s) of House Resolution 
8, the yeas and nays are ordered.
  Pursuant to clause 8 of rule XX, further proceedings on this question 
are postponed.
  Pursuant to clause 1(c) of rule XIX, further consideration of H.R. 
7666 is postponed.

                          ____________________